Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Nepetalactone | 490-10-8 | C10H14O2 | (4aS,7S,7aR)-4,7-dimethyl-5,6,7,7a-tetrahydrocyclopenta[c]pyran-1(4aH)-one | |
Nepetalacton | 21651-62-7 | C10H14O2 | 166.22 | |
Nepafenac Impurity D | 78281-71-7 | C15H13ClN2O2 | 288.74 | 2-Amino-3-benzoyl-5-chlorobenzeneacetamide; |
Nepafenac D5 | 1246814-53-8 | C15H9D5N2O2 | 259.28 | Nepafenac D5; Nepafenac-d5; Nevanac-d5; AHR 9434-d5; |
Nepafenac | 78281-72-8 | C15H14N2O2 | 254.28 | Nevanac; 2-Amino-3-benzoylbenzeneacetamide; 2-(2-Amino-3-benzoylphenyl)acetamide |
Neoxanthin | 14660-91-4 | C40H56O4 | 600.8702 | NEOXANTHIN; (1R,3S)-6-[(3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1S,4S,6R)-4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenylidene]-1,5,5-trimethyl-cyclohexane-1,3-diol; NEOXANTHIN(SH); (3S,3'S,5 |
Neotuberostemonone | 954379-68-1 | C22H31NO6 | 405.5 | (1R,2R,3S,6R,7S,10S)-2-Ethyl-6-methyl-10-[(2S,4S)-4-methyl-5-oxotetrahydro-2-furanyl]-4-oxa-11-azatricyclo[9.4.1.03,7]hexadecane-5,8,16-trione |
Neotuberostemonine | 143120-46-1 | C22H33NO4 | 375.5 | (2S,7aR,8R,8aR,11S,11aR,11bS,11cR)-8-Ethyl-11-methyl-2-[(2S,4S)-4 -methyl-5-oxotetrahydro-2-furanyl]dodecahydroazepino[3,2,1-hi]fur o[3,2-e]indol-10(2H)-one |
Neotripterifordin | 149249-32-1 | C20H30O3 | 318.45 | |
Neostigmine Methylsulfate | 51-60-5 | C13H22N2O6S | 334.39 | Hodostin; Neostigmeth; [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;methyl sulfate; |
Neostigmine Iodide | 1212-37-9 | C12H19IN2O2 | 350.20 | [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium;iodide;SB 24; TL-1321; |
Neostigmine Bromide | 114-80-7 | C12H19N2O2.Br | 303.2 | N/A |
Neostigmine | 59-99-4 | C12H19N2O2 | 223.33 | CCRIS 3079; CCRIS3079; CCRIS-3079; 3-[[(Dimethylamino)carbonyl]oxy]-N,N,N-trimethylbenzenaminium;Eustigmin;Eustigmine;Vagostigmine;Prostigmin;Polstigmine |
Neostibosan | 554-76-7 | C6H8NO3Sb | 263.89 | 4-Aminobenzenestibonic acid;4-Stibonobenzenamine;Astaril;Bayer-693;Aniline, p-stibono-;Ethylstibamine;Stibosamin;Stibanilic acid |
Neosperidin dihydrochalcone | 20702-77-6 | C28H36O15 | 612.58 | 1-[4-[[2-O-(6-Deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(3-hydroxy-4-methoxyphenyl)-1-propanone |
Neosophoramine | 52932-74-8 | C15H20N2O | 244.3 | Azacycloundecane-2,9-dione,11,11-dimethyl; 11,11-dimethyl-1-azacycloundecane-2,9-dione; 11,12,13,14-tetradehydro-matridin-15-one; |
Neo-rehmannioside | 1333387-64-6 | C21H36O9 | 432.51 | |
Neorauflavene | 53734-75-1 | C21H20O5 | 352.4 | 4-(5-Methoxy-8,8-dimethyl-2H,8H-benzo[1,2-b:5,4-b']dipyran-3-yl)-1,3-benzenediol |
Neorauflavane | 53734-74-0 | C21H22O5 | 354.4 | 4-[(R)-4,8-Dihydro-5-methoxy-8,8-dimethyl-2H,3H-benzo[1,2-b:5,4-b']dipyran-3-yl]-1,3-benzenediol |
Neoprzewaquinone A | 630057-39-5 | C36H28O6 | 556.6 | Neoprzewaquine A |
Neophytadiene | 504-96-1 | C20H38 | 278.52 | 2-(4,8,12-Trimethyltridecyl)buta-1,3-diene; 7,11,15-trimethyl-3-methylidenehexadec-1-ene |
NEOPENTYLLITHIUM | 7412-67-1 | C5H11Li | 78.08 | NEOPENTYLLITHIUM; 1-Lithio-2,2-dimethylpropane; 2,2-Dimethylpropyllithium |
Neopentylglycol-bis-acetoacetate | 14276-67-6 | C13H20O6 | 272.29 | 3-oxobutanoic acid 2,2-dimethyl-1,3-propanediyl ester; Acetoacetic acid 2,2-dimethyltrimethylene ester; 2,2-Dimethyl-1,3-propanediyl acetoacetate; neopentylglycolycol bis acetoacetate |
NEOPENTYLBORONIC ACID | 701261-35-0 | C5H13BO2 | 115.96652 | NEOPENTYLBORONIC ACID; 2,2-Dimethylpropylboronic acid; Neopentylboronic acid / 2,2-Dimethylpropylboronic acid |
NEOPENTYL GLYCOL PROPOXYLATE DIACRYLATE | 84170-74-1 | [H2C=CHCO2(C3H6O)nCH2]2C(CH3)2 | 0 | PROPOXYLATED NEOPENTYL GLYCOL DIACRYLATE; NEOPENTYL GLYCOL PROPOXYLATE DIACRYLATE; 2-ethanediyl)],.alpha.,.alpha.'-(2,2-dimethyl-1,3-propanediyl)bis[.omega.-[(1-oxo-2-propenyl)oxy]Poly[oxy(methyl-1; neopentylglycolpropoxylate(1po/oh)diacrylate; poly[oxy(m |
NEOPENTYL GLYCOL DIGLYCIDYL ETHER, BROMINATED | 31452-80-9 | 11H18Br2O4 | 0 | 1,3-Propanediol,2,2-bis(bromomethyl)-,polymerwith(chloromethyl)oxirane; 3-propanediol,2,2-bis(bromomethyl)-polymerwith(chloromethyl)oxirane; Dibromoneopentylglycol,chloromethyloxiranepolymer; NEOPENTYL GLYCOL DIGLYCIDYL ETHER, BROMINATED; NEOPENTYL GLYCOL |
Neopentyl glycol adipate | 27925-07-1 | C22H38N2O8 | 250.289 | POLY(NEOPENTYL GLYCOL ADIPATE); NEOPENTYL GLYCOL ADIPATE; Adipicacid,neopentylglycolpolyester; Hexanedioicacid,polymerwith2,2-dimethyl-1,3-propanediol; Neopentylglycol,adipicacidpolyester; Neopentylglycol,adipicacidpolymer |
Neolactotetraosylceramide | 153565-90-3 | C62H114N2O23 | 1255.57 | Globosides; Gal (b1-4) GlcNAc (b1-3) Gal (b1-4) Glc b1-1 Ceramide; Lacto-N-neotetraosyl ceramide |
Neokurarinol | 52483-00-8 | C27H34O7 | 470.6 | |
Neokestose | 3688-75-3 | C18H32O16 | 504.44 | O-b-D-Fructofuranosyl-(1,6)-b-D-fructofuranosyl-a-D-glucopyranoside |
Neoagarohexaose | 25023-93-2 | C36H56O28 | 936.81 | |
Neocarrahexadecaose-41,3,5,7,9,11,13,15-octa-O-sulfate sodium salt | 157297-04-6 | C96H138Na8O97S8 | 3284.51 | |
Neocarradecaose-41,3,5,7,9-penta-O-sulfate sodium salt | 133628-75-8 | C60H87Na5O61S5 | 2059.58 | |
Neocarrabiose-4-O-sulfate sodium salt | 108321-76-2 | C12H19NaO13S | 426.33 | |
Neocarrabiose | 6215-96-9 | C12H20O10 | 324.28 | 3-O-(3,6-Anhydro-a-D-galactopyranosyl)-D-galactopyranose |
Neocaesalpin O | 1053189-53-9 | C26H34O10 | 506.542 | (1S,4aR,5S,6R,6aS,7S,11aS,11bS)-4a,7-dihydroxy-4,4,7,11b-tetramethyl-9-oxo-1,2,3,4,4a,5,6,6a,7,9,11a,11b-dodecahydrophenanthro[3,2-b]furan-1,5,6-triyl triacetate |
Neocaesalpin L | 952473-86-8 | C26H36O11 | 524.557 | 14-O-Demethylneocaesalpin M |
Neobyakangelicol | 35214-82-5 | C17H16O6 | 316.3 | (-)-9-(2-Hydroxy-3-methyl-3-butenyloxy)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one |
Neobavaisoflavone | 41060-15-5 | C20H18O4 | 322.36 | 3''-Prenyldaidzein; 7-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]chromen-4-one; |
Neoaureothin | 28900-27-8 | C28H31NO6 | 477.6 | Spectabilin |
Neoaureothin | 59795-94-7 | C28H31NO6 | 477.6 | NSC 260179; Spectinabilin; 2-methoxy-3,5-dimethyl-6-[(4Z)-4-[(2E,4E,6E)-2,4,6-trimethyl-7-(4-nitrophenyl)hepta-2,4,6-trienylidene]oxolan-2-yl]pyran-4-one |
Neoastilbin | 54081-47-9 | C21H22O11 | 450.396 | (2S,3S)-Taxifolin 3-rhamnoside; (2S,3S)-dihydroquercetin 3-O-alpha-L-rhamnoside; (2S,3S)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside |
Neoantimycin | 22862-63-1 | C36H46N2O12 | 698.8 | |
Neoandrographolide | 27215-14-1 | C26H40O8 | 480.60 | 3-[2-[(1R,4a,4aS,5R,8aS)-5-[(b-D-Glucopyranosyloxy)methyl]decanhydro-5,8a-dimethyl-2-methylene-1-naphthalenyl]ethyl]-2(5H)-furanone |
Neoagarotetraose | 16033-31-1 | C24H38O19 | 630.55 | |
Neoagarobiose | 484-58-2 | C12H20O10 | 324.28 | 3-O-(3,6-anhydro-L-galactosyl)-b-D-galactopyranose |
NEO 212 | 1361198-79-9 | C17H20N6O4 | 372.38 | [(4S)-4-Isopropenyl-1-cyclohexen-1-yl]methyl [(3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazin-8-yl)carbonyl]carbamate |
Nemoralisin C | 1443421-84-8 | C20H28O5 | 348.4 | (6S)-6-[(1E,6S)-6-(4,5-Dihydro-5,5-dimethyl-4-oxo-2-furanyl)-6-hydroxy-2-methyl-1-hepten-1-yl]-5,6-dihydro-4-methyl-2H-pyran-2-one |
Nemoralisin | 942480-13-9 | C20H28O4 | 332.4 | 6-[(1E)-6-(5,5-Dimethyl-4-oxo-4,5-dihydro-2-furanyl)-2-methyl-1-h epten-1-yl]-4-methyl-5,6-dihydro-2H-pyran-2-one |
Nemonapride | 75272-39-8 | C21H26ClN3O2 | 387.91 | rel-5-Chloro-2-methoxy-4-(methylamino)-N-[(2R,3R)-2-methyl-1-(phennylmethyl)-3-pyrrolidinyl]benzamide; cis-5-Chloro-2-methoxy-4-(methylamino)-N-[2-methyl-1- (phennylmethyl)-3-pyrrolidinyl]benzamide; Emilace; Emonapride; YM 09151; YM 09151-2 |
Nemadipine A | 54280-71-6 | C19H18F5NO4 | 419.3 | 1,4-Dihydro-2,6-dimethyl-4-(pentafluorophenyl)-3,5-pyridinedicarboxylic acid diethyl ester |
Nemadectin | 102130-84-7 | C36H52O8 | 612.8 | S541A, LL-F28249 alpha |
Nelumol A | 77836-86-3 | C21H30O4 | 346.5 | (2E)-3-[4-[[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]oxy]-3,5-dimethoxyphenyl]-2-propen-1-ol |
Nelotanserin | 839713-36-9 | C18H15BrF2N4O2 | 437.24 | 1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea;APD 125 |
Nelonicline | 1026134-63-3 | C17H19N3OS | 313.42 | (3R,4S,5S)-4-((5-Phenyl-1,3,4-thiadiazol-2-yl)oxy)-1-azaadamantane;ABT-126;ABT126;2-(((3R,4r,5S,7s)-1-azaadamantan-4-yl)oxy)-5-phenyl-1,3,4-thiadiazole |
Nelociguat | 625115-52-8 | C19H17FN8O2 | 408.39 | Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate;Carbamic acid, N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-pyrimidinyl]-, methyl ester;N-Desmethyl Riociguat;Riociguat Imp |
Nelfinavir-d3 | 1217629-70-3 | C32H42D3N3O4S | 570.8 | (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide |
Nelfinavir Sulfoxide Impurity (Impurity B) | 1041389-28-9 | C32H45N3O5S | 583.8 | Nelfinavir Sulfoxide; (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfinyl)butyl]-3-isoquinolinecarboxamide; USP Nelfinavir Related Compound A; |
Nelfinavir Sulfone Impurity (Impurity C) | 1041389-29-0 | C32H45N3O6S | 599.8 | Nelfinavir Sulfone; (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfonyl)butyl]-3-isoquinolinecarboxamide; |
Nelfinavir Regeoisomer (Impurity D) | 159878-04-3 | C32H45N3O4S | 567.8 | [3S-(3S,4aS,8aS,2'R,3'R)]-2-[3'-N-CBz-amino-2'-hydroxy-4'-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide; [(1R,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-Dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-[(phenylthio)methyl]propyl] |
Nelfinavir Oxazole Impurity (Impurity A) | 188936-07-4 | C26H39N3O4 | 457.62 | |
Nelfinavir Mesylate | 159989-65-8 | C33H49N3O7S2 | 663.89 | AG-1341 |
Nelfinavir Hydroxy-tert-butylamide | 213135-56-9 | C32H45N3O5S | 583.8 | Nelfinavir Hydroxy-tert-butylamide; (3S,4aS,8aS)-Decahydro-N-(2-hydroxy-1,1-dimethylethyl)-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide; |
Nelfinavir | 159989-64-7 | C32H45N3O4S | 567.78 | Viracept; AG 1341; AG-1341; AG1341 |
Nelarabine | 121032-29-9 | C11H15N5O5 | 297.27 | Arranon, 506U78, GW506U78; GW-506U78; GW 506U78; Nelarabine; NSC-686673; NS-686673; NSC686673; |
Neladenoson dalanate | 1239309-58-0 | C35H34ClN7O4S2 | 716.27 | BAY 10-67197;2-[4-[2-[[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methylsulfanyl]-3,5-dicyano-6-pyrrolidin-1-ylpyridin-4-yl]phenoxy]ethyl (2S)-2-[[(2S)-2-aminopropanoyl]amino]propanoate |
Negundonorin A | 1401618-51-6 | C29H40O5 | 468.634 | |
Negsehisandrin G | 1023744-69-5 | C28H36O7 | 484.589 | Angeloyl-(+)-gomisin K3 |
Naringin | 10236-47-2 | C27H32O14 | 580.53 | Aurantiin; AI3-19008; AI319008; AI3 19008; Naringin; Naringoside |
Nefopam-d3 N-Oxide | 1346603-50-6 | C17H16NO2D3 | 272.36 | 3,4,5,6-Tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine 5-Oxide- d3 |
Nefopam-d3 | 1346603-30-2 | C17H16NOD3 | 256.37 | 3,4,5,6-Tetrahydro-5-(methyl-d3)-1-phenyl-1H-2,5-benzoxazocine Hydrochloride; |
Nefopam Hydrochloride | 23327-57-3 | C17H19NO.HCl | 289.8 | Nefopam Hydrochloride |
Nefiracetam | 77191-36-7 | C14H18N2O2 | 246.3 | |
Neferine | 2292-16-2 | C38H44N2O6 | 4-[(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-methylisoquinolin-1-yl)methyl]-2-[[1,2,3,4-tetrahydro-6-methoxy-1-[(4-methoxyphenyl)methyl]-2-methylisoquinolin-7-yl]oxy]phenol; 4''-O-Methylliensinine; Methylliensinine; Phenol,4-[[(1S)-1,2,3,4-tetrahydro-6,7-diMeth | |
Nefazodone HCl | 82752-99-6 | C25H33Cl2N5O2 | 506.46 | BMY 13754; BMY13754; BMY-13754; Dutonin; Nefazodone HCl; Rulivan; MJ 13754 1; MJ-13754-1; MJ137541. 3H-1,2,4-Triazol-3-one, 2-3-4-(3-chlorophenyl)-1-piperazinylpropyl-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-, monohydrochloride;Nefazodone HCl;BMY-13754;MJ-1 |
NEFAZODONE | 83366-66-9 | C25H32ClN5O2 | 470.01 | 2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one;82752-99-6(HYDROCHLORIDE) |
Nedocromil | 69049-73-6 | C19H17NO7 | 371.34 | FPL 59002 |
Nedaplatin | 95734-82-0 | C2H8N2O3Pt | 303.17 | |
Necrox-5 (methanesulfonate) | 1383718-29-3 | C25H31N3O3S.2CH4O3S | 645.8 | 5-[(1,1-dioxido-4-thiomorpholinyl)methyl]-2-phenyl-N-[(tetrahydro-2H-pyran-4-yl)methyl]-1H-indol-7-amine, dimethanesulfonate; Necrosis Inhibitor 5 |
Necrosulfonamide | 1360614-48-7 | C18H15N5O6S2 | 461.47 | (2E)-N-[4-[[(3-Methoxy-2-pyrazinyl)amino]sulfonyl]phenyl]-3-(5-nitro-2-thienyl)-2-propenamide |
Necrostatin-5 | 337349-54-9 | C19H17N3O2S2 | 383.5 | Nec-5; 2-[[3,4,5,6,7,8-hexahydro-3-(4-methoxyphenyl)-4-oxo[1]benzothieno[2,3-d]pyrimidin-2-yl]thio]-acetonitrile; 3-p-methoxyphenyl-5,6-tetramethylenothieno[2,3-d]pyrimidin-4-one-2-mercaptoethylcyanide |
Necrostatin-1 Inactive Control | 64419-92-7 | C12H11N3OS | 245.3 | Nec-1i; 5-(Indol-3-ylmethyl)-2-thiohydantoin |
Necrostatin-1 | 4311-88-0 | C13H13N3OS | 259.33 | |
Necrostatin 2 S enantiomer | 852391-20-9 | C13H12ClN3O2 | 277.71 | |
Necrostatin 2 racemate | 852391-15-2 | C13H12ClN3O2 | 277.71 | |
Necrostatin 2 | 852391-19-6 | C13H12ClN3O2 | 277.71 | 2,4-Imidazolidinedione, 5-[(7-chloro-1H-indol-3-yl)methyl]-3-methyl-, (5R)- |
Nebumetone Impurity D | 113-52-0 | C19H25ClN2 | 316.87 | 10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride; Chrytemin; Imiprin; G-22355; Tofranil; |
Nebumetone Impurity B | 343272-51-5 | C19H22N2 | 278.4 | 5-(6-Methoxy-2-naphthalenyl)-3-methyl-2-vyclohexen-1-one; |
Nebumetone Impurity A | 343272-52-6 | C18H20O2 | 268.36 | 3-(6-Methoxy-2-naphthalenyl)-5-methylcyclohexanone; |
Nebularine | 550-33-4 | C10H12N4O4 | 252.23 | |
Nebramcyin | 11048-13-8 | |||
Nebracetam | 116041-13-5 | C12H16N2O | ||
Nebivolol Impurity II HCl (SS,RS) | 920299-27-0 | C22H25F2NO4. HCl | 441.91 | |
Nebivolol Impurity I HCl (RR,SR) | 920275-20-3 | C22H25F2NO4. HCl | 441.91 | |
Nebivolol Impurity C (Mixture of Diastereomers) | 99199-90-3 | C11H11FO2 | 194.21 | 6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; |
Nebivolol Impurity 5 | 99199-91-4 | C17H18FNO2 | 287.34 | |
Nebivolol Impurity 4 | 129050-29-9 | C17H18FNO2 | 287.34 | |
Nebivolol Impurity 3 | 1029684-20-5 | C17H18FNO2 | 287.34 | |
Nebivolol Impurity 2 HCl (SR,RS) | 920275-19-0 | C22H25F2NO4. HCl | 441.91 | |
Nebivolol Impurity 14 (D-Nebivolol) (SR,RR) HCl | 213132-06-0 | C22H25F2NO4. HCl | 441.91 | |
Nebivolol Impurity 13 HCl (SS,SS) | 920275-27-0 | C22H25F2NO4. HCl | 441.91 | |
Nebivolol Impurity 12 HCl (RR,RR) | 920275-25-8 | C22H25F2NO4. HCl | 441.91 | |
Neamine hydrochloride | 15446-43-2 | C12H26N4O6 4HCl | 468.20 | 2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-a-D-glucopyranosyl)-D-streptamine hydrochloride; Neomycin A tetrahydrochloride |
Neamine Disulfate | 71155-47-0 | C12H26N4O6. 2 H2O4S | 322.36 2 98.08 | |
NE 100 hydrochloride | 149409-57-4 | C23H33NO2.HCl | 391.97 | 4-Methoxy-3-(2-phenylethoxy)-N,N-dipropylbenzeneethanamine hydrochloride |
NDT 9513727 | 439571-48-9 | C36H35N3O4 | 573.68 | N,N-Bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-Imidazole-5-methanamine |
n-Dotriacontanol | 6624-79-9 | C32H66 O | 466.86600 | |
NDMC101 | 1308631-40-4 | C13H9ClFNO2 | 265.7 | N-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide |
N-Diphenylmethylene-O-(2,3,6,2,3,4,6-hepta-O-acetyl-b-D-lactosyl)-L-serine, benzyl ester | 337903-59-0 | C49H55NO20 | 977.96 | N-(Diphenylmethylene)-O-[2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-b-D-glucopyranosyl]-L-serine phenylmethyl ester |
N-Diphenylmethyl 2,5-anhydro-2,5-imino-D-glucitol | 132198-31-3 | C19H23NO4 | 329.39 | (2R,3R,4R,5S)-1-(Diphenylmethyl)-3,4-dihydroxy-2,5-pyrrolidinedimethanol |
N-Dimethyl Rivastigmine (Rivastigmine EP Impurity B) | 25081-93-0 | C13H20N2O2 | 236.32 | Dimethylcarbamic Acid 3-[1-(Dimethylamino)ethyl]phenyl Ester; Dimethylcarbamic Acid m-[1-(Dimethylamino)ethyl]phenyl Ester; m-[1-(dimethylamino)ethyl]phenolDimethylcarbamate (ester); USP Rivastigmine Related Compound B |
N-Didesmethyl Trimebutine-d5 HCl | 1189893-33-1 | C20H20NO5D5·HCl | 400.91 | N,N-Didesmethyl Trimebutine-d5 Hydrochloride; 3,4,5-Trimethoxybenzoic Acid 2-Amino-2-phenylbutyl-d5 Ester Hydrochloride |
N-Didesmethyl Trimebutine HCl | 84333-60-8 | C20H25NO5.HCl | 395.88 | N,N-Didesmethyl Trimebutine Hydrochloride; 3,4,5-Trimethoxybenzoic Acid 2-Amino-2-phenylbutyl Ester Hydrochloride |
N-Despropyl-macitentan | 1103522-45-7 | C16H14Br2N6O4S | 546.19 | N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-sulfamide, ACT-132577 |
N-Despropyl Ropinirole HCl | 173990-76-6 | C13H18N2O. HCl | 254.76 | 4-[2-(Propylamino)ethyl]-1,3-dihydro-2H-indol-2-one Hydrochloride; 1,3-Dihydro-4-[2-(propylamino)ethyl]-2H-indol-2-one Hydrochloride; SKF 104557 Hydrochloride; |
N-Despropyl propafenone HCl | 1188263-52-6 | C18H21NO3.HCl | 335.83 | 1-[2-(3-Amino-2-hydroxypropoxy)phenyl]-3-phenyl-1-propanone Hydrochloride |
N-Desmethyl-PK 11195 | 124236-61-9 | C20H19ClN2O | 338.83 | 3-Isoquinolinecarboxamide, 1-(2-chlorophenyl)-N-(1-methylpropyl)-; ACMC-1C1J3; N-butan-2-yl-1-(2-chlorophenyl)isoquinoline-3-carboxamide |
N-DESMETHYLCLOMIPRAMINE HYDROCHLORIDE | 303-48-0 | C18H22Cl2N2 | 337.29 | NORCLOMIPRAMINE HYDROCHLORIDE; desmethylclomipramine; 5H-Dibenzb,fazepine-5-propanamine, 3-chloro-10,11-dihydro-N-methyl-; n-desmethylclomipramine; N-DESMETHYLCLOMIPRAMINE,1.0MG/MLINMETHANOL; 3-Chloro-10,11-dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propana |
N-Desmethyl zopiclone-d8 Hydrochloride | 1189719-74-1 | C16H8D8Cl2N6O3 | 419.29 | (Piperazine-d8)-1-carboxylic Acid 6-(5-Chloro-pyridin-2-yl)-7-oxo-6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5yl Ester Hydrochloride; |
N-Desmethyl Tramadol HCl | 1018989-94-0 | C15H23NO2. HCl | 285.82 | N-Demethyltramadol Hydrochloride; (1R,2R)-rel-1-(3-Methoxyphenyl)-2-[(methylamino)methyl]-cyclohexanol Hydrochloride; cis-(+/-)-N-Demethyltramadol;N-Monodesmethyltramadol Hydrochloride |
N-Desmethyl zopiclone Hydrochloride | 59878-63-6 | C16H16Cl2N6O3 | 411.24 | Piperazine-1-carboxylic Acid 6-(5-Chloro-pyridin-2-yl)-7-oxo-6,7-dihydro- 5H-pyrrolo[3,4-b]pyrazin-5yl Ester Hydrochloride |
N-Desmethyl Zolmitriptan-d3 | 1217623-11-4 | C15H16N3O2D3 | 276.36 | (4S)-4-[[3-[2-(Methyl-d3-amino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone; 183C91-d3 |
N-Desmethyl Zolmitriptan | 139264-35-0 | C15H19N3O2 | 273.34 | (4S)-4-[[3-[2-(Methylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone; 183C91; Zolmitriptan USP Related Compound A |
N-Desmethyl Vandetanib | 338992-12-4 | C21H22BrFN4O2 | 461.34 | N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-(4-piperidinylmethoxy)-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(piperidin-4-yl)methoxy]quinazoline |
N-Desmethyl Trimebutine-d5 HCl | 1286632-72-1 | C21H22NO5D5·HCl | 414.93 | N-Demethyl Trimebutine-d5 Hydrochloride; 3,4,5-Trimethoxybenzoic Acid 2-(Methylamino)-2-phenylbutyl-d5 Ester Hydrochloride; N-Monodesmethyltrimebutine-d5 Hydrochloride; JO 1069-d5 Hydrochloride |
N-Desmethyl Trimebutine HCl | 294882-33-0 | C21H27NO5. HCl | 409.9 | N-Demethyl Trimebutine Hydrochloride; 3,4,5-Trimethoxybenzoic Acid 2-(Methylamino)-2-phenylbutyl Ester Hydrochloride; N-Monodesmethyltrimebutine Hydrochloride; JO 1069 Hydrochloride; Nortrimebutine Hydrochloride |
N-Desmethyl sildenafil-d8 | 1185168-06-2 | C21H20N6O4SD8 | 468.61 | 5-[2-Ethoxy-5-(1-piperazinylsulfonyl)phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one-d8; Desmethylsildenafil-d8; UK 103320-d8 |
N-Desmethyl Toremifene | 110503-61-2 | C25H26ClNO | 391.95 | 2-[4-[(1Z)-4-Chloro-1,2-diphenyl-1-buten-1-yl]phenoxy]-N-methylethanamine; (Z)-4-Chloro-1,2-diphenyl-1-[4-[2-(N-methylamino)ethoxy]phenyl]-1-butene |
N-Desmethyl Topotecan | 190710-79-3 | C23H23N3O5 | 407.43 | (4S)-4-Ethyl-4,9-dihydroxy-10-[(methylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione |
N-Desmethyl Tamoxifen HCl | 15917-65-4 | C25H27NO.HCl | 393.96 | (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N-methylethanamine Hydrochloride; N-Demethyltamoxifen Hydrochloride; N-Desmethyl Tamoxifen Hydrochloride |
N-Desmethyl Sildenafil | 139755-82-1 | C21H28N6O4S | 460.56 | 5-[2-Ethoxy-5-(1-piperazinylsulfonyl)phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; Desmethylsildenafil; UK 103320; |
N-Desmethyl Rifampicin | 13292-45-0 | C42H56N4O12 | 808.93 | 3-[(1-Piperazinylimino)methyl]-rifamycin; 3-Piperazinoiminomethyl Rifamycin SV; 4-N-Demethylrifampicin; AF/AP; Demethylrifampicin; N-Demethylrifampicin; N-Demethylrifampin; NSC 143416; Rifampicin AF/AP; Rifampin |
N-Desmethyl Rosiglitazone-d4 | 1215407-67-2 | C17H13N3O3SD4 | 347.43 | 5-[[4-[2-(2-Pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione-d4; SB 237216-d4 |
N-Desmethyl rosiglitazone | 257892-31-2 | C17H17N3O3S | 343.41 | 5-[[4-[2-(2-Pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione; SB 237216; |
N-Desmethyl Rivastigmine | 1070660-34-2 | C13H20N2O2 | 236.32 | N-Ethylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester |
N-Desmethyl Regorafenib N-Oxide (M5 Metabolite) | 835621-12-0 | C20H13ClF4N4O4 | 484.79 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-2-pyridinecarboxamide 1-Oxide |
N-Desmethyl Regorafenib | 1343498-72-5 | C20H13ClF4N4O3 | 468.79 | BAY-751098; BAY 751098; BAY751098; Regorafenib metabolite M4;UNII-58I22S7HYD;4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)picolinamide |
N-Desmethyl Prochlorperazine-d8 Dimaleate Salt | 1246817-68-4 | C27H22D8ClN3O8S | 600.11 | 2-Chloro-10-[3-(1-piperazinyl)propyl]-phenothiazine-d8 Dimaleate |
N-Desmethyl Prochlorperazine Dimaleate | 13500-92-0 | C19H22ClN3S 2 C4H4O4 | 359.92 2x116.07 | |
N-Desmethyl Dofetilide | 176447-94-2 | C18H25N3O5S2 | 427.54 | N-[4-[2-[[2-[4-[(Methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide |
N-Desmethyl Orphenadrine | 15301-93-6 | C17H21NO | 255.36 | methyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine; |
N-Desmethyl Netupitant | 290296-72-9 | C29H30F6N4O | 564.576 | 2-[3,5-bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-piperazin-1-ylpyridin-3-yl]propanamide Netupitant metabolite N-desmethyl Netupitant SCHEMBL1399508 SRVSDBHUBFLSFE-UHFFFAOYSA-N |
N-Desmethyl Nefopam HCl | 147656-98-2 | C16H17NO. HCl | 239.32 36.46 | |
N-Desmethyl Mephenytoin-d5 | 119458-27-4 | (±)-5-Ethyl-5-phenyl-D5- imidazolidine-2,4-dione | ||
N-Desmethyl eletriptan hydrochloride | 1391054-78-6 | C21H24N2O2S.HCl | 404.95 | (R)-5-[2-(Phenylsulfonyl)ethyl]-3-(2-pyrrolidinylmethyl)-1H-indole Hydrochloride |
N-Desmethyl Doxepin HCl | 2887-91-4 | C18H19NO·HCl | 301.816 | |
N-Desmethyl Dovitinib-d8 | 1246814-93-6 | C20H11FN6OD8 | 386.45 | 4-Amino-5-fluoro-3-[6-(1-piperazinyl-d8)-1H-benzimidazol-2-yl]-2(1H)-quinolinone |
N-Desmethyl Dovitinib | 668432-44-8 | C20H19FN6O | 378.41 | 4-Amino-5-fluoro-3-[6-(1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone |
N-Desmethyl dextrorpan O-b-D-glucuronide | 19153-89-0 | C22H29NO7 | 419.48 | |
N-Desmethyl Dapoxetine HCl | 157166-71-7 | C20H22ClNO | 327.86 | |
N-Desmethyl clozapine-d8 | 1189888-77-4 | C17H9ClD8N4 | 320.9 | Norclozapine-d8; 3-chloro-6-(2,2,3,3,5,5,6,6-octadeuteriopiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine |
N-Desmethyl clozapine | 6104-71-8 | C17H17ClN4 | 312.80 | Norclozapine; Desmethylclozapine; 3-chloro-6-piperazin-1-yl-11H-benzo[b][1,4]benzodiazepine |
cis-exo-5-Norbornene-2,3-Dicarboximide | 6319-06-8 | C9H9NO2 | 163.17 | Noreximide |
N-Desmethyl Clomipramine Hydrochloride | 29854-14-6 | C18H22Cl2N2 | 337.29 | 3-Chloro-10,11-dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride; Chlordesipramine Hydrochloride; Demethylchlorimipramine Hydrochloride; Norchlorimipramine Hydrochloride; Norclomipramine Hydrochloride |
N-Desmethyl Clomipramine D3 hydrochloride | 1189971-04-7 | C18H19D3Cl2N2 | 340.31 | 3-Chloro-10,11-dihydro-N-(methyl-d3)-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride; Chlordesipramine-d3 Hydrochloride; Demethylchlorimipramine-d3 Hydrochloride; Norchlorimipramine-d3 Hydrochloride; Norclomipramine-d3 Hydrochloride |
N-Desmethyl Clarithromycin | 101666-68-6 | C37H67NO13 | 733.93 | N-Demethyl-6-O-methylerythromycin; 3"-N-Demethylclarithromycin; N-(Desmethyl)clarithromycin; N-Demethylclarithromycin; USP Clarithromycin Impurity D" |
N-desmethyl bendamustine | 41515-13-3 | C15H19Cl2N3O2 | 344.24 | nor-Bendamustine; 4-[6-[bis(2-chloroethyl)amino]-1H-benzimidazol-2-yl]butanoic acid |
N-Desmethyl Azelastine | 47491-38-3 | C21H22ClN3O | 367.88 | Desmethylazelastine; 4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1H-azepin-4-yl)-1(2H)-phthalazinone; Azelastine Hydrochloride Impurity |
N-Desethyl Etifoxine | 21715-43-5 | C15H13ClN2O | 272.74 | 6-Chloro-4-methyl-4-phenyl-4H-3,1-benzoxazin-2-amine; 2-Amino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine; |
N-Desbutyl Dronedarone-d6 HCl | 1346598-70-6 | C27H30N2O5SD6·HCl | 543.157 | Desbutyl Dronedarone-d6 HCl; DTXSID10747515; SR 35021-d4; Desbutyl Dronedarone-d4 Hydrochloride; FT-0665950 |
N-Desbutyl Dronedarone HCl | 197431-02-0 | C27H36N2O5S·HCl | 537.11 | N-[2-Butyl-3-[4-[3-(butylamino)propoxy]benzoyl]-5-benzofuranyl]-methanesulfonamide Hydrochloride |
N-Desalkyl itraconazole | 1427177-48-7 | C31H30Cl2N8O4 | 649.54 | cis-4-[4-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-3H-1,2,4-triazol-3-one; |
N-Desacetyl-N-formyl Thiocolchicoside | 219547-29-2 | C26H31NO10S | 549.59 | N-[(7S)-3-(b-D-Glucopyranosyloxy)-5,6,7,9-tetrahydro-1,2-dimethoxy-10-(methylthio)-9-oxobenzo[a]heptalen-7-yl]formamide |
N-Desacetyl-N,O-descarbonyl O-Acetyl Linezolid | 333753-71-2 | C15H22FN3O3 | 311.35 | (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol 2-Acetate; (2S)-1-Amino-3-[[3-fluoro-4-(4-morpholinyl)phenyl]amino]-2-propanol Acetate (Ester) |
N-Desacetyl Thiocolchicoside | 177991-81-0 | C25H31NO9S | 521.58 | (S)-7-Amino-1,2-dimethoxy-10-(methylthio)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6,7-dihydrobenzo[a]heptalen-9(5H)-one |
N-Desacetyl Lacosamide HCl | 1322062-76-9 | C11H17ClN2O2 | 244.72 | 2-Amino-N-benzyl-3-methoxy-propionamide HCl |
N-Des[2-(2-hydroxyethoxy)ethyl] Quetiapine Dihydrochloride | 111974-74-4 | C17H17N3S. 2 HCl | 368.32 | 11-(1-Piperazinyl)-dibenzo[b,f][1,4]thiazepine Dihydrochloride; DBTP; Norquetiapine; Quetiapine EP Impurity B; |
N-Demethyllincomycin | 2256-16-8 | C17H32N2O6S | 392.51 | (2S-trans)-Methyl 6,8-dideoxy-6-(4-propyl-2-pyrrolidinecarboxamido)-1-thio-D-erythro-D-galacto-octopyranoside; Antibiotic U-11973E; Lincomycin D; Lincomycin EP Impurity C |
N-Demethylerythromycin A | 992-62-1 | C36H65NO13 | 719.92 | N-Desmethyl Erythromycin A; |
N-Demethylechitamine | 60048-88-6 | C21H26N2O4 | 370.449 | Methyl (1s,9r,10s,12s,13e)-13-ethylidene-10-hydroxy-18-(hydroxymethyl)-8,15-diazapentacyclo[10.5.1.01,9.02,7.09,15]octadeca-2,4,6-triene-18-carboxylate |
N-demethyl-6-O-methyl-N-[(phenylmethoxy)carbonyl]-2'-(phenylmethylcarbonate) Erythromycin | 81103-10-8 | C53H79NO17 | 1002.19 | Oxacyclotetradecane Erythromycin Deriv. |
N-Demethyl Vandetanib-D4 | 1346603-93-7 | C21H18BrFN4O2D4 | 465.36 | N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[4-(piperidinyl-d4)methoxy]-4-quinazolinamine; 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[[(piperidin-4-yl)-d4]methoxy]quinazoline |
N-Demethyl Olanzapine | 161696-76-0 | C16H18N4S | 298.408 | 2-methyl-4-(1-piperazinyl)-10H-Thieno[2,3-b][1,5]benzodiazepine; 4'-Desmethylolanzapine; Desmethylolanzapine; LY 170055; N-Demethylolanzapine |
N-Deformyl-N-pivaloyl Orlistat | 1356017-35-0 | C33H61NO5 | 551.86 | N-Deformyl-N-pivaloyl Orlistat; N-Desformyl-N-pivaloyl Orlistat; |
N-Deformyl-N-benzyloxycarbonyl Orlistat | 108051-94-1 | C36H59NO6 | 601.87 | N-Deformyl-N-benzyloxycarbonyl Orlistat; N-[(Phenylmethoxy)carbonyl]-L-Leucine (1S)-1-[[(2S,3S)-3-Hexyl-4 -oxo-2-oxetanyl]methyl]dodecyl Ester; |
N-Decyl-N,N-dimethyl-1-decanaminium bicarbonate | 148788-55-0 | C23H49NO3 | 387.64006 | N-Decyl-N,N-dimethyl-1-decanaminium bicarbonate; 1-Decanaminium, N-decyl-N,N-dimethyl-, carbonate (2:1); DIDECYL DIMETHYLAMMONIUM CARBONATE |
N-Dansylethylenediamine | 35060-08-3 | C14H19N3O2S | 293.38 | |
ND-646 | 1434639-57-2 | C28H32N4O7S | 568.645 | BCP29105; ND 646; CS-7887; 2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanamide |
NCS-382 | 520505-01-5 | C13H14O3 | 218.25 | 6,7,8,9-Tetrahydro-5-hydroxy-5H-benzocyclohept-6-ylideneacetic acid |
NCRW0005-F05 | 342779-66-2 | C16H13F2NO2 | 289.28 | 3,3-difluoro-4-(4-methoxyphenyl)-1-phenylazetidin-2-one |
ND-630 | 1434635-54-7 | C28H31N3O8S | 569.63 | 2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid |
N-Cocoalkyl-1,3-diaminopropane | 61791-63-7 | 73.1181 | N-Cocoalkyl-1,3-diaminopropane; N-Coconut-1,3-propyl diamine | |
NCL 00017509 | 1507367-00-1 | C15H12N6O | 292.3 | 3-[(6-Ethynyl-9H-purin-2-yl)amino]benzeneacetamide |
N-Cilexetil Candesartan Ethyl Ester | 1391054-45-7 | C35H38N6O6 | 638.73 | Ethyl-1-([2'-[1-(1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl)-2-ethoxy-1H-benzimidazole-7-carboxylate; |
N-Chloroethyl-N-Ethylaniline | 92-49-9 | C10H14ClN | 183.68 | N-ETHYL-N-CHLOROETHYL ANILINE; N-CHLOROETHYL-N-ETHYLANILINE; 2-(n-ethylanilino)ethylchloride; 4-chloro-n,n-diethyl-anilin; emery5770; ethyl(chloroethyl)aniline; n-(2-chloroethyl)-n-ethyl-anilin; n-(2-chloroethyl)-n-ethyl-benzenamin |
NCGC00244536 | 2003260-55-5 | C25H22N2O2 | 382.45 | 3-(8-hydroxyquinolin-6-yl)-N-(3-phenylpropyl)benzamide; CHEMBL3785491; BDBM50158844 |
NCC-149 | 1316652-41-1 | C16H14N4O2S | 326.37 | N-hydroxy-3-(1-((phenylthio)methyl)-1H-1,2,3-triazol-4-yl)benzamide |
Z-Val-Gly-Arg p-nitroanilide acetate salt | 86170-43-6 | C29H40N8O9 | 644.68 | Chromozym Try |
N-Cbz-trans-1,4-cyclohexanediamine | 149423-77-8 | C14H20N2O2 | 248.32 | 1-N-CBZ-TRANS-1,4-CYCLOHEXYLDIAMINE; N-CBZ-TRANS-1,4-CYCLOHEXANEDIAMINE; TRANS-(4-AMINO-CYCLOHEXYL)-CARBAMIC ACID BENZYL ESTER; N-Cbz-trans-1,4-cyclohexanediaminehydrochloride |
N-Cbz-N'-BoC-L-ornithine | 7733-29-1 | C18H26N2O6 | 366.41 | CBZ-ORN(BOC)-OH; N-ALPHA-BENZYLOXYCARBONYL-N-DELTA-BOC-L-ORNITHINE; N-ALPHA-BENZYLOXYCARBONYL-N-DELTA-T-BUTYLOXYCARBONYL-L-ORNITHINE; N-ALPHA-BENZYLOXYCARBONYL-N-DELTA-TERT-BUTYLOXYCARBONYL-L-ORNITHINE; N-ALPHA-CARBOBENZOXY,N-DELTA-T-BUTOXYCARBONYL-L-ORNI |
N-Cbz-L-Aspartic acid 4-tert-butyl ester | 5545-52-8 | C16H21NO6 | 323.34 | CBZ-L-ASPARTIC ACID 4-TERT-BUTYL ESTER; N-CBZ-L-ASPARTIC ACID 4-TERT-BUTYL ESTER; N-BENZYLOXYCARBONYL-L-ASPARTIC ACID 4-TERT-BUTYL ESTER; Z-ASPARTIC ACID(OTBU)-OH; Z-ASP(OTBU)-OH; Z-L-ASPARTIC ACID 4-TERT-BUTYL ESTER |
N-Cbz-D-glucosamine | 16684-31-4 | C14H19NO7 | 313.3 | 2-N-Carboxybenzyl-2-deoxy-D-glucosamine; 2-(Benzyloxycarbonylamino)-2-deoxy-D-glucose |
N-BUTYLTRIETHYLAMMONIUM CHLORIDE | 24344-65-8 | C10H24ClN | 193.76 | N-BUTYLTRIETHYLAMMONIUM CHLORIDE; N-Butyl-N,N,N-triethylammonium chloride |
n-Butyltin HydrOxide Oxide Hydrate | 2273-43-0 | C4H10O2Sn | 208.83 | |
N-Butyl-N-ethylethane-1,2-diamine | 94279-45-5 | C12H26Mg | 194.63984 | N-Butyl-N-ethylethane-1,2-diamine; n-Butyl-n-octylmagnesium |
n-Butylmagnesium Bromide 1.0 M In Tetrahydrofuran | 693-03-8 | C4H9BrMg | 161.32300 | |
n-Butylidenephthalide | 551-08-6 | C12H12O2 | 188.22 | N-BUTYLIDENEPHTHALIDE; 3-BUTYLIDENEPHTHALIDE; FEMA 3333; BUTYLIDENE PHTHALIDE; 1(3H)-Isobenzofuranone,3-butylidene-; 3-butylidene-1(3h)-isobenzofuranon; 3-butylidene-1(3H)-Isobenzofuranone; 3-butylidene-phthalid |
n-Butylethylmagnesium | 62202-86-2 | C6H14Mg | 110.48 | butylethyl-magnesiu; N-BUTYLETHYLMAGNESIUM; butylethylmagnesium; Magnesium, butylethyl-; N-BUTYLETHYLMAGNESIUM, 1,3M SOLUTION IN HEPTANE; N-BUTYLETHYLMAGNESIUM, 0.9M SOLUTION IN HEPTANE; n-Butylethylmagnesium1.3M solution in heptaneAcroSeal§3; n-Butylethy |
N-Butyldeoxymannojirimycin HCl | 155501-85-2 | C10H21NO4 HCl | 255.74 | N-Butyldeoxymannojirimycin hydrochloride; (2R,3R,4R,5R)-1-Butyl-2-(hydroxymethyl)-3,4,5-piperidinetriol hydrochloride |
N-Butylacetamide | 1119-49-9 | C6H13NO | 115.17 | N-Butylacetamide; N-Butyl-N-phenyl acetamide |
N-Butyl-2-chloro-acetamide | 5349-24-6 | C6H12ClNO | 149.62 | ASINEX-REAG BAS 02927056; N-BUTYL-2-CHLORO-ACETAMIDE; TIMTEC-BB SBB010319; N-butyl-2-chloro-ethanamide |
n-BUTYL TIGLATE | 7785-66-2 | C9H16O2 | 156.23 | 2-Butenoic acid, 2-methyl-, butyl ester, (2E)-, Butyl 2-methylcrotonate (E), n-BUTYL TIGLATE |
N-Butyl Tadalafil | 171596-31-9 | C25H25N3O4 | 431.48 | (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2-butyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione |
n-Butyl sulfate | 15507-13-8 | C4H10 O4 S | 154.1848 | |
N-Butyl Scopolamine Bromide (N-Butyl Hyoscine Bromide) | 149-64-4 | C21H30BrNO4 | 440.37 | Hyoscine butylbromide; Buscopan; (-)-Scopolamine butylbromide; Butylscopolammonium bromide; Butylscopolamine bromide |
n-Butyl methanesulfonate | 1912-32-9 | C5H12O3S | 152.23 | N-BUTYL METHANESULPHONATE; methanesulfonicacid,butylester; n-Butyl methanesulfonate; n-butylmethanesulfonate; BUTYL METHANE SULFONATE; BUTYLMESYLATE |
n-BUTYL HEXANOATE | 626-82-4 | C10H20O2 | 172.26 | Butyl caproate, Hexanoic acid, butyl ester, n-Butyl Caproate, n-BUTYL HEXANOATE |
N-Benzyl-tert-butyl-d9-amine | 1060688-77-8 | C6H5CH2NHC(CD3)3 | 172.319 | |
N-Benzylstearamide | 5327-45-7 | C25H43NO | 373.62 | N-(Phenylmethyl)octadecanamide; N-Benzyloctadecanamide |
N-Benzylquinidinium chloride | 77481-82-4 | C27H31ClN2O2 | 451 | N-BENZYLQUINIDINIUM CHLORIDE; Benzylquinidiniumchloride; N-Benzylquinidinium Chloride [Chiral Phase-Transfer Catalyst] |
N-Benzylacetamidine hydrobromide | 186545-76-6 | C9H12N2·HBr | 229.1 | 1-(Benzylamino)ethaniminium bromide |
N-benzyl-4-amino-piperidine-4-carboxamide | 170921-49-0 | C13H19N3O | 233.3 | N-BENZYL-4-AMINO-PIPERIDINE-4-CARBOXAMIDE; 4-Amino-1-benzylpiperidine-4-carboxamide |
N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide | 1391053-09-0 | C13H20N2O3 | 252.32 | 2-[2-[(2-Hydroxyethyl)amino]ethoxy]-N-(phenylmethyl)acetamide; |
N-Benzyl-2,3,4,6-tetra-O-benzyl-1,5-dideoxy-imino-L-iditol | 151963-95-0 | C41H42NO4 | 613.80 | |
NBD Methylhydrazine | 214147-22-5 | C7H7N5O3 | 209.16 | 4-(1-Methylhydrazino)-7-nitrobenzofurazan; 1-methyl-1-(4-nitro-2,1,3-benzoxadiazol-7-yl)hydrazine |
N-Benzoyl-D-phenylglycine | 10419-67-7 | C15H13NO3 | 255.26862;g/mol | |
N-Benzoyl-D-glucosamine | 655-42-5 | C13H17NO6 | 283.28 | |
N-Acetyl Zonisamide | 68936-43-6 | C10H10N2O4S | 254.27 | N-[(1,2-Benzisoxazol-3-ylmethyl)sulfonyl]-acetamide; N-Acetyl-3-(sulfamoylmethyl)-1,2-benzisoxazole |
N-Acetyl Dapsone | 565-20-8 | C14H14N2O3S | 290.34 | N-[4-[(4-Aminophenyl)sulfonyl]phenyl]-acetamide; Acetyldapsone; MADDS; Monoacetyldapsone |
N744 tosylate | 72616-22-9 | C25H29N2O4S2.C7H7O3S | 656.83 | |
N-Acetyl Benzocaine | 5338-44-3 | C11H13NO3 | 207.23 | Ethyl 4-Acetamidobenzoate; 4'-Carbethoxyacetanilide; Ethyl N-acetyl-4-aminobenzoate; NSC 28987; NSC 3160; p-(Acetylamino)benzoic acid ethyl ester; Benzoic acid, 4-(acetylamino)-, ethyl ester |
N1,N1,N2,N2-tetramethylethane-1,2-diamine | 1344-70-3 | 79.545 | BLACK COPPER OXIDE; COPPER(II) OXIDE ON ALUMINA; COPPER(II) OXIDE, BLACK; COPPER(+2)OXIDE; COPPER MONOXIDE; COPPER OXIDE; COPPER OXIDE BLACK; CUPRIC OXIDE, BLACK | |
N1, N4-Bis-Boc-Spermidine | 85503-20-4 | C17H35N3O4 | 345.48 | |
N1-(SEC-BUTYL)-2-AMINOBENZAMIDE | 30391-87-8 | C11H16N2O | 192.26 | N1-(SEC-BUTYL)-2-AMINOBENZAMIDE; 2-AMINO-N-SEC-BUTYLBENZAMIDE |
N,N-Dimethylethylamine hydrochloride | 58114-25-3 | C4H12ClN | 109.59778;g/mol | N,N-dimethylethanamine; hydrochloride; N,N-Dimethylethylaminehydrochloride; Ethanamine,N,N-dimethyl-,hydrochloride; 58114-25-3; SCHEMBL435643 |
N,N-Dimethyl-D-glucosamine | 69947-77-9 | C8H17NO5 | 207.22 | 2-Deoxy-2-(dimethylamino)-D-glucose |
N-(p-amylcinnamoyl)anthranilic acid | 110683-10-8 | C21H23NO3 | 337.4 | ACA; 4-Amylcinnamoylanthranilic acid |
N-(4-Hydroxyphenyl)glycine | 122-87-2 | C8H9NO3 | 167.16 | HYDROXY-N-PHENYLGLYCINE; LABOTEST-BB LT00452650; GLYCIN; GLYCIN, PHOTO; n-(4-hydroxyphenyl)-glycin; p-hydroxyphenylglycine |
N-(4-Hydroxyphenyl)-5-methyl-2-1H-Pyridone-d4 | 1188263-50-4 | C12H7NO2CD4 | 205.25 | 1-(4-Hydroxyphenyl)-5-methyl-2(1H)-pyridinone-d4 |
N-(4-Hydroxyphenyl)-5-Methyl-2-1H-Pyridone | 851518-71-3 | C12H11NO2 | 201.23 | 1-(4-Hydroxyphenyl)-5-methyl-2(1H)-pyridinone; F 351 |
N-(4-HYDROXYMETHYLBENZYL)TRIFLUOROACETAMIDE | 171723-95-8 | C10H10F3NO2 | 233.1871096 | N-(4-HYDROXYMETHYLBENZYL)TRIFLUOROACETAMIDE; 2,2,2-Trifluoro-N-(4-hydroxymethyl-benzyl)-acetamide |
Mometasone Furoate | 83919-23-7 | C27H30Cl2O6 | 521.431 | Elocon; Nasonex; Sch32088; Twisthaler; Elomet; Asmanex; Mometasone 17-furoate |
Molybdate(2-),dioxodithioxo-, diammonium, (T-4)- (9CI) | 16150-60-0 | H4N . 1/2 Mo O2 S2 | 192.08900 | |
N-Benzoyl-2'-o-[(methylthio)methyl]-3',5'-o-[1,1,3,3-tetrakis(1-methylethyl)-1,3-disiloxanediyl]cytidine | 139434-68-7 | C30H47N3O7SSi2 | 649.95 | N-[1-[(6aR,8R,9R,9aR)-9-(methylsulfanylmethoxy)-2,2,4,4-tetra(propan-2-yl)-6a,8,9,9a-tetrahydro-6H-furo[3,2-f][1,3,5,2,4]trioxadisilocin-8-yl]-2-oxopyrimidin-4-yl]benzamide; 139434-68-7; CM-1944; 2'-O-Methylthiomethyl-3',5'-TIPDS-N4-benzoylcytidine; N-Ben |
Naphyrone HCl | 850352-11-3 | C19H23NO . ClH | 317.85 | 1-(Naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one hydrochloride; 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone; 1-(2-Naphthalenyl)-2-(1-pyrrolidinyl)-1-pentanone Hydrochloride |
Naphthol AS-BI b-D-glucuronide | 37-87-6 | C24H22BrNO9 | 548.34 | |
Naphthol AS-BI b-D-galactopyranoside | 51349-63-4 | C24H24BrNO8 | 534.35 | 7-Bromo-3-(b-D-galactopyranosyloxy)-N-(2-methoxyphenyl)-2-naphthalenecarboxamide |
N,N'-bis[(2-chlorophenyl)methyl]propane-1,3-diamine dihydrochloride | 2056-19-1 | C17H22Cl4N2 | 396.182 g/mol | |
N-(4-METHOXYPHENYL)GUANIDINEHYDROCHLORIDE | 73709-20-3 | C8H11N3O.HCl | 0 | |
Monascin | 21516-68-7 | C21H26O5 | 358.44 | |
Moluccanin diacetate | 121700-27-4 | C24H22O10 | 470.4 | [(2S,3S)-3-(4-acetyloxy-3,5-dimethoxyphenyl)-7-oxo-2,3-dihydropyrano[3,2-g][1,4]benzodioxin-2-yl]methyl acetate |
Moluccanin | 121700-26-3 | C20H18O8 | 386.4 | trans-2,3-Dihydro-3-(4-hydroxy-3,5-dimethoxyphenyl)-2-(hydroxymethyl)-7H-pyrano[2,3-g]-1,4-benzodioxin-7-one |
MIBG hemisulfate | 87862-25-7 | C8H10IN3.1/2 H2O4S | 324.13 | Iobenguane sulfate; M-Iodobenzylguanidine hemisulfate; 3-Iodobenzyl-guanidine hemisulfate; 3-Iodobenzylguanidine hemisulfate; 2-[(3-iodophenyl)methyl]guanidine sulfuric acid |
Mibefradil dihydrochloride | 116666-63-8 | C29H40Cl2FN3O3 | 568.55 (anhydrous basis) | (1S,2S)-2-[2[[3-(2-Benzimidazolyl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride hydrate, Ro 40-5967 hydrate |
Mibefradil | 116644-53-2 | C29H38FN3O3 | 568.55 | Mibefradil;Mibefradil dihydrochloride |
Mianserin-d3 Dihydrochloride | 81957-76-8 | C18H19Cl2N2D3 | 340.31 | 1,2,3,4,10,14b-Hexahydro-2-(methyl-d3)-dibenzo[c,f]pyrazino[1,2-a]azepine Hydrochloride; (+/-)-Mianserin-d3 Hydrochloride; Mianserine-d3 Dihydrochloride |
Mianserin Hydrochloride | 21535-47-7 | C18H20N2.HCl | 300.83 | ORG GB-94 HCl; Mianserin hydrochloride; Tolvon; Tolvin; ORG GB 94; Lerivon. |
Mianserin | 24219-97-4 | C18H20N2 | 264.3649 | 1,2,3,4,10,14b-hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine;f)pyrazino(1,2-a)azepine,1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo(;MIANSERIN;MIANSERINE;Dibenzoc,fpyrazino1,2-aazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-;MIANSERIN,1.0MG/MLINMETHANOL;D |
NBD-X, SE | 145195-58-0 | C16H17N5O7 | 391.34 | NBD-C6, SE; Succinimidyl 6-(N-(7-nitrobenz-2-oxa-1,3-diazoyl-4-yl)amino)hexanoate; NBD-X N-succinimidyl ester; (2,5-dioxopyrrolidin-1-yl) 6-[(4-nitro-2,1,3-benzoxadiazol-7-yl)amino]hexanoate |
NBD-PE | 178119-00-1 | C49H90N5O11P | 956.24 | |
NBD-C12-HPC | 105539-26-2 | C42H74N5O11P | 856.05 | |
NBD-Fructose | 940961-04-6 | C12H14N4O8 | 342.3 | 1-NBDF; 1-(7-nitro-1,2,3-benzadiazole)-Fructose; 1-deoxy-1-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-fructose |
NBD-557 | 333352-59-3 | C17H24BrN3O2 | 382.3 | NBD 557; NBD557 |
NBD-556 | 333353-44-9 | C17H24ClN3O2 | 337.84 | NBD 556; NBD556 |
Naxifylline | 166374-49-8 | C18H24N4O3 | 344.42 | Naxifylline (USAN/INN); DNC000519; D05125; 1,3-dipropyl-8-((1R,2R,4R,5R,6R)-3-oxatricyclo[3.2.1.02,4]octan-6-yl)-3,7-dihydro-1H-purine-2,6-dione |
NB-caged Tyrosine hydrochloride | 207727-86-4 | C16H16N2O5.HCl | 352.77 | O-[(2-Nitrophenyl)methyl]-L-tyrosine hydrochloride |
NB-598 Maleate | 155294-62-5 | C31H35NO5S2 | 565.74 | NB598 Maleate; NB 598 Maleate |
NB-598 hydrochloride | 136719-25-0 | C27H32ClNOS2 | 486.13 | NB 598 hydrochloride; NB598 hydrochloride |
NB-598 | 131060-14-5 | C27H31NOS2 | 449.67 | NB 598; NB598 |
NAZUMAMIDE A | 138949-86-7 | C28H43N7O8 | 605.68 | 2,5-DIHYDROXY-BZ-ARG-PRO-ILE-ABU; 2,5-DIHYDROXY-BZ-ARG-PRO-ILE-ABU-OH; NAZUMAMIDE A |
Naxagolide | 88058-88-2 | C15H21NO2 | 247.336 | |
Navuridine | 84472-85-5 | C9H11N5O4 | 253.22 | AZdU; AzUrd; CS-87; CS87; CS 87; AZddU; NSC 380882; NSC380882; NSC-380882; 1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; 3'-Azido-2',3'-dideoxyuridine |
Navitoclax | 923564-51-6 | C47H55ClF3N5O6S3 | 974.611 | ABT-263; ABT 263; ABT263; 4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide |
Naveglitazar | 476436-68-7 | C25H26O6 | 422.47 | 2-methoxy-3-[4-[3-(4-phenoxyphenoxy)propoxy]phenyl]propanoic acid; LY 519818; |
Navarixin | 862464-58-2 | C21H23N3O5.H2O | 428.48 | SCH 527123; MK-7123; PS 291822; (R)-2-hydroxy-N,N-dimethyl-3-((2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide |
Navamepent | 1251537-11-7 | C18H24O4 | 304.39 | (5S,8E,10E,12R)-5,12-Dihydroxy-8,10-pentadecadiene-6,14-diynoic Acid 1-Methylethyl Ester;RX 10045 |
Naringin dihydrochalcone | 18916-17-1 | C27H34O14 | 582.55 | 1-[4-[(2-O-(6-Deoxy-a-L-rhamnopyranosyl)-b-D-glucopyranosyl]oxy]-2,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone |
Naringenin-7-O-b-D-glucuronide | 158196-34-0 | C21H20O11 | 448.38 | (2S)-3,4-Dihydro-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2H-1-benzopyran-7-yl-D-glucopyranosiduronic acid |
Naringenin trimethyl ether | 38302-15-7 | C18H18O5 | 314.3 | 4',5,7-trimethoxyflavanone; |
Naringenin triacetate | 3682-04-0 | C21H18O8 | 398.4 | 2-(4-Acetoxyphenyl)-4-oxochroMan-5,7-diyl diacetate |
Naringenin chalcone | 73692-50-9 | C15H12O5 | 272.25 | Chalconaringenin; Isosalipurpol; trans-2'4'6'4-tetrahydroxychalcone |
Naringenin 4',7-diacetate | 18196-13-9 | C19H16O7 | 356.3 | (S)-4',5,7-Trihydroxyflavanone 4',7-diacetate; [4-(7-acetyloxy-5-hydroxy-4-oxo-2,3-dihydrochromen-2-yl)phenyl] acetate |
Naringenin | 480-41-1 | C15H12O5 | 272.256 | Naringenin; NSC 11855; NSC-11855; NSC11855; (S)-Naringenin; (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2S)-Naringenin; Naringetol |
Naringenin | 67604-48-2 | C15H12O5 | 272.25 | 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-on; (+/-)-Naringenin |
Nargenicin A1 | 70695-02-2 | C28H37NO8 | 515.60 | Antibiotic 47444; CP 47,444; NSC 355066 |
Nargenicin | 75923-01-2 | C28H37NO8 | 515.6 | Nargenicin B1, CP 51467 |
Nardosinonediol | 20489-11-6 | C15H24O3 | 252.354 | (3R,4aR,5R)-3-hydroxy-4-(2-hydroxypropan-2-yl)-4a,5-dimethyl-2,3,4,5,6,7-hexahydronaphthalen-1-one |
Nardoeudesmol A | 1445952-30-6 | C15H24O2 | 236.354 | |
Narchinol B | 1356822-09-7 | C12H16O3 | 208.257 | (4R,4aS,5R,7S)-4,7-dihydroxy-4a,5-dimethyl-4,5,6,7-tetrahydronaphthalen-1-one |
Naratriptan N-oxide | 1159977-52-2 | C17H25N3O3S | 351.47 | N-Nethyl-3-(1-methyl-1-oxido-4-piperidinyl)-1H-indole-5-ethanesulfonamide; |
Naratriptan N-Nitroso | 1216880-64-6 | C17H24N4O3S | 364.47 | N-Methyl-3-(1-methyl-4-piperidinyl)-1-nitroso-1H-indole-5-ethanesulfonamide; |
Naratriptan Impurity C | 1346604-16-7 | C31H41N5O2S | 547.77 | 2,2-Bis-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonic Acid Methylamide; |
Naratriptan Hydrochloride | 143388-64-1 | C17H25N3O2S.HCl | 371.93 | Naratriptan HCl; Naratriptan Hydrochloride; Amerge; Naramig; GR-85548A; GR 85548A; GR85548A; |
Naratriptan D3 Hydrochloride | 1190021-64-7 | C17H23D3ClN3O2S | 374.94 | Naramig-d3; Amerge-d3.; HY-B0197AS; CTK8G1636; DTXSID40662141 |
Naratriptan | 121679-13-8 | C17H25N3O2S | 335.47 | Naratriptan;Naratriptane;N-Methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide;N-methyl-2-[3-(1-methyl-4-piperidyl)-1H-indol-5-yl]ethanesulfonamide |
Narasin sodium | 58331-17-2 | C43H71NaO11 | 787.0 | 4-Methylsalinomycin sodium |
Narasin | 55134-13-9 | C43H72O11 | 765.0 | 4-Methylsalinomycin, A28086A, C7819A |
N-Arachidonylglycine | 179113-91-8 | C22H35NO3 | 361.52 | N-[1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl]-glycine; Arachidonyl Glycine; (all-Z)-N-(1-Oxo-5,8,11,14-eicosatetraenyl)glycine; N-[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraenyl]glycine |
N-ArachidonylGABA | 128201-89-8 | C24H39NO3 | 389.58 | 4-[[(5Z,8Z,11Z,14Z)-1-Oxo-5,8,11,14-eicosatetraenyl]amino]butanoic acid; 4-[(1-oxo-5Z,8Z,11Z,14Z-eicosatetraenyl)amino]-butanoic acid |
N-Arachidonyl maleimide | 876305-42-9 | C24H35NO2 | 369.5 | NAM; 1-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenyl]pyrrole-2,5-dione |
N-Arachidonoyl taurine | 119959-65-8 | C22H37NO4S | 411.6 | N-Arachidonoyltaurine; N-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-taurine |
N-Arachidonoyl dopamine | 199875-69-9 | C28H41NO3 | 439.6 | NADA; (5Z,8Z,11Z,14Z)-N-[2-(3,4-dihydroxyphenyl)ethyl]icosa-5,8,11,14-tetraenamide |
Naquotinib mesylate | 1448237-05-5 | C31H46N8O6S | 658.82 | ASP8273 mesilate;6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide monomethanesulfonate;448232-80-1 (free base) |
Naquotinib | 1448232-80-1 | C30H42N8O3 | 562.719 | ASP 8273; (R)-5-((1-acryloylpyrrolidin-3-yl)oxy)-6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazine-2-carboxamide |
Naproxen EP Impurity D | 116883-61-5 | C14H13IO3 | 356.16 | |
Naproxen EP Impurity A | 52079-10-4 | C13H12O3 | 216.24 | (S)-O-Desmethyl Naproxen; O-Desmethyl Naproxen; |
Naproxen Acyl Glucuronide | 41945-43-1 | C20H22O9 | 406.38 | 1-[(a-S)-6-Methoxy-a-methyl-2-naphthaleneacetate] |
Naphthol AS nonanoate | 10523-82-7 | C26H29NO3 | 403.51 | |
Naphthofluorescein di-O-(b-D-galactopyranoside) | 133551-98-1 | C40H36O15 | 756.7 | |
Nandrolone-3,4-13C2 | 2952-73-6 | C1613C2H26O2 | 276.38 | |
Naphazoline Nitrate | 5144-52-5 | C14H14N2 . HNO3 | 273.29 | 2-(1-Naphthylmethyl)imidazoline nitrate; |
Naphazoline Impurity D | 22126-67-6 | C14H14N2 | 210.28 | 4,5-dihydro-2-(2-naphthalenylmethyl)-1H-imidazole; |
Naphazoline Impurity C | 132-75-2 | C12H9N | 167.21 | 1-Naphthyl Acetonitrile; |
Naphazoline Impurity A | 36321-43-4 | C14H16N2O | 228.3 | N-(2-Aminoethyl)-1-naphthylacetamide; N-(2-Aminoethyl)-1-naphthaleneacetamide; N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide; |
Naphazoline hydrochloride | 550-99-2 | C14H14N2.HCl | 246.74 | 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride; |
Naphazoline | 835-31-4 | C14H14N2 | 210.28 | 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;aphcon-a, AK-Con, All Clear, Clear Eyes |
Napabucasin | 83280-65-3 | C14H8O4 | 240.22 | BBI608; 2-acetylnaphtho[2,3-b]furan-4,9-dione; 2-acetylbenzo[f][1]benzofuran-4,9-dione |
NAP226-90 (Rivastigmine EP Impurity A) | 139306-10-8 | C10H15NO | 165.24 | (S)-3-[1-(Dimethylamino)ethyl]phenol; 3-[(1S)-1-(Dimethylamino)ethyl]phenol; |
Nantradol Hydrochloride | 65511-42-4 | C27H36ClNO4 | 474.04 | UM1159;UM-1159;MCV4161;MCV-4161;Nantradol HCl;9-Hydroxy-6-methyl-3-((5-phenylpentan-2-yl)oxy)-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate hydrochloride;CP-44001-1;[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-(5-phenylpentan-2-yloxy)-5,6,6a,7,8,9,10, |
Nanterinone mesylate | 102791-74-2 | C16H19N3O4S | 349.40 | 6-(2,4-Dimethylimidazol-1-yl)-8-methyl-1H-quinolin-2-one methanesulfonic acid;UK-61260;UK61260;6-(2,4-Dimethyl-1H-imidazol-1-yl)-8-methylquinolin-2(1H)-one methanesulfonate |
Nanterinone | 102791-47-9 | C15H15N3O | 253.30 | UK-61260;6-(2,4-Dimethyl-1h-imidazol-1-yl)-8-methylquinolin-2-ol;UK61260 |
Nantenine | 2565-01-7 | C20H21NO4 | 339.391 | O-Methyldomesticine; Domestine; Nantenin |
Nanofin | 504-03-0 | C7H15N | 113.2 | 2,6-dimethylpiperidine; |
Nanchangmycin | 65101-87-3 | C48H80O13 | 889.1 | Sulfametoxydiazine |
NANAOMYCIN A | 52934-83-5 | C16H14O6 | 302.281 | Nanafrocin; RosanomycinA; NanaomycinA; Nanafrocine; Nanafrocinum; NanomycinA |
NAN-190 hydrobromide | 115338-32-4 | C23H27N3O3.BrH | 474.40 | NAN-190 hydrobromide; 2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione hydrobromide; NAN-190; Nan 190 |
N-Amyl b-D-glucopyranoside | 66957-71-9 | C11H22O6 | 250.29 | |
Nampt-IN-1 | 1698878-14-6 | C20H25N3O5S | 419.49 | 2-hydroxy-2-methyl-N-[2-(2-pyridin-3-yloxyacetyl)-3,4-dihydro-1H-isoquinolin-6-yl]propane-1-sulfonamide Nampt-IN-1 CHEMBL3586462 SCHEMBL16634738 |
Namitecan | 372105-27-6 | C23H22N4O5 | 434.45 | ST 1968; (4S)-11-((E)-((2-Aminoethoxy)imino)methyl)-4-ethyl-4-hydroxy-1,12-dihydro-14H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H)-dione |
N'-AMINOOXYMETHYLCARBONYLHYDRAZINO-D-BIOTIN | 139585-03-8 | C12H21N5O4S | 331.39 | N'-AMINOOXYMETHYLCARBONYLHYDRAZINO-D-BIOTIN; Arp(AldehydeReactiveProbe); N-(Aminooxyacetyl)-N'-biotinyl-hydrazine; O-(biotinylcarbazoylmethyl)hydroxylamine |
N-Aminocaronyl Felbamate (Allophanate) | 1797130-34-7 | C12H15N3O5 | 281.27 | |
Naminidil | 220641-11-2 | C15H19N5 | 269.35 | 1-cyano-3-(4-cyanophenyl)-2-[(2R)-3,3-dimethylbutan-2-yl]guanidine; Naminidil; UNII-7K50VT05OD |
N-Amidinobenzamide | 3166-00-5 | C8H9N3O | 163.18 | N-AMIDINOBENZAMIDE; Benzamide, N-(aminoiminomethyl)- (9CI); 1-Benzoylguanidine; 2-Benzoylguanidine; N-(Aminoiminomethyl)benzamide; N-(diaminomethylene)benzamide; N-(diaminomethylidene)benzamide; N-[bis(azanyl)methylidene]benzamide |
NAMI-A | 201653-76-1 | C8H15Cl4N4ORuS | 458.18 | ImH[trans-RuCl4(DMSO)Im]; Na[trans-RuCl(4)(DMSO)Im; Imidazolium trans-imidazoledimethyl sulfoxide-tetrachlororuthenat; Imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III); Imidazolium-bis(imidazole)dimethylsulfoxideimidazotetrachlo |
Naluzotan | 740873-06-7 | C23H38N4O3S | 450.64 | PRX00023;N-(3-(4-(4-((cyclohexylmethyl)sulfonamido)butyl)piperazin-1-yl)phenyl)acetamide |
Naltrexone | 16590-41-3 | C20H23NO4 | 341.40 | (4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one naltrexone 16590-41-3 Celupan ReVia Vivitrex Vivitrol Depade N-Cyclopropylmethylnoroxymorphone Naltrexonum Naltrexon |
Naloxone methiodide | 93302-47-7 | C20H24INO4 | 469.31 | |
Naloxone HCl | 357-08-4 | C19H21NO4.HCl | 363.84 | (4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one hydrochloride; Naloxone HCl; EN-15304; EN15304; EN 15304; NIH7890; Naloxone hydrochloride; Narcan; Narcanti; Nalonee; |
Naloxone Fluorescein | 88641-41-2 | C42H38N4O10S | 790.84 | |
Naloxegol oxalate | 1354744-91-4 | C36H55NO15 | 741.82 | (4R,4aS,7S,7aR,12bS)-7-((2,5,8,11,14,17,20-heptaoxadocosan-22-yl)oxy)-3-allyl-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol oxalate; NKTR-118; NKTR 118; NKTR118; AZ-13337019; AZ13337019; AZ 13337019; EGylated naloxol; N |
Naloxegol | 854601-70-0 | C34H53NO11 | 651.78 | Movantik;NKTR-118;(4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol |
N-Allyloxycarbonyl-b-lactosamine | 209977-55-9 | C16H27NO12 | 425.38 | |
N-Allylmaleimide | 2973-17-3 | C7H7NO2 | 137.14 | N-Allylmaleimide |
N-Allyl-2,2,2-trifluoroacetamide | 383-65-3 | C5H6F3NO | 153.10 | N-ALLYL-2,2,2-TRIFLUOROACETAMIDE; N-Allyltrifluoroacetamide |
N-Allyl methacrylamide | 2186-33-6 | C7H11NO | 125.17 | N-ALLYL METHACRYLAMIDE; 2-Propenamide, 2-methyl-N-2-propenyl-; 2-Methyl-N-(2-propenyl)-2-propenamide; 2-methyl-N-prop-2-enyl-prop-2-enamide; 2-methyl-N-prop-2-enylprop-2-enamide; N-allyl-2-methyl-acrylamide |
N-Alkyl-(C10-C16)-N-benzyl-N,N-dimethylammonium chloride | 68989-00-4 | |||
Naftoxate | 28820-28-2 | 0 | Naftoxate; K-F-224; KF-224; N-Methyl-N-(1-naphtyl)dithiocarbamic acid benzoxazol-2-yl ester | |
Naftopidil dihydrochloride | 57149-08-3 | C24H28N2O3.2HCl | 465.41 | KT-611 |
Naftopidil | 57149-07-2 | C24H28N2O3 | 392.49 | Naftopidil; BM-15275; KT-611; BM 15275; KT 611; BM15275; KT611; Flivas |
Naftazone-d6 | 15687-37-3 | C11H3N3O2D6 | 221.25 | 2-[1-Oxonaphthalen-2(1H)-ylidene]hydrazinecarboxamide-d6; |
Naftifine-d3 HCl | 1246833-81-7 | C21H18ND3·HCl | 326.86 | (E)-N-Methyl-N-(3-phenyl-2-propen-1-yl)-1-naphthalenemethanamine -d3 |
Naftifine HCl | 65473-14-5 | C21H21N·HCl | 323.86 | (E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine hydrochloride; AW 105843; AW105843; AW-105843; AW 105-843; SN 105843; SN105843; SN-105843; Naftifine, Naftifine hydrochloride; Naftin |
Naftifine cis-Isomer | 65473-08-7 | C21H21N | 287.41 | (Z)-N-Methyl-N-(3-phenyl-2-propen-1-yl)-1-naphthalenemethanamine Hydrochloride;(Z)-N-Cinnamyl-N-methyl-1-naphthalenemethanamine Hydrochloride; |
N6-Benzoyl-9-(2'-deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)adenine 3'-CE phosphoramidite | 2248740-48-7 | C47H51FN7O7P | 875.95 | |
N6022 | 1208315-24-5 | C24H22N4O3 | 414.465 | N 6022; N-6022 |
N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine | 120442-40-2 | C27H31N5O6 | 521.56 | N6-[2-(3,5-DIMETHOXYPHENYL)-2-(-2-METHYLPHENYL)ETHYL]ADENOSINE; CGS 24012 |
N6,3'-O-Dibenzoyl-2'-deoxyadenosine | 51549-54-3 | C24H21N5O5 | 459.47 | N6,3'-O-Dibenzoyl-2'-deoxy-D-adenosine; 6-N-benzoyl-3'-O-benzoyl-2'-deoxyadenosine; N-Benzoyl-2'-deoxyadenosine 3'-benzoate; (2R,3S,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl benzoate |
N6-(4-Hydroxybenzyl)adenosine | 110505-75-4 | C17H19N5O5 | 373.36 | N6-(4-Hydroxybenzyl)-adenosine; 110505-75-4; N6-(4-hydroxybenzyl)adenine riboside; N6-(4-hydroxybenzyl)adenosine; CHEMBL224024; P-Topolin riboside |
N6-(Hydroxymethyl)adenosine (~90%) | 98897-14-4 | C11H15N5O5 | 297.27 | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(6-((hydroxymethyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol; N-(Hydroxymethyl)adenosine |
N6-(Diisobutylaminomethylidene)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | 207981-34-8 | C32H39N7O5 | 601.71 | |
N6-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-O2-(diphenylcarbamoyl)-2'-deoxyisoguanosine | 207981-37-1 | C53H57N7O7 | 904.08 | |
N20C hydrochloride | 1177583-87-7 | C17H20N2O.HCl | 304.82 | 2-[(3,3-Diphenylpropyl)amino]acetamide hydrochloride |
N-2-[2-(2,2,2-Trifluoroethoxy)phenoxy]ethylsilodosin | 1453221-45-8 | C35H41F6N3O6 | 713.718 | |
Myristoleic acid methyl ester | 56219-06-8 | C15H28O2 | 240.4 | Methyl myristoleate; cis-9-tetradecenoate methyl ester; Methyl cis-9-tetradecenoate |
N-(2,6-Dimethylphenyl)-1-piperazineacetamide | 5294-61-1 | C14H21N3O | 247.34 | |
N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide | 1258011-97-0 | C27H45NO3 | 431.7 | (Z)-N-[1-(3,4-dihydroxyphenyl)propan-2-yl]octadec-9-enamide |
Monooctyl maleate | 7423-42-9 | C12H20O4 | 228.2884 | 2-Butenedioicacid(Z)-,mono(2-ethylhexyl)ester; mono(2-ethylhexyl)ester; MONOOCTYL MALEATE; MONO(2-ETHYLHEXYL) MALEATE; 2-ETHYLHEXYL MALEATE; 2-ETHYLHEXYL MALEATE MONO; MALEIC ACID MONOOCTYL ESTER; MALEIC ACID MONO(2-ETHYLHEXYL) ESTER |
MONO-N-HEPTYLTIN TRICHLORIDE | 59344-47-7 | C7H15Cl3Sn | 324.263 | MONO-N-HEPTYLTIN TRICHLORIDE; Trichloroheptyl Stannane |
Miltirone | 27210-57-7 | C19H22O2 | 282.38 | Miltiron; Rosmariquinone; NSC 639662 |
Miltefosine | 58066-85-6 | C21H46NO4P | 407.57 | Hexadecylphosphocholine |
Milrinone Related Compound A | 80047-24-1 | C12H11N3O2 | 229.23 | 5-Descyano Milrinone 5-Carboxyamide; 1,6-Dihydro-2-methyl-6-oxo-[3,4'-Bipyridine]-5-carboxamide; Win 47338 |
Milrinone Impurity 3 | 98293-81-3 | C12H7N3O3 | 241.2 | 5-Cyano-1,6-dihydro-6-oxo-[3,4'-bipyridine]-2-carboxylic Acid |
Milrinone Impurity 2 | 400063-10-7 | C12H7N3O2 | 225.2 | 2-(Dihydroxymethyl)-6-oxo-1,4,5,6-tetrahydro-[3,4'-bipyridine]-5-carbonitrile |
Milrinone | 78415-72-2 | C12H9N3O | 211.22 | Primacor; Corotrope; Corotrop; Milrinona |
Miloxacin-D3 | 1228182-43-1 | 5-Methoxy-D3-8-oxo-5,8- dihydro-[1,3]dioxolo[4,5- g]quinoline-7-carboxylic acid | ||
Miloxacin | 37065-29-5 | C12H9NO6 | 0 | Miloxacin; 1,4-Dihydro-1-methoxy-6,7-methylenebisoxy-4-oxo-3-quinolinecarboxylic acid; 5,8-Dihydro-5-methoxy-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid; AB-206; Antibiotic AB-206; D02303 |
Milnacipran Impurity 3 | 19532-98-0 | C10H12N2O2 | 192.21 | N,N'-Dimethylphthalamide; N1,N2-dimethyl-1,2-benzenedicarboxamide; N,N'-Dimethylphthalamide; N,N'-Dimethylphthalic Diamide; N,N'-Dimethyl-phthalamide |
Milnacipran Impurity 2 | 1353644-49-1 | C15H21NO2 | 247.34 | |
Milnacipran Impurity 13 | 710339-49-4 | C12H16N2OBr | 270.17 | |
Milnacipran Impurity 11 | 1410831-12-7 | C11H10O2 | 174.20 | |
Naftifine | 65472-88-0 | C21H21N | 287.41 | (E)-N-methyl-N-(naphthalen-1-ylmethyl)-3-phenylprop-2-en-1-amine;AW105843;AW-105843;SN105843;SN-105843;N-trans-cinnamyl-n-methyl-(1-naphthylmethyl)amine;(E)-N-Methyl-N-(3-phenyl-2-propenyl)-1-naphthalenemethanamine |
Naftalofos | 1491-41-4 | C16H16NO6P | 349.28 | Naftalofos; Naphthalophos; Phtalophos; Maretin; Rametin; Rawetin; (1,3-dioxobenzo[de]isoquinolin-2-yl) diethyl phosphate |
Nafronyl oxalate | 3200-06-4 | C26H35NO7 | 473.56 | Nafronyl oxalate; 3200-06-4; 2-(Diethylamino)ethyl 3-(naphthalen-1-yl)-2-((tetrahydrofuran-2-yl)methyl)propanoate oxalate; Naftidrofuryl oxalate; Naftidrofuryl (oxalate); Dubimax |
NAFRONYL | 31329-57-4 | C24H33NO3 | 383.52 | 2-(Diethylamino)ethyl 3-(1-naphthyl)-2-(tetrahydro-2-furanylmethyl)propanoate; 2-(Diethylamino)ethyl ester tetrahydro-alpha-(1-naphthalenylmethyl)-2-furanpropanic acid; 2-(Diethylamino)ethyl tetrahydro-alpha-(1-naphthylmethyl)-2-furanpropionate; 2-(diethy |
Nafoxidine HCl | 1847-63-8 | C29H32CINO2 | 462.03 | 1-[2-[4-(6-methoxy-2-phenyl-3,4-dihydronaphthalen-1-yl)phenoxy]ethyl]pyrrolidine;hydrochloride; NAFOXIDINEHYDROCHLORIDE; NafoxidineHCl; 1847-63-8; U11100A |
Nafoxidine | 1845-11-0 | C29H31NO2 | 425.56 | 1-(2-(p-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy)ethyl)pyrrolidine; 5-20-01-00210 (Beilstein Handbook Reference); BRN 1440873; Nafoxidina; Nafoxidina [INN-Spanish]; Nafoxidine; Nafoxidinum; Nafoxidinum [INN-Latin]; NSC 70735; UNII-4RIY10WM82 |
Nafiverine | 5061-22-3 | C34H38N2O4 | 538.684 | Nafiverine; UNII-WLT400RC9Q; DA-914; 5061-22-3; Nafiverina; Nafiverinum |
NAFION 350, PERFLUORINATED MEMBRANE, RE- INFORCED WITH TEFLON, 0.01IN. THICK | 170006-88-9 | |||
Nafenopin | 3771-19-5 | C20H22O3 | 310.39 | 2-Methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid; |
Nafcillin-d5 Sodium Salt | 1356354-25-0 | C21H17N2O5SD5 | 441.49 | (2S,5R,6R)-6-[[(2-(Ethoxy-d5)-1-naphthalenyl)carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt; Naftopen-d5 |
Nafcillin sodium salt monohydrate | 7177-50-6 | C21H21N2O5S·H2O·Na | 454.47 | |
Nafcillin | 147-52-4 | C21H22N2O5S | 414.48 | Nafcillin; Naphcillin; Nafcilina; Nafcilline; Nafcillinum; Nallpen; (2S,5R,6R)-6-[(2-ethoxynaphthalene-1-carbonyl)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
Nafazatrom | 59040-30-1 | C16H16N2O2 | 268.32 | 5-Methyl-2-(2-naphthalen-2-yloxyethyl)-4H-pyrazol-3-one;2,4-Dihydro-5-methyl-2-[2-(2-naphthalenyloxy)ethyl]-3H-pyrazol-3-one;BAY-g-6575;Bay-g6575;Nafazatromum;3-Methyl-1-(2-(naphthalen-2-yloxy)ethyl)-1H-pyrazol-5(4H)-one |
Nafarelin Acetate Hydrate (1:x:x) | 86220-42-0 | C66H83N17O13.xC2H4O2.xH2O | 5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-3-(2-naphthyl)-D-alanyl-L-leucyl-L-arginyl-L-prolylglycinamide acetate salt hydrate | |
Nafarelin Acetate | 78115-72-7 | C68H89N17O16 | 1400.56 | acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-y |
Nafamostat hydrochloride | 80251-32-7 | C19H19N5O2Cl2 | 420.29 | Benzoic acid,4-[(aminoiminomethyl)amino]-,6- (aminoiminomethyl)-2-naphthalenyl ester,dihydrochloride;Nafamostat mesylate dihydrochloride;6-Amidino-2-naphthyl p-guanidinobenzoate dimethanesulfonate dihydrochloride |
Nadolol Impurity D | 67247-26-1 | C30H43NO8 | 545.68 | |
Nadolol EP Impurity G | 33841-03-1 | C17H27NO2 | 277.41 | De(2,3-dihydroxy) Nadolol; 1-[(1,1-Dimethylethyl)amino]-3-[(5,6,7,8-tetrahydro-1-naphthalenyl)oxy]-2-propanol; 1-(tert-Butylamino)-3-[(5,6,7,8-tetrahydro-1-naphthyl)oxy]-2-propanol; |
Nadolol EP Impurity F | 2116-22-5 | C17H23NO2 | 273.38 | 1-(tert-Butylamino)-3-(naphthalen-1-yloxy)propan-2-ol; |
Nadolol D9 | 1432056-38-6 | C17H18NO4D9 | 318.46 | 5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalenediol-d9 |
Nadolol (Mixture of Diastereomers) | 220045-89-6 | C17H27NO4 | 309.41 | 5-[3-[(1,1-Dimethylethyl)amino]-2-hydroxypropoxy]-1,2,3,4-tetrahydro-2,3-naphthalenediol; |
Nadifloxacin isomer 2 | 130539-72-9 | C19H17FN2O4 | 356.36 | |
Nadifloxacin isomer 1 | 87488-29-7 | C14H13FN2O3 | 276.27 | |
Nadifloxacin | 124858-35-1 | C19H21FN2O4 | 360.38 | Nadifloxacine; Nadixa; OPC-7251; OPC7251; OPC 7251 |
NADA-green | 2253733-11-6 | C9H9N5O5.HCl | 303.66 | 3-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-alanine hydrochloride |
NAD 299 hydrochloride | 184674-99-5 | C18H23FN2O2.HCl | 354.85 | (3R)-3-(Dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrochloride |
NAD 299 | 169758-66-1 | C18H23FN2O2.HCl | ||
N-Acetyltryptamine | 1016-47-3 | C12H14N2O | 202.26 | N-[2-(1H-indol-3-yl)ethyl]-acetamide; 3-(2-N-Acetylaminoethyl)indole |
N-Acetylsulfathiazole-d4 | 1020718-91-5 | C11H7N3O3S2D4 | 301.38 | N-Acetylsulfathiazole-d4; N-[2,3,5,6-tetradeuterio-4-(1,3-thiazol-2-ylsulfamoyl)phenyl]acetamide |
N-Acetylsulfanilic acid | 121-62-0 | C8H9NO4S | 215.22636 | N-Acetylsulfanilicacid;121-62-0;acetanilidsulfonicacid;N-Acetylsulphanilicacid;4-acetamidobenzenesulfonicacid;4-acetamidobenzene-1-sulfonicacid |
N-Acetylstepharine | 4880-87-9 | C20H21NO4 | 339.391 | N-Acetylstepharine; Stepharine, 6-acetyl-; Spiro[2,5-cyclohexadiene-1,7'(1'H)-cyclopent[ij]isoquinolin]-4-one, 1'-acetyl-2',3',8',8'a-tetrahydro-5',6'-dimethoxy-, (R)- |
N-Acetylneuraminic acid | 131-48-6 | C11H19NO9 | 309.27 | 5-N-Acetyl-beta-D-neuraminic acid; N-Acetyl-D-neuraminic acid; N-acetylneuramic acid; N-acetyl-beta-neuraminic acid; NANA |
N-Acetylneuraminic Acid Methyl Ester | 22900-11-4 | C12H21NO9 | 323.3 | N-Acetylneuraminic acid methyl ester; N-Acetyl-D-neuraminic acid methyl ester; (2S,4S,5R,6R)-methyl 5-acetamido-2,4-dihydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate |
N-acetyl-S-geranylgeranyl-L-cysteine | 139332-94-8 | C25H41NO3S | 435.7 | AGGC; (2R)-2-acetamido-3-[(2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]sulfanylpropanoic acid |
N-Acetylserotonin b-D-glucuronide | 18430-06-3 | C18H22N2O8 | 394.38 | |
N-Acetylserotonin | 1210-83-9 | C12H14N2O2 | 218.3 | N-Acetyl-5-hydroxytryptamine; NAS; Normelatonin; N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]acetamide |
N-Acetyl-S-benzyl-L-cysteine | 19542-77-9 | C12H15NO3S | 253.32 | N-Acetyl-S-(phenylmethyl)-L-cysteine; N-Acetyl-3-(benzylthio)-alanine; Benzylmercapturic Acid; Acetyl Benzyl Cysteine; S-Benzylmercapturic Acid |
N-Acetyl-S-2-hydroxyethyl-L-cysteine | 15060-26-1 | C7H13NO4S | 207.25 | S-(2-HYDROXYETHYL)MERCAPTURIC ACID; N-ACETYL-S-(2-HYDROXYETHYL)-L-CYSTEINE; S-(2-Hydroxyethyl)mercapturic Acid, HEMA; R-(2-Hydroxyethyl)mercapturic Acid, HEMA |
N-Acetyl-S-(n-propyl-d7)-L-cysteine | 1331909-69-3 | CD3CD2CD2SCH2CH(NHCOCH3)COOH | 212.31 | L-S-Propylmercaputuric Acid-d7; (2R)-2-acetamido-3-(1,1,2,2,3,3,3-heptadeuteriopropylsulfanyl)propanoic acid |
N-Acetyl-S-(2-hydroxyethyl-d4)-L-cysteine Dicyclohexylamine Salt | 1331894-57-5 | HOCD2CD2SCH2CH(NHCOCH3)COOH·(C6H11)2NH | 392.59 | L-S-(2-Hydroxyethyl-d4)mercapturic Acid; (2R)-2-acetamido-3-(1,1,2,2-tetradeuterio-2-hydroxyethyl)sulfanylpropanoic acid;N-cyclohexylcyclohexanamine |
N-Acetylneuraminic acid methyl ester | 50998-13-5 | C12H21NO9 | 323.3 | Methyl 5-acetamido-3,5-dideoxy-D-glycero-b-D-galacto-non-2-ulopyranosonate |
N-Acetylneuraminic acid dimer disodium salt | 149331-75-9 | C22H34N2O17 2Na | 644.49 | 8-O-(N-Acetylneuraminyl)-N-acetylneuraminic acid disodium salt; N-Acetyl-8-O-(N-acetyl-a-neuraminyl)-neuraminic acid disodium salt; Neu5Ac-a-2,8-Neu5Ac 2Na |
N-Acetylneuraminic acid dihydrate | 50795-27-2 | C11H19NO9·2H2O | 345.30 | Sialic acid dihydrate; Neu5Ac dihydrate; N-Acetyl-D-neuraminic acid dihydrate; 5-Acetamido-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid dihydrate |
N-Acetylneuraminic acid 9-phosphate | 37992-17-9 | C11H20NO12P | 389.25 | |
N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE-6-O-STEAROYL | 60398-08-5 | C37H66N4O12 | 758.94 | 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine; N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE-6-O-STEAROYL; N-acetylmuramyl-6-O-stearoyl-L-alanyl-*D-isogluta; N-ACETYLMURAMYL-6-O-STEAROYL-L-ALANYL-D-ISOGLUTAMINE) |
N-Acetylmuramyl-L-alanyl-D-isoglutamine hydrate | 53678-77-6 | C19H32N4O11 xH2O | 492.48 (anydrous basis) | N-Ac-Mur-Ala-D-Glu-NH2; N-Acetylmuramyl-L-Ala-D-Glu-NH2; Muramyl dipeptide; Adjuvant peptide |
N-Acetylmuramic acid methyl ester | 99689-20-0 | C12H21NO8 | 307.30 | 2-Acetamido-3-O-(D-1-carboxyethyl)-2-deoxy-D-glucose methyl ester |
N-Acetylmesalamine-d3 | 1309935-89-4 | C9H6D3NO4 | 198.19 | 5-(Acetylamino)-2-hydroxybenzoic-d3 Acid; 3-Carboxyparacetamol-d3; 5-Acetamidosalicylic Acid-d3; CJ 46A-d3; N-Acetylmesalamine-d3; N-(Acetyl)-5-aminosalicylic Acid-d3; NSC 54183-d3; |
N-acetyl-L-Valine-15N | 355808-21-8 | C7H13[15N]O3 | 160.18 | |
N-Acetyl-L-talosaminuronic acid | 90319-06-5 | C8H13NO7 | 235.19 | |
N-Acetyl-L-cysteine ethyl ester | 59587-09-6 | C7H13NO3S | 191.245 | L-Cysteine, N-acetyl-, ethyl ester; Ethyl (2R)-2-acetamido-3-sulfanylpropanoate |
N-Acetyl-L-aspartic-2,3,3-d3 Acid | 284665-15-2 | HOOCCD2CD(NHCOCH3)COOH | 178.16 | Ac-L-Asp-OH-d3 |
N-Acetyl-L-alanine-3,3,3-d3 | 1485548-36-4 | CD3CH(NHCOCH3)COOH | 134.15 | 2-Acetamidopropionic Acid-d3; Ac-L-Ala-OH-d3 |
N-Acetyl-heparin | 134498-62-7 | |||
N-Acetylglycyl-D-glutamic acid | 135701-69-8 | C9H14N2O6 | 246.22 | (2R)-2-[(2-acetamidoacetyl)amino]pentanedioic acid |
N-Acetyl-glucosaminyl thiazoline triaacetate | 67109-74-4 | |||
N-Acetyl-glucosaminyl thiazoline | 179030-22-9 | C8H13NO4S | 219.26 | (5R,6S,7R)-5-(Hydroxymethyl)-2-methyl-5,6,7,7a-tetrahydro-3aH-pyrano[3,2-d]thiazole-6,7-diol; GlcNAc thiazoline; NAG-thiazoline |
N-Acetyl-D-quinovosamine | 40614-71-9 | C8H15NO5 | 205.21 | 2-Acetamido-2,6-dideoxy-D-glucose; N-Acetylquinovosamine; N-Acetyl-6-deoxy-D-glucosamine |
N-acetyldopamine | 2494-12-4 | C10H13NO3 | 195.218 | N-acetyldopamine |
N-Acetyl-D-mannosaminuronic acid sodium | 32452-11-2 | C8H12NO7Na | 257.17 | |
N-Acetyl-D-mannosamine | 7772-94-3 | C8H15NO6 | 221.21 | 2-Acetamido-2-deoxy-D-mannose monohydrate; 2-Acetamido-2-deoxy-D-mannopyranose |
N6-Benzoyl-8-oxo-2'-deoxyadenosine | 142948-08-1 | C17H17N5O5 | 371.32 | |
N6-Benzoyl-8-benzyloxy-2'-deoxyadenosine | 142979-40-6 | C24H23N5O5 | 461.47 | |
N6-Benzoyl-7-deaza-2'-deoxyadenosine | 95261-09-9 | C18H18N4O4 | 354.37 | |
N6-Benzoyl-5'-O-(dimethoxytrityl)-8-oxo-2'-deoxyadenosine | 142979-41-7 | C38H35N5O7 | 673.73 | |
N6-Benzoyl-5'-O-DMT-adenosine | 81246-82-4 | C38H35N5O7 | 673.73 | N6-Benzoyl-5'-O-DMT-D-adenosine |
N6-Benzoyl-5'-O-(dimethoxytrityl)-7-deaza-2'-deoxyadenosine | 90335-57-2 | C39H36N4O6 | 656.77 | |
N6-Benzoyl-5'-O-(dimethoxytrityl)-3'-deoxyadenosine | 84138-86-3 | C38H35N5O6 | 657.73 | |
N6-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyadenosine | 64325-78-6 | C38H35N5O6 | 657.71 | N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxyadenosine; 5'-O-(Dimethoxytrityl)-N-benzoyldeoxyadenosine; 5'-O-(Dimethoxytrityl)-N6-benzoyl-2'-deoxyadenosine; N6-Benzoyl-5'-O-(dimethoxytrityl)deoxyadenosine |
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide | 110764-72-2 | C39H37N5O7 | 687.7 | 5'-O-DMT-N6-BENZOYL-2'-O-METHYL-ADENOSINE; 5-O-DMT-N6-BENZOYL-2-O-METHYL-ADENOSINE; N6-BENZOYL-5'-(DIMETHOXYTRITYL)-2'-O-METHYLADENOSINE; 5'-O-(4,4'-Dimethoxytrityl)-N6-benzoyl-2'-O-methyl adenosine |
N6-Benzoyl-3'-deoxyadenosine | 76902-49-3 | C17H17N5O4 | 355.37 | |
N6-Benzoyl-3'-deoxy-5'-O-DMT-cytidine 2'-CE phosphoramidite | 157327-96-3 | C46H52N5O8P | 833.91 | N-Benzoyl-5'-dimethoxytrityl-3'-deoxycytidine-2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 3'-dC-CE Phosphoramidite; 3'-dC CEP |
N6-Benzoyl-3'-deoxy-5'-O-DMT-adenosine 2'-CE phosphoramidite | 207347-42-0 | C47H52N7O7P | 857.93 | 3'-dA-CE Phosphoramidite; N-Benzoyl-5'-dimethoxytrityl-3'-deoxyadenosine-2'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 3'-dA CEP |
N6-Benzoyl-3-deaza-2'-deoxy-5'-O-DMT-3-methyladenosine 3'-CE phosphoramidite | 666257-76-7 | C49H55N6O7P | 870.99 | 3-Deaza-dA CEP; 3-Deaza-2'-deoxy-D-adenosine 3'-CE phosphoramidite |
N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-adenosine 3'-CE phosphoramidite | 144994-95-6 | C54H67N6O8PSi | 987.20 | 7-Deaza-Adenosine CEP; N6-Benzoyl-2'-tert-butyldimethylsilyl-7-deaza-5'-O-DMT-D-adenosine 3'-CE phosphoramidite |
N6-Aminoadenosine | 5746-27-0 | C10H14N6O4 | 282.26 | |
N6-Benzoyl-2'-deoxy-5'-O-DMT-8-oxoadenosine 3'-CE phosphoramidite | 142979-42-8 | C47H52N7O8P | 873.95 | N6-Benzoyl-2'-deoxy-5'-O-DMT-8-oxo-D-adenosine 3'-CE phosphoramidite; N6-Benzoyl-5'-O-DMT-8-oxo-2'-deoxyadenosine 3'-CE phosphoramidite |
N-[[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]hydroxyphosphinyl]-D-alanine | 376633-24-8 | C12H19N6O5P | 358.29 | GS 7160 |
N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine | 82834-12-6 | C10H19NO4 | 217.26 | |
N-(4-Azido-2,3,5,6-tetrafluorobenzyl)-3-maleimidylpropionamide | 139428-49-2 | C17H15N5O3F4 | 371.25 | N-(4-Azido-2,3,5,6-tetrafluorobenzyl)-3-maleimidylpropionamide; N-(4-Azido-2,3,5,6-tetrafluorobenzyl)-3-maleimidylpropionamide (TFPAM-3) |
N-(2-Fluorophenyl)-guanidine | 41213-65-4 | C7H8FN3 | 153.16 | N-(2-FLUORO-PHENYL)-GUANIDINE |
N-(2-Fluorophenyl)-1,2-Diaminobenzene | 28898-03-5 | C12H11N2F | 0 | N-(2-FLUOROPHENYL)-1,2-DIAMINOBENZENE |
Mirtazapine-d4 | 1215898-55-7 | C17H15D4N3 | 269.38 | 1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine-d4; Org-3770-d4; Remeron-d4; Zispin-d4 |
Mirtazapine-d3 | 1216678-68-0 | C17H16D3N3 | 268.37 | 1,2,3,4,10,14b-Hexahydro-2-(methyl-d3)-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine; Org-3770-d3; Remeron-d3; Zispin-d3; |
Minocycline Impurity D (7-Aminosancycline HCl) | 95940-02-6 | C21H24ClN3O7 | 465.88 | (4S,4aS,5aR,12aS)-7-Amino-4-(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl |
Mirtazapine Impurity F (10-Oxo Mirtazapine) | 191546-97-1 | C17H17N3O | 279.34 | 1,3,4,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-10(2H)-one |
Mirtazapine Impurity E | 191546-94-8 | C17H21N3 | 267.37 | 4-Methyl-1-(3-methyl-2-pyridinyl)-2-phenylpiperazine; 2(RS)-4-Methyl-1-(3-methylpyridin-2-yl)-2-phenylpiperazine |
Mirtazapine Impurity C | 191546-96-0 | C17H17N3O | 279.34 | 1-Oxo Mirtazapine; 3,4,10,14b-Tetrahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepin-1(2H)-one |
Mirtazapine Impurity B | 61337-89-1 | C17H21N3O | 283.37 | 2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol; 1-(3-Hydroxymethyl-2-pyridyl)-4-methyl-2-phenylpiperazine; 1-[3-(Hydroxymethyl)pyridin-2-yl)-4-methyl-2-phenylpiperazine; 2-(4-Methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol |
Methyl-4-deoxy-a-L-threo-hex-4-enopyranosiduronic acid | 31718-88-4 | C7H10O6 | 190.15 | |
methyl4-chloro-6-methylquinoline-2-carboxylate | 905807-65-0 | C12H10ClNO2 | 235.67 | METHYL 4-CHLORO-6-METHYL-QUINOLINE-2-CARBOXYLATE; 2-QUINOLINECARBOXYLIC ACID, 4-CHLORO-6-METHYL-, METHYL ESTER |
N-Acetyl-D-lactosamine heptaacetate | 73208-61-4 | C28H39NO18 | 677.61 | 2-(Acetylamino)-2-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-D-glucopyranose 1,3,6-triacetate; N-Acetyllactosamine heptaacetate |
N-Acetyl-D-glucosamine | 7512-17-6 | C8H15NO6 | 221.21 | 2-Acetamido-2-deoxy-D-glucopyranose; GlcNAc |
N-Acetyl-D-lactosamine | 32181-59-2 | C14H25NO11 | 383.35 | LacNAc; Galactopyranosyl-b-1,4-N-acetyl-D-glucosamine; 2-Acetamido-2-deoxy-D-lactose; Galb1-4GlcNAc |
N-Acetyl-D-glucosamine 6-acetate | 131832-93-4 | C10H17NO7 | 263.24 | 2-(Acetylamino)-2-deoxy-D-glucose 6-acetate; (N,6-O)-Diacetyl-D-glucosamine |
N-Acetyl--D-glucosamine 1-phosphate disodium salt | 31281-59-1 | C8H15NNaO9P | 345.15 | sodium;[(2R,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]hydrogenphosphate;31281-59-1;N-Acetyl--D-glucosamine1-phosphatedisodiumsalt;N-ACETYL-ALPHA-D-GLUCOSAMINE6-PHOSPHATEDISODIUMSALT |
N-Acetyl-D-galactosamine-6-O-sulphate sodium salt | 204575-07-5 | C8H14NO9SNa | 323.25 | 2-Acetamido-2-deoxy-D-galactose 6-(hydrogen sulphate), monosodium salt |
N-Acetyl-D-galactosamine-4-O-sulphate sodium salt | 660839-03-2 | C8H14NO9SNa | 323.25 | 2-Acetamido-2-deoxy-D-galactose 4-(hydrogen sulphate) monosodium salt |
N-Acetyl-D-galactosamine-4,6-di-O-sulphate sodium salt | 157296-98-5 | C8H13NO12S2Na2 | 425.29 | 2-Acetamido-2-deoxy-D-galactose 4,6-bis(hydrogen sulphate) sodium salt |
N-Acetyl-D-galactosamine | 1811-31-0 | C8H15NO6 | 221.21 | GalNAc; 2-Acetamino-2-deoxy-a-D-galactopyranose; N-Acetylchondrosamine |
N-Acetyl-D-galactopyranosamine | 14215-68-0 | C8H15NO6 | 221.209 | GalNAc; 2-acetamido-2-deoxy-D-galacto-hexopyranose; N-[(3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide |
N-Acetyldesloratadine | 117796-52-8 | C21H21ClN2O | 352.86 | 1-[4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinyl]-ethanone; 1-Acetyl-4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine |
N-ACETYL-D-ALA-D-ALA | 19993-26-1 | C8H14N2O4 | 202.20776 | acetylalanylalanine; N-ACETYL-D-ALA-D-ALA |
N-acetyl-D-[UL-13C6]glucosamine | 478518-83-1 | 13C6C2H15NO6 | 227.16 | 2-acetamido-2-deoxy-D-[UL-13C6]glucose |
N-Acetyl-d3-glycine-2,2-d2 | 1219805-82-9 | CD3CONHCD2COOH | 122.13 | Acetamidoacetic Acid-d5; Aceturic Acid-d5; Ac-Gly-OH-d5; 2,2-dideuterio-2-[(2,2,2-trideuterioacetyl)amino]acetic acid |
N-acetyl-D-[UL-13C6;15N]glucosamine | 478529-41-8 | 13C6C2H1515NO6 | 228.15 | 2-[15N]acetamido-2-deoxy-D-[UL-13C6]glucose |
N-acetyl-D-[2-13C]glucosamine | 478529-39-4 | 13CC7H15NO6 | 222.2 | 2-acetamido-2-deoxy-D-[2-13C]glucose |
N-acetyl-D-[1-13C]glucosamine | 253679-94-6 | 13CC7H15NO6 | 222.2 | 2-acetamido-2-deoxy-D-[1-13C]glucose |
N-Acetyl-a-D-glucosamine-1-phosphate disodium salt | 374726-40-6 | C8H14NO9P 2Na | 345.15 | N-Acetyl-D-glucosamine-1-phosphate disodium salt |
N-Acetyl-a-D-glucosamine | 10036-64-3 | C8H15NO6 | 221.21 | N-[(2S,3R,4R,5S,6R)-2,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl]acetamide; 2-Acetamido-2-deoxy-a-D-glucopyranose |
N-Acetyl-9-O-(N-acetyl-a-neuraminosyl)-neuraminic acid | 96425-77-3 | C22H36N2O17 | 600.52 | 5-(Acetylamino)-9-O-(N-acetyl-a-neuraminosyl)-3,5-dideoxy-D-glycero-D-galacto-2-nonulosonic acid |
N-Acetyl-9-azido-9-deoxy-neuraminic acid | 76487-51-9 | C11H18N4O8 | 334.28 | 5-(Acetylamino)-9-azido-3,5,9-trideoxy-D-glycero-D-galacto-2-nonulosonic acid; 9-Azido-N-acetylneuraminic acid |
N-Acetyl-5'-O-DMT-2'-O-[[[tris(1-methylethyl)silyl]oxy]methyl]-adenosine 3'-CE phosphoramidite | 253586-13-9 | C52H72N7O9PSi | 998.23 | |
N-Acetyl-5-methoxy serine | 98632-99-6 | C6H11NO4 | 161.15600 | |
N-Acetyl-5-[1,2-bis(acetyloxy)ethyl]-5'-O-DMT-2'-deoxycytidine 3'-CE phosphoramidite | 364613-34-3 | C47H58N5O12P | 915.96 | Masked 5-formyl-dC CEP |
N-Acetyl-5-[1,2-bis(acetyloxy)ethyl]-5'-O-DMT-2'-deoxycytidine | 364613-33-2 | C47H58N5O12P | 915.96 | |
N-Acetyl-4,6-(p-methoxybenzylidene)-2-deoxy-1-O-methyl-a-D-galactosamine | 188666-34-4 | C17H23NO7 | 353.37 | Methyl 2-(acetylamino)-2-deoxy-4,6-O-[(4-methoxyphenyl)methylene]-a-D-galactopyranoside |
N-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)adenosine | 828247-65-0 | C23H41N3O7Si2 | 527.76 | |
N-Acetyl-3-(3-pyridyl)-alanine | 170092-30-5 | C10H12N2O3 | 208.21400 | |
N-acetyl-3-(2,5-difluorophenyl)-D-alanine | 266360-55-8 | C11H11F2NO3 | 243.21 | |
N-Acetyl-2-piperidone | 3326-13-4 | C7H11NO2 | 141.16 | N-Acetyl-2-piperidone; 1-Acetyl-piperidin-2-one |
N-Acetyl-2-O-propargyl-a-neuraminic acid | 1208376-36-6 | C14H21NO9 | 347.32 | |
N-Acetyl-2-O-methyl-a-neuraminic acid methyl ester 4,7,8,9-tetraacetate | 73208-80-7 | C21H31NO13 | 505.47 | Methyl(methyl-5-acetamido-4,7,8,9-tetra-D-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranoside)onate |
N-acetic acid-1-aMino-3-adaMantanol | 1032564-18-3 | C12H19NO3 | 225.29 | Vildagliptin Impurity 4; N-acetic acid-1-aMino-3-adaMantanol; (3-hydroxyadamantan-1-ylamino)acetic acid; 2-((3-Hydroxyadamantan-1-yl)amino)acetic acid |
Nabumetone-d3 | 1216770-08-9 | C15H13O2D3 | 231.31 | 4-[6-(Methoxy-d3)-2-naphthalenyl]-2-butanone; 1-(2'-Methoxy-d3-naphth-6'-yl)butan- 3-one; 4-[6-(Methoxy-d3)-2-naphthyl]-2-butanone |
Nabumetone impurity F | 29619-45-2 | C22H18O2 | 314.37712;g/mol | UNII-PQZ1W35X4K; 6,6'-Dimethoxy-2,2'-binaphthalene; NSC-408779; 29619-45-2; 2-methoxy-6-(6-methoxynaphthalen-2-yl)naphthalene; NSC408779 |
Nabumetone Impurity E | 343272-53-7 | C27H26O3 | 398.51 | Nabumetone Dimer Impurity; 1,5-Bis(6-methoxy-2-naphthalenyl)-3-pentanone; |
Nabumetone | 42924-53-8 | C15H16O2 | 228.29 | BRL-14777; BRL 14777; BRL14777 |
NAB 2 | 1504588-00-4 | C23H20ClN3O | 389.88 | N-[(2-Chlorophenyl)methyl]-1-(2,5-dimethylphenyl)-1H-benzimidazole-5-carboxamide |
NAADP tetrasodium salt | 5502-96-5 | C21H23N6Na4O18P3 | 832.32 | Nicotinic acid adenine dinucleotide phosphate tetrasodium salt |
NA4 N-Glycan | 82867-74-1 | C90H150N6O66 | 2372.15 | A4G4 N-Glycan; Asialo, galactosylated, tetra-antennary N-linked glycan; [Gal-GlcNAc]4-Man3-GlcNAc2 |
NA3F N-Glycan | 115142-60-4 | C82H137N5O60 | 2152.96 | Asialo, fucosylated, triantennary N-linked glycan |
NA3 N-Glycan | 82867-73-0 | C76H127N5O56 | 2006.82 | A3G3 N-Glycan; Asialo, galactosylated, tri-antennary N-linked glycan; (Gal-GlcNAc)3-Man3-GlcNAc2 |
NA2FB N-Glycan | 1598374-91-4 | C76H127N5O55 | 1990.82 | Asialo, galactosylated, fucosylated, bisected, bi-antennary N-linked glycan |
NA2F N-Glycan | 1309851-94-2 | C68H114N4O50 | 1787.63 | FA2G2 N-Glycan; Asialo, galactosylated, fucosylated, bi-antennary N-linked glycan; (Gal)2(GlcNAc)2(Man)3(GlcNAc)2Fuc; Mannotriose-[fucosyl-di-(N-acetylglucosamine)] bis(galactosyl-N-acetylglucosaminyl) |
N7-(2-Hydroxyethyl)adenine | 126595-74-2 | C7H9N5O | 179.18 | 6-Amino-7H-purine-7-ethanol |
N6-Phenyl-ATP | 105740-47-4 | C16H20N5O13P3(free acid) | 583.28 (free acid) | N; -Phenyladenosine-5'-O-triphosphate, Sodium salt |
N6-Phenyladenosine | 23589-16-4 | C16H17N5O4 | 343.34 | N6-Phenylaminopurine riboside |
N6-Octanoyl Cordycepin | 77378-05-3 | C18H27N5O4 | 377.44 | 3'-Deoxy-N-(1-oxooctyl)adenosine; N6-Octanoyl-3'-deoxyadenosine |
N6-Methyl-ATP | 3130-39-0 | C11H18N5O13P3(free acid) | 521.21 (free acid) | m6ATP; N; -Methyl-adenosine-5'-triphosphate, Sodium salt |
N6-Methyl-adenosine | 60209-41-8 | C11H15N5O4 | 281.27 | (-)-6-(Methylamino)purine riboside |
N6-methyladenosine | 1867-73-8 | C11H15N5O4 | 281.27 | Adenosine, N-methyl-; 6-Methyladenosine; N(6)-Methyladenosine |
N6,2'-O-dimethyladenosine | 57817-83-1 | C12H17N5O4 | 295.3 | Adenosine, N-methyl-2'-O-methyl-; N(6),O(2)-Dimethyladenosine; n6,2'-O-dimethyladenosine |
N6-Lauroyl Cordycepin | 77378-06-4 | C22H35N5O4 | 433.54 | 3'-Deoxy-N-(1-oxododecyl)adenosine |
N6-Isopentenyladenosine-5'-monophosphate Sodium Salt | 128030-99-9 | 415.34 | N-(3-Methyl-2-buten-1-yl)-5'-adenylic Acid Sodium Salt; 6-(2-Isopentenyl)adenosine 5'-Monophosphate Sodium Salt; Isopentenyladenine Ribotide Sodium Salt; Isopentenyladenosine 5'-Phosphate Sodium Salt; Isopentenyladenosine-5'-monophosphate Sodium Salt; N-( | |
N,N,2',3'-Tetrabenzoyladenosine | 58463-04-0 | C38H29N5O8 | 683.67 | N,N-Dibenzoyladenosine 2',3'-Dibenzoate |
N6-Cyclopropyl-9H-purine-2,6-diamine Methanolate | 120503-69-7 | C8H10N6 | 190.21 | Cyclopropyldiaminopurine Abacavir; 2-Amino-6-cyclopropylamino-9H-purine Methanolate |
N6-Cyclopentyl-ATP | 189822-11-5 | C15H24N5O13P3(free acid) | 575.30 (free acid) | N; -Cyclopentyladenosine-5'-O-triphosphate, Sodium salt |
N6-Cyclopentyl-adenosine | 41552-82-3 | C15H21N5O4 | 335.36 | CPA |
N6-Cyclohexyladenosine | 36396-99-3 | C16H23N5O4 | 349.38 | Cyclohexyladenosine; N-Cyclohexyladenosine; (2R,3R,4S,5R)-2-[6-(cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
N6-Carbamoyl threonyl adenosine | 24719-82-8 | C15H19N6O8.Na | 434.34 | |
N6-Benzyl-ATP | 40922-97-2 | C17H22N5O13P3(free acid) | 597.30 (free acid) | N; -Benzyl-adenosine-5'-triphosphate, Sodium salt |
N6-Benzyl-ADP | 40811-89-0 | C17H21N5O10P2(free acid) | 517.32 (free acid) | N; -Benzyl-adenosine-5'-diphosphate, Sodium salt |
N6-Benzyladenine-7-glucoside | 56159-42-3 | C18H21N5O5 | 387.39 | 6-Benzylamino-7-b-D-glucopyranosylpurine |
N6-Benzyladenine-3-glucoside | 56159-41-2 | C18H21N5O5 | 387.39 | 6-benzylamino-3-b-D-glucopyranosylpurine |
N6-(Diisobutylaminomethylidene)-2'-deoxyisoguanosine | 207981-31-5 | C19H30N6O4 | 406.49 | |
N6-(6-Aminohexyl)-2'-deoxyadenosine | 147218-60-8 | C16H26N6O3 | 350.43 | |
N6-(6-Amino)hexyl-dATP | 106519-33-9 | C16H29N6O12P3(free acid) | 590.36 (free acid) | N6-(6-Amino)hexyl-2'-deoxyadenosine-5'-triphosphate |
N6-(6-Amino)hexyl-ATP-Biotin | 126320-25-0 | C26H43N8O15P3S (free acid) | 832.65 (free acid) | N6-(6-Amino)hexyl-adenosine-5'-triphosphate-Biotin |
N6-(6-Amino)hexyl-ATP | 53602-93-0 | C16H29N6O13P3(free acid) | 606.35 (free acid) | N6-(6-Amino)hexyl-adenosine-5'-triphosphate |
N6-(4-Amino)butyl-ATP | 280577-98-2 | C14H25N6O13P3(free acid) | 578.30 (free acid) | N6-(4-Amino)butyl-adenosine-5'-triphosphate |
N6-(2-Phenylethyl)-adenosine | 20125-39-7 | C18H21N5O4 | 371.39 | 2-(hydroxymethyl)-5-[6-(2-phenylethylamino)purin-9-yl]oxolane-3,4-diol |
N6-(2-Hydroxyethyl)-2'-deoxyadenosine | 137058-94-7 | C12H17N5O4 | 295.29 | 2'-Deoxy-N-(2-hydroxyethyl)adenosine |
N6-(1-Deoxy-D-fructos-1-yl)-N2-[(phenylmethoxy)carbonyl]-L-Lysine | 170929-44-9 | C20H30N2O9 | 442.46 | |
N4-Ethyl-2'-deoxycytidine | 70465-61-1 | C11H17N3O4 | 255.25 | |
N-4-Cbz-2-piperazinecarboxylic acid | 64172-98-1 | C13H16N2O4 | 264.28 | 4-CBZ-2-PIPERAZINECARBOXYLIC ACID; 4-CBZ-PIPERAZINE-2-(+/-)-CARBOXYLIC ACID; 4-CBZ-PIPERAZINE-2-CARBOXYLIC ACID; 4-N-CBZ-2-PIPERAZINE CARBOXYLIC ACID; PIPERAZINE-1,3-DICARBOXYLIC ACID 1-BENZYL ESTER; N-4-CBZ-2-PIPERAZINECARBOXYLIC ACID; Piperazine-2-carbo |
N-4-Boc-N-1-Fmoc-2-piperazine carboxylic acid | 183742-23-6 | C25H28N2O6 | 452.49962;g/mol | 183742-23-6; N-4-Boc-N-1-Fmoc-2-piperazinecarboxylicacid; 4-boc-1-fmoc-2-piperazinecarboxylicacid; 1-(((9h-fluoren-9-yl)methoxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylicacid; 1-Fmoc-4-Boc-piperazine-2-carboxylicacid; 4-(tert-butoxycarbonyl) |
N-4-Boc-N-1-Cbz-2-piperazine carboxylic acid | 126937-41-5 | C18H24N2O6 | 364.39 | 126937-41-5; N-4-Boc-N-1-Cbz-2-piperazinecarboxylicacid; 4-Boc-1-Cbz-2-piperazinecarboxylicacid; 1-((Benzyloxy)carbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylicacid; 1-(benzyloxycarbonyl)-4-(tert-butoxycarbonyl)piperazine-2-carboxylicacid; 4-Boc-1- |
N-4-Boc-2-piperazinecarboxylic acid tert-butyl ester | 438631-75-5 | C14H26N2O4 | 286.36 | di-tert-butyl piperazine-1,3-dicarboxylate; REF DUPL: N-4-Boc-2-piperazinecarboxylic acid tert-butyl ester |
N-4-Boc-2-Piperazinecarboxylic acid methyl ester | 129799-08-2 | |||
N-4-Boc-2-piperazineacetic acid methyl ester | 183742-33-8 | C12H22N2O4 | 258.31 | TERT-BUTYL 3-(2-METHOXY-2-OXOETHYL)PIPERAZINE-1-CARBOXYLATE; N-4-BOC-2-PIPERAZINEACETIC ACID METHYL ESTER; METHYL 4-BOC-PIPERAZINE-2-ACETATE; METHYL PIPERAZIN-2-YLACETATE, N4-BOC PROTECTED; 3-METHOXYCARBONYLMETHYL-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL E |
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]cytidine | 81246-76-6 | C37H35N3O8 | 649.7 | Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-; N-(1-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; N-Benzoyl-5'-O-(4,4'-dimethoxytrityl)cytidine |
N4-Benzoyl-5'-O-DMT-2'-deoxycytidine 3'-CE phosphoramidite | 102212-98-6 | C46H52N5O8P | 833.93 | |
N4-Benzoyl-5-(furan-2-yl)-2'-deoxycytidine | 1119734-59-6 | C20H19N3O6 | 397.38 | |
N4-Benzoyl-2'-O-methylcytidine | 52571-45-6 | C17H19N3O6 | 361.36 | |
N4-Benzoyl-2'-deoxy-5'-O-DMT-5-methylcytidine 3'-CE phosphoramidite | 105931-57-5 | C47H54N5O8P | 847.93 | N4-Bz-5'-DMT-5-Me-dC phosphoramidite; N4-Benzoyl-2'-Deoxy-5'-O-DMT-5-methyl-D-cytidine 3'-CE phosphoramidite; N4-Benzoyl-5'-O-DMT-5-methyl-2'-Deoxycytidine 3'-CE phosphoramidite |
N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite | 182495-83-6 | C47H53FN5O8P | 865.92 | |
N4-Benzoyl-2'-deoxy-5'-O-DMT-2',2'-difluorocytidine 3'-CE phosphoramidite | 142808-44-4 | C46H50F2N5O8P | 869.89 | Gemcitabine amidite; Gemcitabine 3'-CE phosporamidite |
N4-Anisoyl-2'-deoxycytidine | 48212-99-3 | C17H19N3O6 | 361.35 | N4-p-Anisoyl-2'-deoxy-D-cytidine |
N4-Acetyl-5'-O-DMT-2'-O-triisopropylsilyloxymethyl-5-methylcytidine 3'-CE phosphoramidite | 872548-65-7 | C52H74N5O10PSi | 988.23 | N4-Acetyl-5'-O-DMT-2'-O-TOM-5-methylcytidine 3'-CE phosphoramidite; 5-MeC-CE Phosphoramidite |
N4-Acetyl-5'-O-DMT-cytidine | 121058-82-0 | C32H33N3O8 | 587.63 | |
N4-Acetyl-5'-O-DMT-2'-O-propynylcytidine 3'-CE phosphoramidite | 1498305-51-3 | C44H52N5O9P | 825.89 | |
N4-Acetyl-5'-O-DMT-2'-O-methylcytidine | 199593-08-3 | C33H35N3O8 | 601.65 | N4-Acetyl-5'-O-DMT-2'-O-methyl-D-cytidine |
N4-Acetyl-3'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine | 123956-65-0 | C38H47N3O8Si | 701.88 | 5'-DMT-3'-TBDMS-N4-Ac-rC |
N4-Acetyl-5'-O-(dimethoxytrityl)-5-methyl-2'-O-methylcytidine | 869355-20-4 | C34H37N3O8 | 615.68 | |
N4-Acetyl-5-methylcytidine | 31077-96-0 | |||
N4-Acetyl-3'-O-acetyl-2'-deoxycytidine | 70284-47-8 | C13H17N3O6 | ||
N4-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)cytidine | 85335-73-5 | C23H41N3O7Si2 | 527.76 | 3',5'-O-TIPPS-N4-acetylcytidine; N4-Acetyl-3',5'-O-TIPPS-cytidine; N4-Acetyl-3',5'-O-(1,1,3,3-tetraisopropyl-1,3-disiloxanediyl)-D-cytidine |
N4-Acetyl-2'-O-tert-butyldimethylsilyl-cytidine | 119794-51-3 | C17H29N3O6Si | 399.51 | |
N4-Acetyl-2'-O-tert-butyldimethylsilylcytidine | 401812-97-3 | C17H29N3O6Si | 399.51 | |
N4-Acetyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-cytidine | 121058-85-3 | C38H47N3O8Si | 701.88 | |
N4-Acetyl-2'-deoxycytidine | 32909-05-0 | C11H15N3O5 | 269.25 | N4-Acetyl-2'-deoxy-D-cytidine |
N4-Acetyl-2'-deoxy-5'-O-DMT-cytidine | 100898-63-3 | C32H33N3O7 | 571.62 | 5'-DMT-N4-acetyl-2'-deoxycytidine; DMT-N4-Ac-dC; N4-Acetyl-5'-O-DMT-2'-deoxy-D-cytidine |
N4-Acetyl-2'-deoxy-5'-O-DMT-5-methylcytidine 3'-CE phosphoramidite | 1873306-74-1 | C42H52N5O8P | 785.86 | N-Acetyl-5'-(4,4'-dimethoxytrityl)-5-methyl-2'-deoxycytidine 3'-[(2-cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite; 5-Methyl-dC(ac) amidite; DMT-5-Methyl-dC(ac) Phosphoramidite |
N4-Acetyl-2'-deoxy-2'-fluorocytidine | 159414-97-8 | C11H14FN3O5 | 287.24 | N4-Acetyl-2'-deoxy-2'-fluoro-D-cytidine; N4-Acetyl-2'-fluoro-2'-deoxycytidine |
N4-(Diisobutylaminomethylidene)-5'-O-(dimethoxytrityl)-5-(1-propynyl)-2'-O-methylcytidine | 869355-38-4 | C43H52N4O7 | 736.91 | |
N-4-(1-Pyrene)butyroylglycine | 228414-55-9 | C22H19NO3 | 345.396 | Py-Gly; N-[1-Oxo-4-(1-pyrenyl)butyl]glycine; |
N3PT | 13860-66-7 | C13H19Cl2N3OS | 336.28 | N3-pyridyl thiamine |
N3-Phenacyl-UDP | 917567-60-3 | C17H20N2O13P2(free acid) | 522.29 (free acid) | N; -Phenacyl-uridine-5'-diphosphate, Sodium salt |
N3-Benzyl-pyridine-2,3-diamine | 79707-12-3 | C12H13N3 | 199.26 | |
3-methyluridine | 2140-69-4 | C10H14N2O6 | 258.23 | Uridine, 3-methyl-; 3-Methyluridine; N-3-Methyluridine |
N2-Ethyl-6-(methylthio)-1,3,5-triazine-2,4-diamine | 4147-58-4 | C6H11N5S | 185.25 | 2-N-ethyl-6-methylsulfanyl-1,3,5-triazine-2,4-diamine |
N3,N3,N6,N6-Tetrakis[4-(dibutylamino)phenyl]-1,4-cyclohexadiene-3,6-diaminium hexafluoroantimonate (1:2) | 5496-71-9 | C62H92N6.2(SbF6) | 1120.35 | IR-ABSORBER 2052 COMPOUND B; IRG-22; DYE 1602; TETRAKIS-(P-DI-N-BUTYLAMINOPHENYL)-P-BENZOQUINONE-BIS-(AMMONIUM-HEXAFLUOROANTIMONATE); QUENCHER IRG-22; N,N,N',N'-TETRAKIS-(4-DIBUTYLAMINO-PHENYL)-PHENYLENE-1,4-DIAMMONIUM BIS-HEXAFLUOROANTIMONATE |
N2-Trityl Olmesartan Medoxomil | 1020157-01-0 | C48H44N6O6 | 800.92 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (5-Methyl-2-oxo -1,3-dioxol-4-yl)methyl Ester; |
N2-DMF-9-(2'-deoxy-5'-O-DMT-b-D-ribofuranosyl)purine 3'-CE phosphoramidite | 178925-41-2 | C43H53N8O6P | 808.93 | 2-(-Dimethylaminomethylidene)amino-9-(2-deoxy-b-D-ribofuranosyl)purine 3'-CE phosphoramidite |
N2,N2-dimethylguanosine | 2140-67-2 | C12H17N5O5 | 311.3 | Guanosine, N2,N2-dimethyl-; N2,N2-Dimethylguanosine; N2-Dimethylguanosine |
Lisinopril Impurity 18 | 116169-90-5 | C20H27F3N2O5 | 432.43 | N2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-N6-(2,2,2-trifluoroacetyl)-L-lysine |
N2-(1-oxohexadecyl)-L-arginine | 58725-47-6 | C22H44N4O3 | 412.60976 | |
N2-(1-Methylethyl)-6-(methylthio)-1,3,5-triazine-2,4-diamine | 4147-57-3 | C7H13N5S | 199.28 | 6-(methylsulfanyl)-N-(propan-2-yl)-1,3,5-triazine-2,4-diamine |
N1-Methyladenosine hydroiodide | 208845-22-1 | C11H16IO4N5 | 409.18 | |
1-methylpseudouridine | 13860-38-3 | C10H14N2O6 | 258.23 | 2,4(1H,3H)-Pyrimidinedione, 1-methyl-5-b-D-ribofuranosyl-; 1-Methylpseudouridine; N1-Methylpseudouridine |
N1-Methoxymethyl picrinine | 1158845-78-3 | C22H26N2O4 | 382.5 | |
N1-methyl-2'-deoxyguanosine | 5132-79-6 | C11H15N5O4 | 281.27 | |
N1-Acetyl Triethylenetetramine | 141998-21-2 | C8H20N4O | 188.27 | N-[2-({2-[(2-aminoethyl)amino]ethyl}amino)ethyl]acetamide; N-acetyl-3,6-diazaoctane-1,8-diamine; N-(2-((2-((2-Aminoethyl)amino)ethyl)amino)ethyl)acetamide; N-Acetyltrien |
N106 | 862974-25-2 | C17H14N4O3S | 354.38 | 4-Methoxy-N-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl-2-benzothiazolamine |
N1,N10-Diacetyl triethylenetetramine | 141998-22-3 | C10H22N4O2 | 230.31 | N,N'-[1,2-Ethanediylbis(imino-2,1-ethanediyl)]bisacetamide; N1,N10-Diacetyltriethylenetetramine |
N1,O2'-Dimethyladenosine Monohydriodide | 59867-24-2 | C12H18IN5O4 | 423.21 | 1-Methyl-2'-O-methyl-adenosine Monohydriodide |
N1,N10-Bis(p-coumaroyl)spermidine | 114916-05-1 | C25H31N3O4 | 437.5 | (2E)-3-(4-Hydroxyphenyl)-N-{3-[(4-{[(2E)-3-(4-hydroxyphenyl)-2-pr openoyl]amino}butyl)amino]propyl}acrylamide |
N-[2-(4-Aminophenyl)ethyl]-adenosine | 89705-21-5 | C18H22N6O4 | 386.41 | APNEA;Adenosine, N6-2-(4-aminophenyl)ethyl;(2R,3R,4S,5R)-2-[6-[2-(4-aminophenyl)ethylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol |
N-[2-(3-Methoxyphenyl)ethyl]-N-methylamine | 33543-62-3 | C10H15NO | 165.2340 | N-[2-(3-Methoxyphenyl)ethyl]-N-methylamine |
N'-[2-(3-methoxyphenoxy)propyl]-2-(3-methylphenyl)ethanimidamide | 6443-50-1 | C19H24N2O2 | 312.406 g/mol | |
N-(3,4-Dimethoxyphenethyl)formamide | 14301-36-1 | C11H15NO3 | 209.24 | N-Formyl-2-(3,4-dimethoxyphenyl)ethylamine; NSC 34982; [2-(3,4-Dimethoxyphenyl)ethyl]formamide |
N-[2-(2-Methoxyphenoxy)ethyl]benzyl amine | 3246-03-5 | C16H19NO2 | 257.34 | N-Benzyl-2-(2-methoxyphenoxy)ethylamine; N-[2-(o-Methoxyphenoxy)ethyl]benzylamine; N-[2-(2-Methoxyphenoxy)ethyl]benzenemethanamine; |
N-[2-(1-piperazinyl)ethyl]ethylenediamine | 24028-46-4 | C8H20N4 | 172.2712 | N-[2-(1-piperazinyl)ethyl]ethylenediamine; 1,2-Ethanediamine, N-2-(1-piperazinyl)ethyl-; 1,2-Ethanediamine,N-[2-(1-piperazinyl)ethyl]-(9CI); N-[2-(1-piperazinyl)ethyl]-1,2-Ethanediamine; n-[2-(1-piperazinyl)ethyl]-2-ethanediamine; N-(2-PIPERAZIN-1-YLETHYL |
N-(S-Nitroso-N-acetyl-D,L-penicillamine)-2-amino-2-deoxy-1,3,4,6-tetra-O-acetyl-b-D-glucopyranose | 202656-49-3 | C21H31N3O12S | 549.55 | 2-[[(2S)-2-(Acetylamino)-3-methyl-3-(nitrosothio)-1-oxobutyl]amino]-2-deoxy-b-D-glucopyranose 1,3,4,6-tetraacetate; RIG200 |
N-[1-13C]acetyl-D-glucosamine | 478518-87-5 | 13CC7H15NO6 | 222.2 | 2-[1-13C]acetamido-2-deoxy-D-glucose |
N-[1,5-bis[4-(trifluoromethyl)phenyl]penta-1,4-dien-3-ylideneamino]-5,5-dimethyl-4,6-dihydro-1H-pyrimidin-2-amine | 67485-29-4 | C25H24F6N4 | 494.48 | TETRAHYDRO-5,5-DIMETHYL-2(1H)-PYRIMIDINONE [3-[4-(TRIFLUOROMETHYL)-PHENYL]-1-[2-[4-(TRIFLUOROMETHYL)-PHENYL]ETHENYL]-2-PROPENYLIDENE]-HYDRAZONE; Tetrahydro-5,5-dimethyl-2(1H)-pyrimidinone[3-[4-(trifluoromethyl)phenyl]-1-[2-[4-(trifluoromethyl)phenyl]ethen |
N-[1,2-Dihydro-1-[(2R,6S)-6-(hydroxymethyl)-2-morpholinyl]-2-oxo-4-pyrimidinyl]-benzamide | 125455-77-8 | C16H18N4O4 | 330.34 | (2R-cis)-N-[1,2-Dihydro-1-[6-(hydroxymethyl)-2-morpholinyl]-2-oxo-4-pyrimidinyl]-benzamide |
N-[1,2-13C2]acetyl-D-glucosamine | 157668-96-7 | 13C2C6H15NO6 | 223.19 | 2-[1,2-13C2]acetamido-2-deoxy-D-glucose |
N-[1,2-13C2]acetyl-D-[UL-13C6]glucosamine | 478529-42-9 | 13C8H15NO6 | 229.14 | 2-[1,2-13C2]acetamido-2-deoxy-D-[UL-13C6]glucose |
N-[1,2-13C2]acetyl-D-[UL-13C6;15N]glucosamine | 478529-44-1 | 13C8H1515NO6 | 230.13 | 2-[1,2-13C2;15N]acetamido-2-deoxy-D-[UL-13C6]glucose |
N-[1,2-13C2]acetyl-D-[1-13C;15N]glucosamine | 478529-43-0 | 13C3C5H1515NO6 | 225.18 | 2-[1,2-13C2;15N]acetamido-2-deoxy-D-[1-13C]glucose |
N-[[4-[(4,10-Dihydro-1-methylpyrazolo[3,4-b][1,5]benzodiazepin-5(1H)-yl)carbonyl]-2-methylphenyl]methyl]-4-[(3,5-dihydroxyphenyl)methyl]-1-piperazinecarboxamide dihydrochloride | 847375-16-0 | C32H35N7O4.2HCl | 654.59 | |
N-[[4-(Chloromethyl)phenyl]methyl]acrylamide | 84787-85-9 | C11H12ClNO | 209.67200 | |
N-[(Dimethylamino)methylene]-2',3'-O-(methoxymethylene)guanosine | 1315092-28-4 | C15H20N6O6 | 380.36 | |
N-[(Dimethylamino)methylene]-2',3',5'-tris-O-[(1,1-dimethylethyl)dimethylsilyl]-adenosine | 1612841-25-4 | C31H60N6O4Si3 | 665.1 | (Z)-N'-(9-((2R,3R,4R,5R)-3,4-Bis((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)-N,N-dimethylformimidamide |
N-[(Acetyl-methyl-amino)-ethenyl-methyl-silyl]-N-methyl-acetamide | 50791-87-2 | C9H18N2O2Si | 200.31034 | N-[(Acetyl-methyl-amino)-ethenyl-methyl-silyl]-N-methyl-acetamide; N,N'-(Vinylsilylene)bis(N-methylacetamide) |
N'-[(6-Methyl-2-pyridyl)methylene]pyrrolidine-1-carbothiohydrazide | 907549-72-8 | C12H16N4S | 248.35 | |
N-[(4-Aminophenyl)methyl]adenosine | 95523-13-0 | C17H20N6O4 | 372.37 | N6-[(P-Aminobenzyl)adenosine |
N-[(3-dimethylamino)-propyl] methacrylamide (DMAPAA) | 3845-76-9 | C8H16N2O | 156.22544;g/mol | 3845-76-9;N-(3-(Dimethylamino)propyl)acrylamide;N,N-Dimethylaminopropylacrylamide;N-[3-(Dimethylamino)propyl]acrylamide;N-(3-Dimethylaminopropyl)acrylamide;N-[3-(dimethylamino)propyl]prop-2-enamide |
N-[(3-(Anilinomethylene)-2-chloro-1-cyclohexen-1-yl)methylene]aniline monohydroChloride | 63857-00-1 | C20H19ClN2.HCl | 359.29 | N-[(2-CHLORO-1-PHENYLIMINOMETHYL-1-CYCLOHEXENE-3-YLIDENE)METHYL]ANILINE HYDROCHLORIDE; N-[(3-(ANILINOMETHYLENE)-2-CHLORO-1-CYCLOHEXEN-1-YL)METHYLENE]ANILINE MONOHYDROCHLORIDE; N-((3-[ANILINOMETHYLIDENE]-2-CHLORO-1-CYCLOHEXEN-1-YL)METHYLIDENE)ANILINE HYDRO |
N,N-Diacetyl-3,6,3,4,6-penta-O-acetyl-1-chlorochitobioside | 7531-49-9 | C26H37ClN2O15 | 653.03 | 2-(Acetylamino)-2-deoxy-4-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]-a-D-glucopyranosyl chloride 3,6-diacetate; 2-Acetamido-4-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-2-deoxy-glucopyranosyl chloride 3,3,4,6,6-pentaacetate |
N,N-Dimethylglycine Methyl Ester | 7148-06-3 | C5H11NO2 | 117.14600 | |
n,n-dimethylglycine hydrochloride | 2491-06-7 | 139.58 | ||
N,N-Dimethylformamide-d | 2914-27-4 | C3H7NO | 74.10 | 1-deuterio-N,N-dimethylformamide; N,N-Dimethylformamide-d; N,N-Dimethylformamide-d1; 2914-27-4; 392901_ALDRICH; DE795 |
N,N-Dimethylformamide sulfur trioxide complex | 29584-42-7 | C3H7NO4S | 153.16 | SULFUR TRIOXIDE DIMETHYLFORMAMIDE COMPLEX; SULFUR TRIOXIDE N,N-DIMETHYLFORMAMIDE COMPLEX; N,N-DIMETHYLFORMAMIDE SULFUR TRIOXIDE COMPLEX; n,n-dimethyl-formamidcompd.withsulfurtrioxide(1:1); N,N-dimethylformamide, compound with sulphur trioxide; Sulphur tri |
N,N-DIMETHYLFORMAMIDE (CARBONYL-13C1) | 32488-43-0 | C3H7NO | 74.1 | N,N-DIMETHYLFORMAMIDE-CARBONYL-13C; N,N-DIMETHYLFORMAMIDE (CARBONYL-13C1); N,N-DIMETHYLFORMAMIDE-CARBONYL-13C, 99 A TOM % 13C; n,n-dimethylform-13c-amide |
N,N-Dimethyl-d6-glycine HCl | 347840-03-3 | 145.62 | N-Methylsarcosine-d6 HCl; (Dimethylamino)acetic Acid-d6 HCl; N-Me-Sar-OH-d6 HCl; N-Me2-Gly-OH-d6 HCl; 2-[bis(trideuteriomethyl)amino]acetic acid hydrochloride | |
N,N-Dimethyl-d3-glycine HCl (N-methyl-d3) | 1219795-14-8 | 142.6 | N-Methylsarcosine-d3 HCl; (Dimethylamino)acetic Acid-d3 HCl; N-Me-Sar-OH-d3 HCl; N-Me2-Gly-OH-d3 HCl | |
N,N-Dimethylcyclohexane-1,4-diamine | 42389-50-4 | C8H18N2 | 142.24 | N,N-DIMETHYL-CYCLOHEXANE-1,4-DIAMINE; N1,N1-DIMETHYLCYCLOHEXANE-1,4-DIAMINE; 4-(N,N-Dimethylamino) cyclohexylamine |
N,N-Dimethylbenzene-1,4-diammonium sulfate | 60160-75-0 | C16H26N4O4S | 370.47 | 4-benzenediamine,n,n-dimethyl-sulfate(2:1); n,n-dimethyl-1,4-benzenediaminesulfate(2:1); n,n-dimethyl-p-phenylenediaminehemisulfate; n,n-dimethyl-p-phenylenediaminhemisulfate; N,N-DIMETHYL-P-PHENYLENEDIAMINE SULFATE; N,N-dimethylbenzene-1,4-diammonium sul |
N,N-Dimethylaniline sulfate | 58888-49-6 | C8H11N.H2SO4 | 219.25 | N,N-dimethylaniline; Dimethylaniline; Dimethylphenylamine; 121-69-7; N,N-Dimethylbenzenamine; (Dimethylamino)benzene |
N,N-DIMETHYLANILINE HYDROCHLORIDE | 5882-44-0 | C8H12ClN | 157.64 | N,N-Dimethylphenylaminehtdrochloride; N,N-DIMETHYLANILINE HYDROCHLORIDE; Benzenamine,N,N-dimethyl-,hydrochloride; Dimethyl-phenyl-ammoniumchloride; N,N-Dimethylanilinehydrochlor; n,n-dimethylaniliniumchloride; n,n-dimethyl-benzenaminhydrochloride; dimethy |
N,N-Dimethylaminochlorodiphenylsilane | 25374-11-2 | C14H16ClNSi | 261.82 | N,N-DIMETHYLAMINOCHLORODIPHENYLSILANE; 1-chloro-n,n-dimethyl-1,1-diphenyl-silanamin; N,N-Dimethylaminochlorodiphenylsilane (90%); 1-chloro-N,N-dimethyl-1,1-diphenylsilylamine; N,N-Dimethylaminochlorodiphenylsilane92%; Chloro-N,N-dimethyldiphenylsilanamine |
N,N-Dimethylacrylamide | 2680-03-7 | C5H9NO | 99.13 | Acrylamide, N,N-dimethyl-; Acylamide, N,N-dimethyl; Dimethylamid kyseliny akrylove; dimethylamidkyselinyakrylove; n,n-dimethyl-2-propenamid; n,n-dimethyl-acrylamid |
N,N-Dimethyl-4-(6-methylbenzothiazol-2-yl)aniline | 10205-62-6 | C16H16N2S | 268.38 | n,n-dimethyl-4-(6-methyl-2-benzothiazolyl)-benzenamin; 2-(4'-(DIMETHYLAMINO)PHENYL)-6-METHYL-BENZOTHIAZOLE; BTA-2; N,N-dimethyl-4-(6-methylbenzothiazol-2-yl)aniline; N,N-Dimethyl-4-(6-methylbenzothiazol-2-yl)benzenamine; N,N-Dimethyl-4-(6-methylbenzothiaz |
N,N-Dimethyl-3-chloropropylamine hydrochloride | 5407-04-5 | C5H13Cl2N | 158.07 | 3-Dimethylaminopropyl Chloride Hydrochloride; 3-Chloro-N,N-dimethyl-1-propanamine Hydrochloride; 1-Chloro-3-(dimethylamino)propane Hydrochloride; N-(3-Chloropropyl)dimethylamine Hydrochloride |
N,N-Dimethyl-3-(4-nitrophenoxy)-1-propanamine | 91430-80-7 | C11H16N2O3 | 224.26 | N,N-DIMETHYL-3-(4-NITROPHENOXY)-1-PROPANAMINE; N,N-Dimethyl-3-(4-nitrophenoxy)propylamine; N,N-dimethyl-3-(4-nitrophenoxy)propan-1-amine; N,N-Dimethyl-3-(4-nitrophenoxy)-1-propanamineHCl |
N,N-Dimethyl-2-hydroxypropylammonium chloride polymer | 25988-97-0 | (C5H12ClNO)n | 0 | N,N-Dimethyl-2-hydroxypropylammonium chloride polymer; Poly(2-hydroxypropyldimethylammonium chloride); Polyquat DMA / E 50 |
N,N-di(pyridin-2-yl)acetamide | 73664-46-7 | C12H11N3O | 213.235 g/mol | |
N,N-Di(1-naphthyl) benzidine | 152670-41-2 | C32H24N2 | 436.54600 | |
N,N-Bis[3-D-gluconamidopropyl]cholamide | 86303-22-2 | C42H75N3O16 | 878.06 | (3a,5b,7a,12a)-N,N-Bis[3-(D-gluconoylamino)propyl]-3,7,12-trihydroxy-cholan-24-amide; BigCHAP |
N,N'-Bis[3-(trimethoxysilyl)propyl]ethylenediamine | 68845-16-9 | C14H36N2O6Si2 | 384.62 | N,N'-BIS[(3-TRIMETHOXYSILYL)PROPYL]ETHYLENEDIAMINE; 2-Ethanediamine,N,N'-bis[3-(trimethoxysilyl)propyl]-1; n,n'-bis[3-(trimethoxysilyl)propyl]-2-ethanediamine; BIS[3-(TRIMETHOXYSILYL)PROPYL]ETHYLENE DIAMINE; 1,4-BIS[3-(TRIMETHOXYSILYL)PROPYL]ETHYLENE-DIAM |
N,N'-bis[3-(Triethoxysilyl)propyl]ethylenediamine | 30858-91-4 | C20H48N2O6Si2 | 468.77592 | 30858-91-4; N,N'-BIS[3-(TRIETHOXYSILYL)PROPYL]ETHYLENEDIAMINE; N,N'-Bis(3-(triethoxysilyl)propyl)ethylenediamine; 4,4,15,15-tetraethoxy-3,16-dioxa-8,11-diaza-4,15-disilaoctadecane; EINECS250-359-4; AC1MI1BY |
N,N-bis[3-(dimethylamino)propyl]-N',N'-dimethylpropane-1,3-diamine | 33329-35-0 | C15H36N4 | 272.47314 | N,N-bis[3-(dimethylamino)propyl]-N',N'-dimethylpropane-1,3-diamine; Tris-(dimethylaminopropyl)amine; 1,3-Propanediamine, N,N-bis3-(dimethylamino)propyl-N,N-dimethyl-; Tris-(3-dimethylamino)-propylamine; Bis(3-dimethylaminopropyl)-n,ndimethylpropanediamine |
N,N'-bis-(Salicylideneamino)ethane-manganese(II) | 53177-12-1 | C16H14ClMnN2O2 | 356.69 | N,N'-bis-(Salicylideneamino)ethane-manganese(II); N,N'-bis-(Salicylidene)-1,2-ethylenediamine-manganese(II) |
N,N-Bis(salicylidene)-o-phenylenediamine Vanadium(IV) oxide Complex | 32065-17-1 | C20H14N2O3V | 381.28 | (6Z)-6-[[2-[[(Z)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]amino]anilino]methylidene]cyclohexa-2,4-dien-1-one;oxovanadium;32065-17-1;HYDROGENPHOSPHATEIONOPHOREI;N,N-BIS(SALICYLIDENE)-O-PHENYLENEDIAMINEVANADIUM(IV)OXIDECOMPLEX;N,Ninvertedexclamationmarka-B |
N,N-bis-(Hydroxyethyl)-4-Fluoro-3-Nitroaniline | 29705-38-2 | C10H13FN2O4 | 244.219623;g/mol | 29705-38-2;2,2'-((4-Fluoro-3-nitrophenyl)azanediyl)diethanol;2,2'-[(4-fluoro-3-nitrophenyl)imino]diethanol;N,N-BIS-(HYDROXYETHYL)-4-FLUORO-3-NITROANILINE;2,2'-[(4-Fluoro-3-nitrophenyl)imino]bis(ethanol);Ethanol,2,2'-((4-fluoro-3-nitrophenyl)imino)bis- |
N,N-bis-(Carboxymethyl)-L-glutamic acid tetrasodiumn salt | 51981-21-6 | C9H9NNa4O8 | 351.13 | TETRASODIUM N,N-BIS(CARBOXYMETHYL)-L-GLUTAMATE; N,N-BIS(CARBOXYMETHYL)-L-GLUTAMIC ACID TETRASODIUM SALT; tetrasodium N,N-bis(carboxylatomethyl)-L-glutamate; TETRASODIUM GLUTAMATE DIACETATE; N,N-BIS-(CARBOXYMETHYL)-L-GLUTAMIC ACID TETRASODIUMN SALT; Glutam |
N-(trans-3-Hydroxycotinine)-b-D-glucuronide | 146275-18-5 | C16H20N2O8 | 368.34 | |
N-(Trimethylsilyl)-4-[(trimethylsilyl)oxy]-2-amine-1,3,5-triazin | 52523-35-0 | C9H20N4OSi2 | 256.4523 | Bis(trimethylsilyl)-5-azacytosine; N-(Trimethylsilyl)-4-[(trimethylsilyl)oxy]-2-amine-1,3,5-triazin; N-(Trimethylsilyl)-4-[(trimethylsilyl)oxy]-1,3,5-triazin-2-amine |
N-(TRIMETHOXYSILYLPROPYL)IMIDAZOLE | 70851-51-3 | C9H18N2O3Si | 230.34 | N-(TRIMETHOXYSILYLPROPYL)IMIDAZOLE; 1-[3-(trimethoxysilyl)propyl]-1H-imidazole; [3-(1-Imidazolyl)propyl]trimethoxysilane; Trimethoxy[3-(1H-imidazole-1-yl)propyl]silane |
N-(Trifluoromethanesulfonyl)trifluoroacetamide | 151198-85-5 | C3HF6NO3S | 245.1 | 2,2,2-trifluoro-N-(trifluoromethylsulfonyl)acetamide; N-(Trifluoromethanesulfonyl)trifluoroacetamide; 151198-85-5; ACMC-209d5u; SCHEMBL319638; CTK4C6941 |
N-(Trifluoroacetyl)-1-desmethyl daunorubicin | 68594-06-9 | C28H26F3NO11 | 609.50 | (8S-cis)-8-Acetyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-10-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-5,12-naphthacenedione; (8S,10S)-8-acetyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-10-[[2,3,6-trideoxy-3-[(trifluoroacet |
N-(trichloromethylthio)phthalimide | 133-07-3 | C9H4Cl3NO2S | 296.55 | 1H-Isoindole-1,3(2H)-dione, 2-[(trichloromethyl)thio]-; 1H-Isoindole-1,3(2H)-dione,2-[(trichloromethyl)thio]-; 2-((trichloromethyl)thio)-1h-isoindole-3(2h)-dione; 2-[(Trichloromethyl)sulfanyl]-1H-isoindole-1,3(2H)-dione; 2-[(Trichloromethyl)thio]1H-iso-in |
N-(Tetrahydro-2H-pyran-4-yl)-3-pyridinemethanamine | 885277-42-9 | C11H16N2O | 192.26 | PYRIDIN-3-YLMETHYL-(TETRAHYDRO-PYRAN-4-YL)-AMINE; N-(Tetrahydro-2H-pyran-4-yl)-3-pyridinemethanamine |
N-(Pyridin-4-ylmethyl)guanidine | 45957-41-3 | C7H10N4 | 150.18 | 1-(pyridin-4-ylmethyl)guanidine; 45957-41-3; N-(PYRIDIN-4-YLMETHYL)GUANIDINE; 4-pyridinylmethylguanidine; Ambcb4015990; AC1Q4Z04 |
N-(tert-Butoxycarbonylmethyl)-3,4-dihydroisoquinoline-6-boronic acid pinacol ester | 949922-33-2 | C21H32BNO4 | 373.29 | tert-butyl 2-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-2(1H)-yl)acetate; 3,4-Dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2(1H)-isoquinolineacetic acid 1,1-dimethylethyl ester; N-(tert-Butoxycarbonylmethyl)-3,4-dih |
N-(tert-Butoxycarbonyl)sulfamide | 148017-28-1 | C5H12N2O4S | 196.22 | Carbamic acid, (aminosulfonyl)-, 1,1-dimethylethyl ester (9CI); Carbamic acid, N-(aminosulfonyl)-, 1,1-dimethylethyl ester; Carbamic acid, (aminosulfonyl)-, 1,1-dimethylethyl ester; N-(Aminosulfonyl)carbamic acid 1,1-dimethylethyl ester; N-(tert-Butoxycar |
N-(TERT-BUTOXYCARBONYL)-L-CYSTEINE METHYL ESTER | 55757-46-5 | C9H17NO4S | 235.3 | |
N-(N-butyl)thiophosphoric triamide | 94317-64-3 | C4H14N3PS | 167.21 | N-(N-BUTYL)THIOPHOSPHORIC TRIAMIDE; N-BUTYLTHIOPHOSPHORIC TRIAMIDE; butyl-phosphorothioictriamid; N-(N-BUTYL)-THIOPHORIC TRIAMIDE (NBPT); N-(n-Butyl)thiophosphoricTriamide=NBPT; N-(N-BUTYL)THIOPHOSPHORICACID; Butylphosphorothioic triamide; N-(n-Butyl)thio |
N-(n-Butyl)phosphoric triamide | 25316-39-6 | C4H14N3OP | 0 | Butyl-phosphoric Triamide; N-(n-Butyl)phosphoric Triamide; N-Butylphosphoric Triamid; N-Butylphosphoric Triamide; N-(N-BUTYL)PHOSPHORIC ACID TRIAMIDE |
N-(n-Butyl)deoxygalactonojirimycin | 141206-42-0 | C10H21NO4 | 219.28 | N-Butyl-1,5-dideoxy-1,5-imino-D-galactitol |
N-(NBD-Aminolauroyl)safingol | 474943-07-2 | C36H63N5O6 | 661.9 | C12 NBD L-threo dihydro Ceramide; NBD L-threo Cer; NBD L-threo Ceramide; N-dodecanoyl-NBD L-threo-Dihydrosphingosine; N-[(2S,3S)-1,3-Dihydroxyoctadecan-2-yl]-12-[(7-nitro-2H-benzimidazol-4-yl)amino]dodecanamide |
n-(m-aminophenyl)aniline | 5840-03-9 | C12H12N2 | 184.23708 | 3-aminodiphenylamine; m-aminodiphenylamine; n-(m-aminophenyl)aniline; n-phenyl-3-benzenediamine; n-phenyl-m-phenylenediamin; 1,3-Benzenediamine, N-phenyl- |
N(L-TYROSINE)-9Z,12Z,15Z-OCTADECATRIENAMIDE | 259143-19-6 | C27H39NO4 | 441.6 | N(L-TYROSINE)-9Z,12Z,15Z-OCTADECATRIENAMIDE; N-(ALPHA-LINOLEOYL) TYROSINE; NALT |
N-(Dithiocarboxy)-N-methyl-D-glucamine sodium salt | 91840-27-6 | C8H16NO5S2 Na | 293.34 | N-(Dithiocarbamoyl)-N-methyl-D-glucamine sodium salt; Sodium N-Methyl-D-glucamine dithiocarbamate |
N-(benzylideneamino)-1-phenylmethanimine | 588-68-1 | C14H12N2 | 208.26 | Benzalazine; Benzaldehyde azine; Benzylideneazine |
N-(Benzoyl)piperazine-2,2,3,3,5,5,6,6-d8 | 1219805-49-8 | C11H6D8N2O | 198.24 | N-(Benzoyl)piperazine--d8 |
N-(9H-fluoren-2-yl)-N-hydroxyacetamide | 53-95-2 | C15H13NO2 | 239.269 g/mol | |
N-(8Z-Heptadecen-1-yl)-O-(3-pyridylmethyl)carbamate | 1450603-63-0 | C24H40N2O2 | 388.6 | Pyridin-3-ylmethyl N-[(Z)-heptadec-8-enyl]carbamate |
N-(7-Oxadecyl)deoxynojirimycin | 160632-05-3 | C15H31NO5 | 305.41 | |
N-(7-Oxa-9,9,9-trifluorononyl)deoxynojirimycin | 383417-50-3 | C13H24F3NO5 | 331.33 | |
N-(4-Methoxybenzylidene)-D-glucosamine | 51471-40-0 | C14H19NO6 | 297.30 | 2-Deoxy-2-[[(4-methoxyphenyl)methylene]amino]-D-glucose |
myo-Inositol 1,2,3,5,6-pentakisphosphate | 26326-85-2 | C6H17O21P5 | 580.06 | InsP5 |
N-(4-Hydroxyphenylacetyl)spermine | 130210-32-1 | C18H32N4O2 | 336.48 | N-(N-(4-Hydroxyphenylacetyl)-3-aminopropyl)-(N'-3-aminopropyl)-1,4-butanediamine |
N-(4-Hydroxyphenyl-2,3,5,6-d4)acetamide-2,2,2-d3 | 1219798-53-4 | C3H2D7NO2 | 158.21 | Acetaminophen-d7; Paracetamol-d7; |
N-(4-Fluorophenyl)-guanidine | 65783-21-3 | C7H8FN3 | 153.16 | N-(4-FLUORO-PHENYL)-GUANIDINE |
N-(4-Chlorobenzyl)-2-cyanoacetamide | 66158-49-4 | C10H9ClN2O | 208.64 | N-(4-CHLOROBENZYL)-2-CYANOACETAMIDE; TIMTEC-BB SBB000477 |
N-(4-chloro-2-methylphenyl)-N'-methylmethanimidamide | 21787-80-4 | C9H11ClN2 | 182.65 g/mol | Demethylchlordimeform; DCDM; Demethylchlorphenamidine; N-Demethylchlordimeform; N-Desmethylchlorodimeform; N'-(4-Chloro-o-tolyl)-N-methylformamidine |
N-(4-Carboxylic)benzoyl-4-piperidone | 672309-93-2 | C13H13NO4 | 247.24 | |
N-(4-Carbethoxyphenyl)-N-4-(6'-benzothiazole)amine | 458550-54-4 | C16H14N2O2S | 298.35 | N-(4-Carbethoxyphenyl)-N-4-(6'-benzothiazole)amine; 458550-54-4; ethyl4-(benzo[d]thiazol-6-ylamino)benzoate; CTK8E8086; MolPort-002-500-115; ZINC2527489 |
N-(4-Carbethoxyphenyl)-N-(3-cyanophenyl)amine | 458550-46-4 | C16H14N2O2 | 266.29 | ethyl4-(3-cyanoanilino)benzoate; N-(4-Carbethoxyphenyl)-N-(3-cyanophenyl)amine; 458550-46-4; Ethyl4-((3-cyanophenyl)amino)benzoate; 4-(3-cyano-phenylamino)-benzoicacidethylester; ETHYL4-[(3-CYANOPHENYL)AMINO]BENZOATE |
N-(4-Bromophenyl-N-(4-carbethoxyphenyl)amine | 458550-44-2 | C15H14BrNO2 | 320.18 | ethyl4-(4-bromoanilino)benzoate; N-(4-Bromophenyl-N-(4-carbethoxyphenyl)amine; 458550-44-2; Ethyl4-((4-bromophenyl)amino)benzoate; 4-(4-bromo-phenylamino)-benzoicacidethylester; ETHYL4-[(4-BROMOPHENYL)AMINO]BENZOATE |
N-(4-Bromophenyl-N-(3-cyanophenyl)amine | 458550-45-3 | C13H9BrN2 | 273.12 | 3-(4-bromoanilino)benzonitrile; N-(4-Bromophenyl-N-(3-cyanophenyl)amine; 458550-45-3; 3-(4-bromophenylamino)benzonitrile; 3-((4-Bromophenyl)amino)benzonitrile; 3-(4-bromo-phenylamino)-benzonitrile |
N-(4-Bromophenyl-N-(3-Boc-aminomethylphenyl)amine | 886362-63-6 | C18H21BrN2O2 | 377.27 | N-(4-Bromophenyl-N-(3-Boc-aminomethylphenyl)amine |
N-(4-biphenyl)-(9,9-dimethylfluoren-2--yl)Amine | 897671-69-1 | C27H23N | 361.47800 | |
N-(4-Aminocyclohexyl)-1,4-cyclohexanediamine | 5123-26-2 | C12H25N3 | 211.35 | N-(4-aminocyclohexyl)-1,4-Cyclohexanediamine; 4,4'-Diaminodicyclohexylamine; 4,4'-Iminobiscyclohexylamine |
N-(4-Aminobutyl)-N-ethylisoluminol | 66612-29-1 | 276.33 | AEBI | |
N-(4-aminobutyl)butane-1,4-diamine | 4427-76-3 | C8H21N3 | 159.272 g/mol | |
N(4)-(N-(6-Trifluoroacetylamidocaproyl)-2-aminoethyl)-5'-O-DMT-5-methyl-2'-deoxycytidine-3'-N,N-diisopropylmethylphosphoramidite | 117032-52-7 | C48H64F3N6O10P | 973.03 | |
N-(4-(Trifluoromethyl)phenyl)anthranilic acid | 57975-93-6 | C14H10F3NO2 | 281.2299096 | 2-[4-(trifluoromethyl)anilino]benzoicacid;57975-93-6;N-(4-(TRIFLUOROMETHYL)PHENYL)ANTHRANILICACID;2-((4-(Trifluoromethyl)phenyl)amino)benzoicacid;2-{[4-(TRIFLUOROMETHYL)PHENYL]AMINO}BENZOICACID;flufenamicacidanalogue,37 |
N-(4-(4-Chloro-6-(3-methyl-1H-pyrazol-5-ylamino)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide | 639090-55-4 | C18H17ClN6OS | 400.88500 | N-(4-(4-Chloro-6-(3-methyl-1H-pyrazol-5-ylamino)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide; N-[4-[[4-Chloro-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide; Yclopropanecarboxylic acid N-[4-[[4-chloro-6-(5-methy |
N-(4-(2,5-Dioxo-4-oxazolidinyl)butyl)-2,2,2-trifluoroacetamide | 42267-27-6 | C9H11F3N2O4 | 268.1899 | 42267-27-6; (S)-N-(4-(2,5-Dioxooxazolidin-4-yl)butyl)-2,2,2-trifluoroacetamide; N-TrifluoroacetylL-LysineN-Carboxyanhydride; Acetamide,N-[4-[(4S)-2,5-dioxo-4-oxazolidinyl]butyl]-2,2,2-trifluoro-; Lys(Tfa)-NCA; C9H11F3N2O4 |
N-(4-(1H-Pyrrolo[2,3-b]pyridin-4-yloxy)-3-fluorophenyl)-1-(4-fluorophenyl)-2-oxo | 888719-03-7 | C25H16F2N4O3 | 458.41 | BMS-2; 1-(4-Fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-1,2-dihydro-2-oxo-3-pyridinecarboxamide |
N-(3-TRIMETHOXYSILYLPROPYL)MORPHOLINE | 31024-54-1 | C10H23NO4Si | 249.38 | N-(3-TRIMETHOXYSILYLPROPYL)MORPHOLINE; 4-[3-(trimethoxysilyl)propyl]morpholine; 4-[3-(trimethoxysilyl)propyl]-morpholin; Morpholine,4-[3-(trimethoxysilyl)propyl]- |
N-(3-Sulfopropyl)-3,3,5,5-tetramethylbenzidine sodium salt | 102062-46-4 | C19H25N2O3S Na | 384.47 | TMBZ-PS; 4-Amino-4-sulfopropylamino-3,3,5,5-tetramethylbiphenyl sodium salt; Sodium 3-((4-amino-3,3,5,5-tetramethyl-[1,1-biphenyl]-4-yl)amino)propane-1-sulfonate |
N-(3-pyridyl)-Indomethacin amide | 261766-29-4 | C24H20ClN3O3 | 433.9 | N-(3-pyridyl)-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetamide; N-3PyIA |
N-(3-Methylbutyryl-d9)glycine | 1330037-21-2 | (CD3)2CDCD2CONHCH2COOH | 168.24 | N-Isovalerylglycine-d9; Isovalerylaminoacetic Acid-d9; 2-[[2,2,3,4,4,4-hexadeuterio-3-(trideuteriomethyl)butanoyl]amino]acetic acid |
N-(3-METHOXY-PHENYL)-GUANIDINE | 57004-60-1 | C8H11N3O | 165.19 | N-(3-METHOXY-PHENYL)-GUANIDINE |
N-(3-Methoxybenzyl)palmitamide | 847361-96-0 | C24H41NO2 | 375.6 | |
N-(2-Morpholinoethyl)acrylamide | 13276-17-0 | C9H16N2O2 | 184.24 | 2-(Morpholinoethyl)acrylamide; N-[2-(4-Morpholinyl)ethyl]-2-propenamide |
N-(2-methyl-5-nitrophenyl)-4(pyridin-3-yl)thiazol-2-amine | 1143459-81-7 | 393.26 | N-(2-methyl-5-nitrophenyl)-4-pyridin-3-yl-1,3-thiazol-2-amine; hydrobromide; 1143459-81-7; AKOS025401898; AN-25822; SC-25124 | |
N-(2-Hydroxy-4-methoxyphenyl)acetamide | 58469-06-0 | C9H11NO3 | ||
N-(2-Hydroxgethyl)moypholine | 6007-64-3 | C6H13NO2 | 131.17 | 4-THIOMORPHOLINE ETHANOL; N-(2-HYDROXYETHYL)THIOMORPHOLINE; N-(2-Hydroxyethyl)thiomopholine; N-(2-Hydroxyethyl)Moypholine; N-(2-Hydroxgethyl)moypholine |
N-(2-ethylhexyl)-1-[2-methyl-4-(2-methylphenyl)diazenyl-phenyl]diazenyl-4H-naphthalen-1-amine | 56358-09-9 | C32H37N5 | 491.66968;g/mol | N-(2-ethylhexyl)-1-[[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]diazenyl]naphthalen-2-amine;56358-09-9;SCHEMBL12955158;W-111114;N-(2-Ethylhexyl)-1-[2-methyl-4-(2-methylphenylazo)phenylazo]naphthalene-2-amine;N-(2-ethylhexyl)-1-[2-methyl-4-(2-methylphenyl |
N-(2-chloroethyl)piperidine | 1932-03-2 | C7H14ClN | 147.65 | 1-(2-chloroethyl)-piperidin; 2-(1-piperidyl)ethylchloride; 2-piperidinoethylchloride; beta-piperidinoethylchloride; n-(2-chloroethyl)piperidine; n-(beta-chloroethyl)piperidine; 1-(2-CHLOROETHYL)PIPERIDINE; 2-CHLOROETHYL PIPERIDINE |
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | 302964-08-5 | C16H13Cl2N5OS | 394.28 | |
N-((Trimethoxysilyl)methyl)hexane-1,6-diamine | 172684-43-4 | C10H26N2O3Si | 250.41 | N-(6-AMINOHEXYL)AMINOMETHYLTRIMETHOXYSILANE; Aminohexylaminomethyltrimethoxysilane; Hexanediaminomethyltrimethoxysilane; N-((Trimethoxysilyl)methyl)hexane-1,6-diamine |
N 20C hydrochloride | 928313-94-4 | C17H20N2O.HCl | 304.81 | 2-(3,3-Diphenylpropylamino)-N,N-diphenylacetamide hydrochloride |
N 0924 hydrochloride | 125572-92-1 | C19H25NOS.HCl | 351.93 | (6R)-6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride |
N 0734 hydrochloride | 102121-01-7 | C19H25NOS.HCl | 351.93 | 6-[propyl(2-thiophen-3-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride |
N 0432 hydrobromide | 96333-05-0 | C14H17NO2.HBr | 312.2 | 6-[methyl(prop-2-ynyl)amino]-5,6,7,8-tetrahydronaphthalene-2,3-diol hydrobromide |
N 0430 hydrobromide | 96333-04-9 | C14H17NO2.HBr | 312.2 | 6-[methyl(prop-2-ynyl)amino]-5,6,7,8-tetrahydronaphthalene-1,2-diol hydrobromide |
N 0426 hydrochloride | 150542-92-0 | C14H17NO.HCl | 251.75 | 7-[methyl(prop-2-ynyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride |
N 0425 hydrochloride | 78621-26-8 | C14H17N.HCl | 235.75 | N-methyl-N-prop-2-ynyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride |
Myristoyl-L-carnitine chloride | 173686-73-2 | C21H42NO4·Cl | 408.02 | L-Myristoylcarnitine; Tetradecanoyl-L-carnitine; [(2R)-3-carboxy-2-tetradecanoyloxypropyl]-trimethylazanium chloride |
Myzodendrone | 101705-37-7 | C16H22O8 | 342.344 | 4-[3-(beta-D-Glucopyranosyloxy)-4-hydroxyphenyl]-2-butanone |
MYXOTHIAZOL | 76706-55-3 | C25H33N3O3S2 | 487.68 | MYXOTHIAZOL; 5-dimethoxy-4-methyl-; 7-(2'-(1,6-dimethyl-2,4-heptadienyl)(2,4'-bithiazol)-4-yl)-6-heptadienamide; myxothiazol from myxobacterium*myxococcus fulvus; MYXOTHIAZOL, VIAL WITH 10 MG*; MYXOTHIAZOL FROM MYXOBACTERIUM 95%; myxothiazolfrommyxobacter |
Myrsinoic acid A | 135743-12-3 | C22H30O3 | 342.47 | Myrsinoic acid A |
Myrrhone | 183551-83-9 | C15H16O2 | 228.29 | (8S)-1,5,8-Trimethyl-8,9-dihydronaphtho[2,1-b]furan-6(7H)-one |
MYRISTYL IODIDE | 19218-94-1 | C14H29I | 324.29 | MYRISTYL IODIDE; TETRADECYL IODIDE; 1-IODOTETRADECANE; 1-iodo-tetradecan; tetradecane,1-iodo-; MYRISTYL IODIDE 97% |
Myristyl chloroFormate | 56677-60-2 | C15H29ClO2 | 276.84 | MYRISTYLCHLOROFORMATE; tetradecyl chloroformate; Chloroformic acid tetradecyl ester; chlorocarbonic acid myristyl ester; tetradecyl carbonochloridate |
Myristyl acetate | 638-59-5 | C16H32O2 | 256.42 | TETRADECYL ACETATE; MYRISTYL ACETATE; 1-tetradecanol,acetate; 1-tetradecanyl acetate; 1-Tetradecyl acetate; aceticacidtetradecylester; Tetradecanol acetate; acetic acid myristyl ester |
Myristoyl-CoA | 3130-72-1 | C35H62N7O17P3S | 977.89 | Myristoyl-Coenzyme A; Tetradecanoyl-CoA; S-Tetradecanoyl-coenzyme A; S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propa |
Myristoyl Pentapeptide-17 | 959610-30-1 | C41H81N9O6 | 796.156 | N2-(1-Oxotetradecyl)-L-lysyl-L-leucyl-L-alanyl-L-lysyl-L-lysinamide |
Myristoleic acid | 544-64-9 | C14H26O2 | 226.4 | cis-9-tetradecenoate; Oleomyristic acid; 9-Tetradecenoic acid; (Z)-tetradec-9-enoic acid |
Myristicin | 607-91-0 | C11H12O3 | 192.21 | 6-Allyl-4-methoxy-1,3-benzodioxole; 4-Methoxy-6-(2-propenyl)-1,3-benzodioxole |
Myristica fragrans, ext. | 84082-68-8 | 0 | Myristica fragrans, ext.; MYRISTICA FRAGRANS (NUTMEG) EXTRACT; Nutmegextract; MYRISTICAFRAGRANSEXTRACT; Muskatnul; MUSKATNUSSOEL EXTRA; Einecs 282-013-3; Fema no. 2792 | |
Myristic Acid Sodium Salt | 822-12-8 | C14H27NaO2 | 250.35 | |
Myristic acid myristyl ester | 3234-85-3 | C28H56O2 | 424.75 | Myristic acid myristyl ester; Myristyl myristate; Tetradecyl myristate |
Myristelaidic acid | 50286-30-1 | C14H26O2 | 226.36 | 9-TRANS TETRADECENOIC ACID; MYRISTELAIDIC ACID; TRANS-9-TETRADECENOIC ACID |
Myristamine oxide | 3332-27-2 | C16H35NO | 257.46 | Myristamine oxide; Tetradecyldimethylamine oxide |
Myristalkonium saccharinate | 137951-75-8 | C30H46N2O3S | 514.763 | |
Myrislignan | 171485-39-5 | C21H26O6 | 374.43 | (aR)-alpha-[(1S)-1-[2,6-Dimethoxy-4-(2-propen-1-yl)phenoxy]ethyl]-4-hydroxy-3-methoxybenzenemethanol; Myrislignan; (-)-erythro-(7R,8S)-8'-4,7-dihydroxy-3,3',5'-triMethoxy-8-O-4'-neolignan |
myo-Inositol 1,3,4,5,6-pentakisphosphate decasodium salt | 20298-95-7 | C6H7Na10O21P5 | 799.87 | InsP5 |
Myrciaphenone A | 26089-54-3 | C14H18O9 | 330.289 | 1-[2,4-dihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]ethanone |
Myrcenol | 543-39-5 | C10H18O | 154.25 | 7-OCTEN-2-OL, 2-METHYL-6-METHYLENE; MYRCENOL; MYRCENOL 50; 2-methyl-6-methylene-7-octen-2-o; 2-Methyl-6-methylene-7-octen-2-ol; 3-Methylene-7-methyl-1-octen-7-ol; 2-methyl-6-methyleneoct-7-en-2-ol; MYCENOL5 |
Myoseverin | 267402-71-1 | C24H28N6O2 | 432.52 | IN1218; 9-Isopropyl-2,6-bis(4-methoxybenzylamino)purine; 9-Isopropyl-N2,N6-bis-(4-methoxybenzyl)-9H-purine-2,6-diamine; AC1L1HSM |
myo-Inositol,2,21-anhydro-2-C-(hydroxymethyl)- (9CI) | 4068-87-5 | C7H12 O6 | 192.1666 | |
myo-Inositol,1,3,4,5-tetrakis(dihydrogen phosphate) | 102850-29-3 | C6H16 O18 P4 | 500.0755 | D-MYO-INOSITOL 1,3,4,5-TETRAKIS-PHOSPHATE AMMONIUM SALT; INS(1,3,4,5)P4, NH4+; MYO-INOSITOL 1,3,4,6-TETRAKIS-PHOSPHATE AMMONIUM SALT; inositol-1,3,4,5-tetrakisphosphate; D-MYO-INOSITOL 1,3,4,5-TETRAKIS-*PHOSPHA TE AMMONIUM; INOSITOLTETRAPHOSPHATE |
myo-Inositol trispyrophosphate hexasodium salt | 23103-35-7 | C6H6Na6O21P6 | 737.88 | ITPP hexasodium salt; myo-Inositol cyclic 1,2 |
myo-Inositol trispyrophosphate | 802590-64-3 | C6H12O21P6 | 605.99 | ITPP; myo-Inositol 1,6 |
Mycosubtilin (9CI) | 1392-60-5 | C55H86N14O16 | 1199.35554;g/mol | Mycosubtilin; Mycosubtiline; AC1MJ13T; AM006809; LS-93773; Pyrrolo(1,2-g)(1,4,7,10,13,16,19,22,25)nonaazacyclooctacosine,cyclicpeptidederiv |
Monoquat iodide | 38873-01-7 | 1-Methyl-4-(pyrid-4- yl)pyridinium iodide | ||
Mycophenolic Acid-13C-d3 (deuterated labelled) | 1261432-16-9 | C17H17O6D3 | 324.35 | |
Mycophenolic Acid Phenolic beta-D-Glucoside | 55533-52-3 | C23H30O11 | 482.48 | (4E)-6-[4-(b-D-Glucopyranosyloxy)-1,3-dihydro-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoic acid |
Mycophenolic acid d3 | 1185242-90-3 | C17H17D3O6 | 323.34 | (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-d3-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid |
Mycophenolic Acid Cyclopropane Analogue | 125198-40-5 | C18H22O6 | 334.37 | 1-Cyclopropane Mycophenolic Acid; 3-(2-((4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)methyl)-1-methylcyclopropyl)propanoic Acid; 2-[(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)methyl]-1-methyl-cyclopropanepropano |
Mycophenolic acid b-D-glucuronide | 31528-44-6 | C23H28O12 | 496.46 | |
Mycophenolic acid acyl-b-D-glucuronide allyl ester | 860615-39-0 | C26H32O12 | 536.53 | 1-[(4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate] b-D-glucopyranuronic acid 2-propen-1-yl ester |
Mycophenolic acid acyl-b-D-glucuronide | 99043-04-6 | C23H28O12 | 496.47 | |
Mycophenolic Acid Acyl Glucoside | 344562-78-3 | C23H30O11 | 482.48 | 1-[(4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate] b-D-glucopyranose |
Mycophenolic acid | 24280-93-1 | C17H20O6 | 320.34 | Mycophenolate, RS-61443 |
Mycophenolate Sodium | 37415-62-6 | C17H19O6.Na | 342.32 | Mycophenolic Acid Monosodium Salt; (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid Sodium Salt; (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid Monosodiu |
Mycophenolate Mofetil-d4 (deuterated) | 1132748-21-0 | C23H27D4NO7 | 437.51 | (4E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-hexenoic Acid-d4 4-methyl-2-(4-morpholinyl)ethyl Ester; Mycophenolic Acid-d4-2-(4-Morpholinyl)ethyl Ester; RS 61443-d4; TM-MMF-d4 |
Mycophenolate Mofetil Impurity E | 31858-66-9 | C18H22O6 | 334.37 | Methyl mycophenolate; Mycophenolic Acid Methyl Ester |
Mycophenolate Mofetil Impurity A HCl | 1322681-36-6 | C22H29NO7.HCl | 455.94 | O-Desmethyl Impurity HCl |
Mycophenolate mofetil hydrochloride | 116680-01-4 | C23H32ClNO7 | 469.96 | RS 61443 HCl |
Mycophenolate Mofetil | 128794-94-5 | C23H31NO7 | 433.49 | RS61443 |
Mycophenolate Impurity D | 1322681-37-7 | C24H33NO7 | 447.53 | O-Methyl Mycophenolate Mofetil; (4E)-6-(1,3-Dihydro-4,6-dimethoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester; |
Mycophenolate Impurity B | 1094322-91-4 | C29H42N2O9 | 562.67 | (4E)-6-[1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-1-[2-(4-morpholinyl)ethoxy]-3-oxo-5-isobenzofuranyl]-4-methyl-4-hexenoic Acid 2-(4-Morpholinyl)ethyl Ester; Mycophenolate mofetil Imp. B (EP) |
Myclobutanil | 88671-89-0 | C15H17ClN4 | 288.78 | Systhane; Rally; 2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(4-chlorophenyl)hexanenitrile |
Mycaminose | 519-21-1 | C8H17NO4 | 191.22 | |
MY-5445 | 78351-75-4 | C20H14ClN3 | 331.8 | 1-(3-Chlorophenylamino)-4-phenylphthalazine |
MX69 | 1005264-47-0 | C27H26N2O4S | 474.57 | 4-(8-(N-(2,3-dimethylphenyl)sulfamoyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-4-yl)benzoic acid; MX69; MX-69; MX 69. |
Musa paradisiaca extract | 89957-82-4 | Musa paradisiaca extract; Banana extract | ||
Murrayone | 19668-69-0 | C15H14O4 | 258.27 | murrayon; 7-methoxy-8-(3-methyl-2-oxobut-3-enyl)chromen-2-one |
Murrayanine | 723-97-7 | C14H11NO2 | 225.247 | 1-Methoxy-9H-carbazole-3-carbaldehyde; 9H-Carbazole-3-carboxaldehyde, 1-methoxy- |
Murraxocin | 88478-44-8 | C17H20O5 | 304.3 | 8-(1-Ethoxy-2-hydroxy-3-methyl-3-buten-1-yl)-7-methoxy-2H-chromen -2-one |
Murraol | 109741-38-0 | C15H16O4 | 260.3 | 8-[(1E)-3-Hydroxy-3-methyl-1-buten-1-yl]-7-methoxy-2H-chromen-2-o ne |
Murrangatin diacetate | 51650-59-0 | C19H20O7 | 360.4 | (3R,4R)-4-(7-Methoxy-2-oxo-2H-chromen-8-yl)-2-methyl-1-butene-3,4 -diyl diacetate |
Murrangatin | 37126-91-3 | C15H16O5 | 276.3 | |
Murralongin | 53011-72-6 | C15H14O4 | 258.3 | 2-(7-methoxy-2-oxochromen-8-yl)-3-methylbut-2-enal |
Muricatacin | 134698-86-5 | C17H32O3 | 284.43 | (-)-Muricatacin; Muricatacin; (5R)-5-[(1R)-1-hydroxytridecyl]oxolan-2-one; 134698-86-5; AC1MHZQV; CHEMBL487910 |
Muricarpone B | 886226-15-9 | C19H22O5 | 330.38 | 1,7-bis(3,4-dihydroxyphenyl)heptan-3-one |
Muramic acid hydrate | 1114-41-6 | C9H17NO7 H2O | 269.25 | |
Muraglitazar acyl-b-D-glucuronide | 875430-26-5 | C36H38N2O12 | 690.71 | |
Muraglitazar | 331741-94-7 | C29H28N2O7 | 516.54 | BMS 298585;N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)glycine;Muraglitazar;N-[(4-Methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine;Pargluva |
MS049 hydrochloride | 2095432-59-8 | C15H24N2O·2HCl | 321.3 | MS049 HCl; MS049 Dihydrochloride; MS-049 hydrochloride; MS 049 hydrochloride; N-methyl-2-(4-phenylmethoxypiperidin-1-yl)ethanamine dihydrochloride |
MS049 | 1502816-23-0 | C15H24N2O | 248.36 | MS-049; MS 049; N-Methyl-2-(4-phenylmethoxypiperidin-1-yl)ethanamine |
MS023 hydrochloride | 2108631-19-0 | C17H25N3O·3HCl | 396.8 | MS023 HCl; MS-023 hydrochloride; MS 023 hydrochloride; N'-methyl-N'-[[4-(4-propan-2-yloxyphenyl)-1H-pyrrol-3-yl]methyl]ethane-1,2-diamine trihydrochloride |
MS023 | 1831110-54-3 | C17H25N3O | 287.41 | MS023; MS-023; MS 023. |
MS0022 | 691392-89-9 | C21H16BrN3O | 406.28 | MS-0022;2-Bromo-N-(4-(8-methylimidazo[1,2-a]pyridin-2-yl)phenyl)benzamide |
MS 245 oxalate | 275363-58-1 | C19H22N2O3S.C2H2O4 | 448.49 | 5-Methoxy-N,N-dimethyl-1-(phenylsulfonyl)-1H-indole-3-ethanamine oxalate |
MS 21570 | 65373-29-7 | C10H11N3S2 | 237.34 | N-Methyl-5-[(phenylmethyl)thio]-1,3,4-thiazadiazol-2-amine; MS21570; MS-21570; MS 21570 |
MS 15203 | 73912-52-4 | C12H11NO5 | 249.22 | 5-[(2-Methyl-1-oxo-2-propen-1-yl)amino]-1,3-benzenedicarboxylic acid |
MRT67307 | 1190378-57-4 | C26H36N6O2 | 464.61 | N-[3-[[5-cyclopropyl-2-[3-(morpholin-4-ylmethyl)anilino]pyrimidin-4-yl]amino]propyl]cyclobutanecarboxamide,1190379-70-4 (HCl) |
MRX-2843 | 1429882-07-4 | C29H40N6O | 488.68 | 4-[2-(2-cyclopropylethylamino)-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexan-1-ol |
MRT 10 | 330829-30-6 | C24H23N3O5S | 465.52 | N-[[[3-Benzoylamino)phenyl]amino]thioxomethyl]-3,4,5-trimethoxybenzamide |
MRS2179 ammonium salt | 228264-19-5 | C11H17N5O9P2·xNH3 | 425.23 | |
MRS 5698 | 1377273-00-1 | C28H23ClF2N6O3 | 564.97 | (1S,2R,3S,4R,5S)-4-[6-[[(3-Chlorophenyl)methyl]amino]-2-[2-(3,4-difluorophenyl)ethynyl]-9H-purin-9-yl]-2,3-dihydroxy-N-methylbicyclo[3.1.0]hexane-1-carboxamide; MRS5698; MRS 5698; MRS-5698 |
MRS 4062 triethylammonium salt | 1309871-50-8 | C18H26N3O15P3.4(C2H5)3N | 1022.09 | N4-Phenylpropoxycytidine-5'-O-triphosphate tetra(triethylammonium) salt; MRS4062; MRS 4062; MRS-4062; MRS 4062 triethylammonium salt |
MRS 2693 trisodium salt | 1448858-83-0 | C9H10IN2Na3O12P2 | 596 | MRS 2693 trisodium salt; MRS 2693; MRS2693; MRS-2693. 5-Iodouridine-5'-O-diphosphate trisodium salt |
MRS 2578 | 711019-86-2 | C20H20N6S4 | 472.67 | |
MRS 2500 tetraammonium salt | 630103-23-0 | C13H18N5O8P2I.4NH3 | 629.29 | (1R*,2S*)-4-[2-Iodo-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hexane-1-methanol dihydrogen phosphate ester tetraammonium salt |
MRS 2365 | 436847-09-5 | C13H16N5O9P2SNa3 | 549.28 | [[(1R,2R,3S,4R,5S)-4-[6-Amino-2-(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hex-1-yl]methyl] diphosphoric acid mono ester trisodium salt; MRS2365; MRS 2365; MRS-2365 |
MRS 2279 | 367909-40-8 | C13H18ClN5O8P2.2NH3 | 503.78 | (1R*,2S*)-4-[2-Chloro-6-(methylamino)-9H-purin-9-yl]-2-(phosphonooxy)bicyclo[3.1.0]hexane-1-methanol dihydrogen phosphate ester diammonium salt |
MRS 2219 | 14141-47-0 | C8H10NO5P | 231.14 | 1,5-Dihydro-3-hydroxy-8-methyl[1,3,2]dioxaphosphepino[5,6-c]pyridin-9-ol-3-oxide; MRS 2219; MRS-2219; MRS2219 |
Moxonidine Impurity D | 352457-33-1 | C8H10ClN5O | 227.65 | 6-Chloro-5-[(4,5-dihydro-1H-imidazol-2-yl)amino]-2-methyl-4(1H)-pyrimidinone; 6-Desmethyl Moxonidine; |
MRS 2179 tetrasodium salt | 1454889-37-2 | C11H13N5O9P2Na4 | 513.16 | MRS 2179 tetrasodium salt; MRS2179 tetrasodium salt; MRS-2179 tetrasodium salt; 2'-Deoxy-N6-methyladenosine 3',5'-bisphosphate tetrasodium salt |
MRS 1845 | 544478-19-5 | C21H22N2O6 | 398.41 | N-PROPARGYLNITRENDIPENE; MRS 1845; 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-1-(2-PROPYNYL)-3,5-PYRIDINEDICARBOXYLIC ACID ETHYL, METHYL ESTER; 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-1-(2-propynyl)-3,5-pyridinedicarboxylicacidethylmethylester |
MRS 1754 | 264622-58-4 | C26H26N6O4 | 486.52 | N-(4-Cyanophenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-acetamide |
Mps1-IN-1 | 1125593-20-5 | C28H33N5O4S | 535.66 | |
MPS1/TTK Inhibitor | 1202055-39-7 | C33H40N8O2 | 580.72 | N-(2,6-diethylphenyl)-4,5-dihydro-8-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-1-methyl-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide |
Mps BAY 2a | 1382477-96-4 | C29H28N6O | 476.57 | N-Cyclopropyl-4-[8-[(2-methylpropyl)amino]-6-(5-quinolinyl)imidazo[1,2-a]pyrazin-3-yl]benzamide; MpsBAY2a; Mps-BAY-2a; Mps BAY 2a |
MPP dihydrochloride | 911295-24-4 | C29H31N3O3.2HCl | 542.5 | 1,3-Bis(4-hydroxyphenyl)-4-methyl-5-[4-(2-piperidinylethoxy)phenol]-1H-pyrazole dihydrochloride |
MPI-5a | 1259296-46-2 | C16H17N3O3 | 299.3 | N-hydroxy-2-(1-methyl-1H-pyrrole-2-carbonyl)-1,2,3,4-tetrahydroisoquinoline-6-carboxamide |
MPI-0479605 | 1246529-32-7 | C22H29N7O | 407.522 | MPI-0479605; MPI 0479605; MPI0479605. |
MPEP Hydrochloride | 219911-35-0 | C14H12ClN | 229.7 | 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride |
MPEP | 96206-92-7 | C14H11N | 193.24 | |
MPEG-5000-DPPE | 205494-72-0 | (C2H4O)nC39H76NO10P | N-(Carbamoyl-methoxypolyethylene glycol 5000)-1,2-dipalmitoyl-cephalin sodium salt; N-(Carbonyl-methoxypolyethylenglycol 5000)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine sodium salt; 1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine, Carbonyl-methoxy | |
MPEG-2000-DMPE | 384835-59-0 | (C2H4O)nC35H68NO10P | N-(Carbonyl-methoxypolyethylenglycol 2000)-1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine sodium salt; 1,2-Dimyristoyl-sn-glycero-3-phosphoethanolamine, Carbonyl-methoxypolyethylenglycol 2000 labeled | |
MPDL3280A | 1380723-44-3 | Atezolizumab; RG-7446; RO 5541267; TECENTRIQ | ||
MPDC | 159262-32-5 | C7H9NO4 | 171.15 | L-anti-endo-3,4-Methanopyrrolidinedicarboxylic acid |
MPC-3100 | 958025-66-6 | C22H25BrN6O4S | 549.40 | |
MPC-0767 | 1310540-32-9 | C26H36BrN7O9S2 | 733.64 | |
MPC 6827 hydrochloride | 917369-31-4 | C17H17N3O.HCl | 315.8 | N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine; hydrochloride; MPC-6827; MPC6827; N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine; verubulin; verubulin hydrochloride; Azixa; MPC-6827; UNII-33380QZ0QW; 917369-31-4 |
MP-A08 | 219832-49-2 | C27H25N3O4S2 | 519.64 | 4-methyl-N-[2-[[2-[(4-methylphenyl)sulfonylamino]phenyl]iminomethyl]phenyl]benzenesulfonamide MP-A08 NSC122314 AC1L9JET Ambcb5562335 SCHEMBL17443540 MCULE-6662772127 N-[2-[[2-(Tosylamino)benzylidene]amino]phenyl]-4-methylbenzenesulfonamide MP A08| |
MOZ-IN-3 | 2055397-18-5 | C20H17FN2O3S | 384.43 | WM-8014; WM 8014; WM8014; 4-fluoro-5-methyl-N'-(phenylsulfonyl)[1,1'-biphenyl]-3-carbohydrazide |
Mozavaptan | 137975-06-5 | C27H29N3O2 | 427.54 | N-(4-(5-(dimethylamino)-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)phenyl)-2-methylbenzamide; OPC-31260; OPC 31260; OPC31260; Mozavaptan |
Moxonidine Impurity C | 352457-34-2 | C9H13N5O2 | 223.24 | 4-Hydroxymoxonidine; 5-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-6-methoxy-2-methyl-4(3H)-pyrimidinone; 5-[(4,5-Dihydro-1H-imidazol-2-yl)amino]-6-methoxy-2-methyl-4(1H)-pyrimidinone; |
Moxonidine Impurity B | 75439-01-9 | C10H15N5O2 | 237.26 | 4-Methoxy Moxonidine; N-(4,5-Dihydro-1H-imidazol-2-yl)-4,6-dimethoxy-2-methyl-5-pyrimidinamine; |
Moxonidine Impurity A | 352457-35-3 | C8H9Cl2N5 | 246.1 | 4,6-dichloro-N-(4,5-dihydro-1H-imidazol-2-yl)-2-methylpyrimidin-5-amine; |
Moxonidine hydrochloride | 75536-04-8 | C9H13Cl2N5O | 278.14 | BDF5895 hydrochloride;4-Chloro-6-methoxy-2-methyl-5-(2-imidazolin-2-yl)aminopyrimidine hydrochloride |
Moxonidine | 75438-57-2 | C9H12ClN5O | 241.68 | 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine; 2-(6-Chloro-4-methoxy-2-methylpyrimidin-5-ylamino)-2-imidazoline; Lomox; Moxon; Norcynt; Normoxocin; Nucynt; Physiotens; |
Moxisylyte hydrochloride | 964-52-3 | C16H26ClNO3 | 315.84 | Carvacrol,5-[2-(dimethylamino)ethoxy]-, acetate (ester), hydrochloride (8CI);Phenol,4-[2-(dimethylamino)ethoxy]-2-methyl-5-(1-methylethyl)-, acetate (ester),hydrochloride (9CI);4-(2-Dimethylaminoethoxy)-5-isopropyl-2-methylphenyl acetatehydrochloride;Opil |
Moxifloxacin-R-isomer (ent-Moxifloxacin) | 268545-13-7 | C21H24FN3O4 | 401.44 | 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid |
Moxifloxacine hydrochloride | 186826-86-8 | C21H24FN3O4.HCl | 437.89 | BAY12-8039 HCl |
Moxifloxacin RR-Isomer (HCl salt form) | 1394029-14-1 | C21H25ClFN3O4 | 437.89 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid monohydrochloride; Moxifloxacin Related Compound G |
Moxifloxacin Related Impurity 2 | 169533-56-6 | C7H14N2 | 126.2 | (1R,6S)-2,8-Diazabicyclo[4.3.0]nonane; (4aS-trans)-Octahydro-1H-pyrrolo[3,4-b]pyridine; Moxifloxacin Impurity 2; |
Moxifloxacin Related Impurity 1 | 158060-81-2 | C7H14N2 | 126.2 | trans-2,8-Diazabicyclo[4.3.0]nonane; (4aR,7aS)-rel-Octahydro-1H-pyrrolo[3,4-b]pyridine; trans-octahydro-1H-Pyrrolo[3,4-b]pyridine; Moxifloxacin Impurity; |
Moxifloxacin Related Compound A (HCl salt form) | 151282-23-4 | C20H22ClF2N3O3 | 425.863 | |
Moxifloxacin N-sulfate | 234080-64-9 | C21H24FN3O7S | 481.5 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-1-sulfo-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Disodium Salt; |
Moxifloxacin Impurity F | 721970-35-0 | C22H26FN3O4 | 415.47 | Moxifloxacin Methyl Ester; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid Methyl Ester; |
Moxifloxacin Impurity E | 1292904-74-5 | C20H22FN3O4 | 387.41 | 8-Hydroxy Moxifloxacin; 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic Acid |
Moxifloxacin Impurity D | 1029364-77-9 | C21H24FN3O4 | 401.44 | Moxifloxacin EP Impurity D; 8-Fluoro-6-methoxymoxifloxacin; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-8-fluoro-6-methoxy-4-oxoquinoline-3-carboxylic acid |
Moxifloxacin Impurity B | 1029364-73-5 | C22H27N3O5 | 413.48 | Moxifloxacin EP Impurity B; 6,8-Dimethoxymoxifloxacin; 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6,8-dimethoxy-4-oxoquinoline-3-carboxylic acid |
Moxifloxacin Impurity 4 | 151213-39-7 | C14H20N2 | 216.33 | (S,S)-6-Benzyl-octahydro-pyrrolo[3,4-b]pyridine; |
Moxifloxacin Impurity 18 | 172426-88-9 | C14H13N2O4 | 292.27 | 7-Amino-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic Acid; |
Moxifloxacin Impurity 16 | 1797982-51-4 | C16H16FNO5 | 321.31 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-7-ethoxy-8-methoxy-4-oxo-3-quinolinecarboxylic Acid; |
Moxifloxacin Impurity 14 | 53764-99-1 | C11H9F3O2 | 230.19 | 4,4,4-trifluoro-1-(3-methylphenyl)butane-1,3-dione; |
Moxifloxacin Impurity 13 | 163266-02-2 | C11H9F3O2 | 230.19 | 4,4,4-Trifluoro-1-(2-methylphenyl)-1,3-butanedione; 1-(2-Methylbenzoyl)-3,3,3-trifluoroacetone; |
Moxifloxacin Hydroxy Quinoline Impurity | 154093-72-8 | C13H9F2NO4 | 281.22 | 1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-hydroxy-4-oxo-3-quinolinecarboxylic Acid; Moxifloxacin 8-Hydroxy Quinolic Acid; |
Moxifloxacin Ethyl Ester | 1403836-23-6 | C23H28FN3O4 | 429.5 | |
Moxifloxacin acyl sulfate | 1217665-86-5 | C21H24FN3O7S | 481.5 | sulfo 7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylate; |
Moxifloxacin acyl glucuronide | 733002-61-4 | C27H32FN3O10 | 577.56 | 1-[1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylate] b-D-glucopyranuronic acid |
Moxifloxacin | 151096-09-2 | C21H24FN3O4 | 401.43 | Avelox |
Morpholino C monomer | 1155373-31-1 | C37H37ClN5O5P | 698.15 | (6-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate |
Moxidectin | 113507-06-5 | C37H53NO8 | 639.82 | ProHeart 6; CL301423; Cydectin |
Moxicoumone | 17692-56-7 | C22H30N2O6 | 418.4834;g/mol | Moxicoumone;17692-56-7;UNII-IG2442S013;Mossicoumone;Moxicoumonum;Moxicumona |
MOTRETINIDE | 56281-36-8 | C23H31NO2 | 353.49774 | MOTRETINIDE; N-Ethyl-9-[4-methoxy-2,3,6-trimethylphenyl]-3,7-dimethyl-2,4,6,8-nonatetraenamide; (2E,4E,6E,8E)-N-Ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetrenamide; Tasmaderm |
Morpholino A monomer | 1155373-30-0 | C38H37ClN7O4P | 722.17 | |
Morpholine-3-acetic acid methyl ester HCl | 885273-89-2 | C7H14ClNO3 | 195.64 | 3-Morpholineacetic acid methyl ester; Morpholine-3-acetic acid methyl ester; Morpholine-3-acetic acid methyl ester hydrochloride |
Morpholine-3,4-dicarboxylic acid 4-tert-butyl ester | 212650-43-6 | C10H17NO5 | 231.25 | 4-N-BOC-3-MORPHOLINECARBOXYLIC ACID; 4-(TERT-BUTOXYCARBONYL)MORPHOLINE-3-CARBOXYLIC ACID; MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER; (S)-Morpholine-3,4-dicarboxylic acid 4-tert-butyl; Morpholine-3,4-dicarboxylic acid 4-tert-butyl; N-Boc-Morpholi |
Nor Lidocaine Hydrochloride | 7729-94-4 | C12H19ClN2O | 242.75 | Monoethylglycinexylidide hydrochloride; Monoethylglycinexylidine HCl (Impurity D); MEGX hydrochloride |
Monoquat-D3 iodide | 22884-38-4 | 1-Methyl-D3-4-(pyrid-4- yl)pyridinium iodide | ||
Montelukast-d6 | 1093746-29-2 | C35H30ClNO3SD6 | 592.24 | 1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl-d6)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid |
Montelukast-Acyl-Glucuronide | 188717-17-1 | C41H44ClNO9S | 762.31 | 1-O-[2-[1-[[(R)-1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(1-methyl-1-hydroxyethyl)phenyl]propylthio]methyl]cyclopropan-1-yl]acetyl]-beta-D-glucopyranuronic acid |
Montelukast Sulfoxide Sodium | 909796-71-0 | C35H35ClNNaO4S | 624.19 | Cyclopropaneacetic acid, 1-[[[1-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]-, sodium salt (1:1) |
Montelukast Methyl Ester | 855473-51-7 | C36H38ClNO3S | 600.21 | 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid Methyl Ester |
Montelukast Sulfoxide (Mixture of Diastereomers) | 909849-96-3 | C35H36ClNO4S | 602.2 | 1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]cyclopropaneacetic Acid; Montelukast M2; Montelukast EP Impurity C; |
Montelukast Sulfone | 1266620-74-9 | C35H36ClNO5S | 618.18 | 1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfonyl]methyl]cyclopropaneacetic Acid; |
Montelukast Sodium Salt | 151767-02-1 | C35H36ClNO3S.Na | 608.17 | MK-0476; MK 0476; MK0476 |
Montelukast S-Enantiomer Sodium Salt | 190078-45-6 | C35H35ClNO3S. Na | 585.19 22.99 | 1-[[[(1S)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid Sodium Salt; L 768232; Montelukast EP Impurity A; |
Montelukast Related Impurity 6 | 1187586-63-5 | C29H26ClNO | 439.99 | |
Montelukast Impurity 5 | 133772-82-4 | C28H24ClNO3 | 457.95 | Montelukast Related Impurity 5 |
Montelukast Related Impurity 4 | 142569-69-5 | C28H24ClNO3 | 457.96 | 2-[3-(S)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]benzoic Acid Methyl Ester; |
Montelukast Related Impurity 3 | 150026-72-5 | C28H24ClNO3 | 457.96 | 2-[3-(R)-[3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl]-3-hydroxypropyl]benzoic Acid Methyl Ester; |
Montelukast Related Impurity 2 | 149968-11-6 | C28H22ClNO3 | 455.95 | 2-[3-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoic Acid Methyl Ester; Methyl (E)-2-[3-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-oxopropyl]benzoate; |
Montelukast Related Impurity 1 | 1258428-71-5 | C29H26ClNO2 | 455.99 | 1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]-1-propanone; |
Montelukast Methylstyrene Impurity | 918972-54-0 | C35H34ClNO2S | 568.18 | Montelukast Styrene; 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-methylethenyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid; Montelukast Impurity; Montelukast EP Impurity B; |
Montelukast Methyl Ketone | 937275-23-5 | C34H32ClNO3S | 570.16 | 1-[[[(1R)-3-(2-Acetylphenyl)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]propyl]thio]methyl]cyclopropaneacetic Acid; Montelukast EP Impurity F; |
Montelukast Methyl Ether | 1351973-25-5 | C36H38ClNO3S | 600.23 | 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-methoxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid ; |
Montelukast Impurity H | 851755-56-1 | C34H32ClNO4S | 586.16 | 2-[(3R)-3-[[[1-(Carboxymethyl)cyclopropyl]methyl]thio]-3-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl]phenyl]propyl]benzoic Acid 1-Methyl Ester; Montelukast Impurity H; (R)-2-[1-[[[1-[3-[(E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(methoxycarbonyl)phen |
Montelukast Dihydro Impurity | 142147-98-6 | C35H38ClNO3S | 588.22 | (R)-1-[[[1-[3-[2-(7-Chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic Acid Monosodium Salt; |
Montelukast Dicyclohexylamine Salt | 577953-88-9 | C47H59ClN2O3S | 767.50 | 1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic N-Cyclohexylcyclohexanamine; Montelukast DCHA |
Montelukast Cyclopropacetaneamide Impurity | 866923-63-9 | C35H37ClN2O2S | 585.21 | 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneacetamide; |
Montelukast CN Impurity | 866923-62-8 | C35H35ClN2OS | 567.2 | Montelukast Cyclopropaneacetonitrile; 1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetonitrile; |
Montelukast Chloro Alcohol Impurity | 880769-28-8 | C29H27Cl2NO | 476.45 | 2-[2-[(3S)-3-[3-[(1E)-2-(7-Chloroquinolin-2-yl)ethenyl]phenyl]-3-chloropropyl]phenyl]-2-propanol |
(R,R)-Montelukast Bis-sulfide | 1187586-61-3 | C41H46ClNO5S2 | 732.39 | 1-[[[(1R)-1-[3-[(1R)-1-[[[1-(Carboxymethyl)cyclopropyl]methyl]thio]-2-(7-chloro-2-quinolinyl)ethyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]-cyclopropaneacetic acid; Montelukast EP Impurity D; Montelukast USP Related Compound C |
Montelukast 1, 2-Diol | 186352-97-6 | C35H36ClNO4S | 602.2 | 1-[1-[[[(1R)-1-[3-[(1E)-2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-3-[2-(1,2-diol-2-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic; |
Montelukast | 158966-92-8 | C35H36ClNO3S | 586.18 | Singulair; sodium 1-(((1-(3-(2-(7-chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropylacetate |
Montan wax | 8002-53-7 | 0 | MONTAN WAX | |
Monostearyl Maleate | 2424-62-6 | C22H40O4 | 368.558 | Monostearyl Fumarate; (Z)-4-octadecoxy-4-oxobut-2-enoic acid |
Monosodium phosphate | 7558-80-7 | NaH2PO4 | 119.976 | Sodium Phosphate Monobasic; Dihydrogen Monosodium Phosphate |
Monosodium acid methane arsonate sesquihydrate | 2163-80-6 | CH4AsNaO3 | 161.95200 | |
Monophosphoryl Lipid A | 1246298-63-4 | C96H181N2O22P | 1746.44 | Monophosphoryl hexaacyl disaccharide; Glycopyranoside Lipid A; Monophosphoryl Lipid A; GLA; MPLA |
Monophosphoryl 3-deacyl Lipid A ammonium salt | 1699735-79-9 | C82H155N2O20P NH3 | 1537.11 | |
Monomyristin | 589-68-4 | C17H34O4 | 302.455 | 2,3-Dihydroxypropyl tetradecanoate; 1-Myristoyl-rac-glycerol; Glyceryl monomyristate |
Monomethylsulochrin | 10056-14-1 | C18H18O7 | 346.33 | methyl 5-hydroxy-2-(2-hydroxy-6-methoxy-4-methylbenzoyl)-3-methoxybenzoate |
Monomethyl sulfate | 75-93-4 | CH4O4S | 112.10506 | methyl hydrogen sulphate; Methyl Hydrogen Sulfate; monomethyl sulfate; (Sulfooxy)methane; Sulfuric acid hydrogen methyl ester; Sulfuric acid methyl ester |
Monomethyl lithospermate B | 122021-74-3 | C36H28MgO16 | 740.9 | |
Monomethyl kolavate | 24513-41-5 | C21H32O4 | 348.5 | (-)- 5,9-Dimethyl-17,19-dinor-8betaH-labda-3,13-diene-15,18-dioic acid 15-methyl ester; (4aR,5S,6R,8aR)-5-[(3E)-5-Methoxy-3-methyl-5-oxo-3-penten-1-yl]-5 ,6,8a-trimethyl-3,4,4a,5,6,7,8,8a-octahydro-1-naphthalenecarboxyl ic acid |
Monomethyl Fumarate-d5 | 1616345-45-9 | C5HO4D5 | 135.13 | Fumaric Acid Monomethyl Ester-d5; (2E)-2-Butenedioic Acid 1-Methyl Ester-d5; (E)-2-Butenedioic Acid Monomethyl Ester-d5; Fumaric Acid Methyl Ester-d5; Methyl Hydrogen Fumarate-d5 |
Monomethyl Fumarate D3 | 1616345-41-5 | C5H3D3O4 | 133.12 | (2E)-2-Butenedioic Acid 1-Methyl Ester-d3; (E)-2-Butenedioic Acid Monomethyl Ester-d3; Fumaric Acid Methyl Ester-d3; Methyl Hydrogen Fumarate-d3; Monomethyl Fumarate-d3 |
Monofucosyllacto-N-hexaose III | 96656-34-7 | C46H78N2O35 | 1219.12 | MLFNH III |
Monofucosyl-para-lacto-N-hexaose IV | 115236-58-3 | C46H78N2O35 | 1219.12 | |
Monohydroxy Etravirine | 1246815-68-8 | C20H15BrN6O2 | 451.29 | Monohydroxy Etravirine; |
Monoglycerides,palm-oil monoglycerides and diglycerides, hydrogenated | 67784-87-6 | |||
Monofucosyl-para-lacto-N-hexaose II | 115236-59-4 | C46H78N2O35 | 1219.10 | MFpLNH I; Lewis a heptasaccharide linear |
Monofucosyllacto-N-hexaose II | 1240020-24-9 | C46H78N2O35 | 1219.10 | MFLNH II; Lewis a heptasaccharide branched |
Monofucosyllacto-N-hexaose I | 341511-38-4 | C46H78N2O35 | 1219.10 | MFLNH I; Lewis c heptasaccharide branched |
Monofucosyl (1-3)-iso-lacto-N-octaose | 692776-59-3 | C60H101N3O45 | 1584.44 | MFiLNO (1-3) |
Monoethyl-d5 Fumarate | 1266398-64-4 | C6H3O4D5 | 149.16 | Fumaric Acid Monoethyl-d5 Ester; (2E)-2-Butenedioic Acid 1-Ethyl-d5 Ester; (2E)-2-Butenedioic Acid Monoethyl-d5 Ester; Fumaric Acid-d5 Ethyl Ester; (E)-4-(Ethoxy-d5)-4-oxo-2-butenoic Acid; Ethyl-d5 Hydrogen Fumarate; Monoethyl-d5 trans-2-Butenedioate |
Mono-ethyl malonate-1,2,3-13C3 | 1189981-54-1 | (13C)C2H8O4 | 135.14 | MONO-ETHYL MALONATE-1,2,3-13C3 |
Monoethyl Glycinexylidine-d6 HCl | 1216698-89-3 | C12H13ClN2OD6 | 248.79 | N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide-d6 Hydrochloride; |
Monoacerein (5-Acetyl Rhein) | 875535-35-6 | C17H10O7 | 326.27 | |
Monoethyl Glycinexylidide | 7728-40-7 | C12H18N2O | 206.28 | MGEX; Monoethylglycinexylidide; N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide; Norlidocaine; L-86; N-Ethylglycinexylidide; 2-(Ethylamino)-2',6'-acetoxylidide |
MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE | 218131-11-4 | 0 | POLYDIMETHYLSILOXANE, MONODICARBINOL TERMINATED; MONODICARBINOL TERMINATED POLYDIMETHYLSILOXANE; POLYDIMETHYLSILOXANE, MONODICARBINOL TERMINATED: VISCOSITY 100-125 CST.; POLY(DIMETHYLSILOXANE), MONODICARBINOL TERMINATED: VISCOSITY 50-60 CST.; VISCOSITY 50 | |
MonoCrotophos | 6923-22-4 | C7H14NO5P | 223.16 | (E)-Dimethyl 1-methyl-3-(methylamino)-3-oxo-1-propenyl phosphate; 3-(Dimethoxyphosphinyloxy)N-methyl-cis-crotonamide; 3-Hydroxy-N-methyl-cis-crotonamide dimethyl phosphate; Apadrin; Azadrin; Azodrin insecticide; Azodrin-71; Bilobran |
Monocrotaline N-Oxide | 35337-98-5 | C16H23NO7 | 341.36 | Monocrotaline Oxide |
MONOCROTALINE | 315-22-0 | C16H23NO6 | 325.36 | MONOCROTALIN; MONOCROTALINE; CROTALIN; CROTALINE; (13-alpha,14-alpha)-14,19-dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dio; (13-alpha,14-alpha)-14,19-Dihydro-12,13-dihydroxy-20-norcrotalanan-11,15-dione; (2,3,4-gh)pyrrolizine-2,6(3h)-dione,(4,5,8,10,1 |
Mono-chloroboranedioxane | 235420-96-9 | C4H10BClO2 | 136.385 | |
Monochlorobimane | 76421-73-3 | C10H11ClN2O2 | 226.66 | mBCl; NSC 602733; Thiolyte MC |
MONOCHLOROACETYLENE | 593-63-5 | C2H Cl | 60.47 | chloroethyne; Chloroethyne; Ethyne,chloro-; Monochloroacetylene; Chloroacetylene; Acetylene,chloro- |
MONOCARBINOL TERMINATED POLYDIMETHYLSILOXANE | 207308-30-3 | 0 | POLYDIMETHYLSILOXANE, MONOCARBINOL TERMINATED; MONOCARBINOL TERMINATED POLYDIMETHYSILOXANE; MONOCARBINOL TERMINATED POLYDIMETHYLSILOXANE; POLYDIMETHYLSILOXANE, MONOCARBINOL TERMINATED: VISCOSITY 80-90 CST.; VISCOSITY 80-90 CST.; MONOCARBINOL TERMINATED PO | |
Monocaprylin | 26402-26-6 | C11H22O4 | 218.29 | Glycerylcaprylate; monooctanoin; octanoicacid,monoesterwith; Octanoicacid,monoesterwith1,2,3-propanetriol; OCTANOIN; MONOCAPRYLIN |
Mono-6-O-(p-toluenesulfonyl)-gamma-cyclodextrin | 97227-33-3 | C55H86O42S | 1451.31 | |
Mono-6-O-(p-toluenesulfonyl)-b-cyclodextrin | 67217-55-4 | C49H76O37S | 1289.17 | 6-O-(p-Toluenesulfonyl)-bCD |
Mono-6-O-(p-toluenesulfonyl)-a-cyclodextrin | 32860-56-3 | C43H66O32S | 1127.03 | 6-O-(p-toluenesulfonyl)-aCD |
MONO-2-(METHACRYLOYLOXY)ETHYL SUCCINATE | 20882-04-6 | C10H14O6 | 230.21 | MONO-2-(METHACRYLOYLOXY)ETHYL SUCCINATE; Butanedioicacid,mono[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]ester; [2-[(2-methyl-1-oxoallyl)oxy]ethyl] hydrogen succinate; [2-(Methacryloyloxy)-ethyl]-hydrogen succinate; 2-METHACRYLOYLOXYETHYL SUCCINIC ACID; 3-[[ |
Monnieriside G | 1401799-34-5 | C21H26O10 | 438.43 | (2R)-2-[1-(beta-D-Glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-4-hydroxy-7-methyl-5H-furo[3,2-g][1]benzopyran-5-one |
MONNA | 1572936-83-4 | C18H14N2O5 | 338.31 | 2-[(4-Methoxy-2-naphthalenyl)amino]-5-nitro-benzoic acid |
Moniliformin | 71376-34-6 | C4HO3Na | 120.00 | 1-Hydroxycyclobut-1-ene-3,4-dione |
Moniliformin | 52591-22-7 | C4HNO3Na | 120.0 | Semisquaric acid sodium salt |
Mogroside I E1 | 88901-39-7 | C36H62O9 | 638.87 | |
Monepantel sulfoxide | 851976-72-2 | C20H13F6N3O3S | 489.391 | N-[1-Cyano-2-(5-cyano-2-trifluoromethylphenoxy)-1-methylethyl]-4-trifluoromethanesufinylbenzamide |
Monepantel | 887148-69-8 | C20H13F6N3O2S | 473.4 | N-[(1S)-1-Cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl]-4-[(trifluoromethyl)thio]benzamide; |
Monensin sodium salt | 22373-78-0 | C36H61NaO11 | 692.85 | Monensin sodium salt |
Monensin A | 17090-79-8 | C36H62O11 | 670.8 | Monensic acid, Lilly 67314, A 3223A |
Monazomycin | 11006-31-8 | C72H133NO22 | 1364.8 | |
Monatin | 146142-94-1 | C14H16N2O5 | 292.29 | (2S,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)pentanedioicacid; Monatin; SCHEMBL2700624; AKOS005145817; 2-Hydroxy-2-(indol-3-ylmethyl)-4-aminoglutaricacid; (S)-4-Hydroxy-4-(1H-indol-3-ylmethyl)-L-glutamicacid |
Monastrol | 254753-54-3 | C14H16N2O3S | 292.353 | Monastrol |
Monastrol | 329689-23-8 | C14H16N2O3S | 292.4 | Ethyl 4-(3-hydroxyphenyl)-6-methyl-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-5-carboxylate |
Monascorubrin | 13283-90-4 | C21H26O5 | 382.46 | |
Monascorubramin | 3627-51-8 | C23H27NO4 | 381.48 | Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1-propenyl)-, [R-(E)]-; Furo[3,2-g]isoquinoline-2,9(7H,9aH)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1E)-1-propenyl-, (9aR)- (9CI); |
moiramide B | 155233-31-1 | C25H49N3O5 | 471.683 | methane; N-[4-[[3-methyl-1-(4-methyl-2,5-dioxopyrrolidin-3-yl)-1-oxobutan-2-yl]amino]-4-oxobutan-2-yl]hexa-2,4-dienamide |
Moguisteine | 119637-67-1 | C16H21NO5S | 339.41 | N/A |
Mogroside VI | 89590-98-7 | C54H92O24 | 1125.29 | |
Mitoxantrone | 65271-80-9 | C22H28N4O6 | 444.48 | |
Mitotane | 53-19-0 | C14H10Cl4 | 320.04 | NCI-C04933; NCI C04933; NCIC04933 |
Mitosene | 247-67-6 | C11H9N | 155.2 | |
Mitoridine | 3911-19-1 | C20H22N2O2 | 322.41 | (19E)-19,20-Didehydro-12-hydroxyajmalan-17-one; Ajmalan-17-one |
Mitoquinone mesylate, ethanol solution | 845959-50-4 | C38H47O7PS | 678.82 | (10-(4,5-dimethoxy-2-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)decyl)triphenylphosphonium methanesulfonate; MitoQ; Mito Q10; MitoQ10; MitoQ-10; Mitoubiquinone mesylate; Mitoquinone methanesulfonate; Mitoquinone mesylate |
Mitoquidone | 91753-07-0 | C20H13NO2 | 299.32 | |
Mitomycin C | 50-07-7 | C15H18N4O5 | 334.3 | Mitomycin; Mitomycin S; Mitiromycin E; Ametycine; Mitocin C; Mutamycin; NSC 26980 |
Mitomycin A | 4055-39-4 | C16H19N3O6 | 349.34 | Mitiromycin B |
Methylene-Bis Paroxetine (DiHCl salt) | 1292846-10-6 | C39H40F2N2O6.2HCl | 743.68 | |
Methylene Simvastatin | 1449248-72-9 | C25H36O5 | 416.56 | 2''-Desethyl-2''-vinyl Simvastatin |
METHYLENE DIMETHACRYLATE | 4245-38-9 | C9H12O4 | 184.18918 | METHYLENE DIMETHACRYLATE |
Methyl 8-hydroxy-3-(2-methoxy-2-oxoethyl)-6-methyl-9-oxo-9H-furo[3,4-b]chromene-1-carboxylate | 96287-41-1 | C17H14O8 | 346.29 | |
Methyl 5-bromo-1-benzothiophene-2-carboxylate | 7312-11-0 | C10H7BrO2S | 271.13 | METHYL 5-BROMO-1-BENZOTHIOPHENE-2-CARBOXYLATE; 5-Bromo-benzothiophene-2-carboxylic acid; 5-BROMO-BENZO[B]THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER |
Methyl 5-benzoyl-furan-2-carboxylate | 58972-21-7 | C13H10O4 | 230.21 | METHYL-5-BENZOYL-2-FURANCARBOXYLATE; METHYL 5-BENZOYL-FURAN-2-CARBOXYLATE; 5-Methoxycarbonyl-2-furyl phenyl ketone; 5-BENZOYL-FURAN-2-CARBOXYLIC ACID METHYL ESTER |
Methyl 5-amino-5-deoxy-a-D-ribofuranoside | 262600-85-1 | C6H13NO4 | 163.17 | |
METHYL 5-AMINO-2-METHYL-3-NITROBENZOATE | 88132-48-3 | C9H10N2O4 | 210.18700 | |
methyl 5-amino-1H-pyrrolo[2,3-b]pyridine-2-carboxylate | 952182-18-2 | O=C(C1=Cc2c(ncc(c2)N)N1)OC | 191.19 | Methyl 5-amino-1H-pyrrolo[2,3-b]pyridine-2-carboxylate |
Methyl 5-Acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-b-D-galacto-2-nonulopyranosylonate | 934591-76-1 | C25H29NO12S | 567.56 | Methyl (Phenyl 5-Acetamido-7,8,9-tri-O-acetyl-5-N,4-O-carbonyl-3,5-dideoxy-2-thio-D-glycero-b-D-galacto-2-nonulopyranosid)onate |
Zanamivir Azide Triacetate Methyl Ester | 130525-58-5 | C18H24N4O10 | 456.41 | (1S,2R)-1-((2R,3R,4S)-3-acetamido-4-azido-6-(methoxycarbonyl)-3,4-dihydro-2H-pyran-2-yl)propane-1,2,3-triyl triacetate; 5-(acetylamino)-2,6-anhydro-4-azido-3,4,5-trideoxy-, methyl ester, 7,8,9-triacetate; Methyl 5-acetamido-7,8,9-O-triacetyl-2,6-anhydro-4 |
Methyl 5-acetamido-4,7,8,9-tetra-O-benzyl-2-chloro-2,3,5-trideoxy-3-phenylthio-D-erytho-L-gluco-2-nonulopyranosonate | 120308-52-3 | C46H48ClNO8S | 810.39 | 5-(Acetylamino)-2-chloro-2,5-dideoxy-3-S-phenyl-4,7,8,9-tetrakis-O-(phenylmethyl)-3-thio-D-erythro-L-gluco-2-nonulopyranosonic Acid Methyl Ester |
Methyl 2-(pyrazin-2-yl)acetate | 370562-35-9 | C7H8N2O2 | 152.15 | METHYL 2-PYRAZINEACETATE |
Mogroside IVa | 88901-41-1 | C54H92O24 | 1125.29 | |
Mogroside IV | 89590-95-4 | C54H92O24 | 1125.29 | Mogroside IV E |
Mogroside IIIe | 88901-37-5 | C48H82O19 | ||
Mogroside III-A2 | 88901-43-3 | C48H82O19 | 963.15 | |
Mogroside IIIA1 | 88901-42-2 | C48H82O19 | 963.15 | |
Mogroside III | 130567-83-8 | C48H82O19 | 963.15 | (3beta,9beta,10alpha,11alpha,24R)-3-(beta-D-Glucopyranosyloxy)-11,25-dihydroxy-9-methyl-19-norlanost-5-en-24-yl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside |
Mogroside Iie | 88901-38-6 | C42H72O14 | 801.02 | Mogroside II E; 7-OXOMOGROSIDE II E |
Mogroside IIA2 | 88901-45-5 | C42H72O14 | 801.01 | |
Mogroside II A1 | 88901-44-4 | C42H72O14 | 801.01 | |
Mogroside I A1 | 88901-46-6 | C36H62O9 | 638.87 | |
Mogrol | 88930-15-8 | C30H52O4 | 476.742 | (23R)-cucurbit-5-ene-3beta,11alpha,23,25-tetraol |
MOG (35-55) | 149635-73-4 | C118H177N35O29S1 | 2582.01 | Myelin oligodendrocyte glycoprotein |
Mofezolac | 78967-07-4 | C19H17NO5 | 339.345 | Disopain; N-22; N 22; N22 |
Mofegiline HCl | 120635-25-8 | C11H13F2N.HCl | 233.69 | Mofegiline hydrochloride;Mofegiline HCl |
Moexipril-d5 | 1356929-49-1 | C27H29N2O7D5 | 503.61 | (3S)-2-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-(phenyl-d5)propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid; RS-10085-d5 |
Moexiprilat-d5 | 1356840-08-8 | C25H25N2O7D5 | 475.56 | (3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-(phenyl-d5)propyl]amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid; [3S-[2[R*(R*)],3R*]]-2-[2-[(1- Carboxy-3-(phenyl-d5)propyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoqu |
Moexiprilat | 103775-14-0 | C25H30N2O7 | 470.53 | (3S)-2-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylicacid; Moexiprilat; MoexiprilatHydrate |
Moexipril HCl | 82586-52-5 | C27H35ClN2O7 | 535.03 | CI-906, PD-109452-2 |
Moexipril | 103775-10-6 | C27H34N2O7 | 498.57 | 2-[2-[(1-Ethoxycarbonyl-3-phenyl-propyl)amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;(3S)-2-[(2S)-2-[[(1S)-1-carbethoxy-3-phenyl-propyl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;RS 10085; |
Moexipril | 109715-88-0 | C27H34N2O7 | 498.57 | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;CI-925;CI925;Perdix;RS10085;RS-10085;(S)-2-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-6,7-dimethoxy-1 |
Moenomycin complex | 11015-37-5 | C69H107N4O35P (for A) | 1583.6 | Bambermycin, Flavomycin |
MODOWN(R) | 42576-02-3 | C14H9Cl2NO5 | 342.13096;g/mol | methyl5-(2,4-dichlorophenoxy)-2-nitrobenzoate; BIFENOX; Methyl5-(2,4-dichlorophenoxy)-2-nitrobenzoate; Modown; 42576-02-3; CaswellNo.561AA |
Modipafant | 122957-06-6 | C34H29ClN6O3 | 605.09 | UK-80067;UNII-1DMI0E5023;122957-06-6;UK80067;AC1MILSU;(R)-ethyl 4-(2-chlorophenyl)-6-methyl-2-(4-(2-methyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl)-5-(pyridin-2-ylcarbamoyl)-1,4-dihydropyridine-3-carboxylate |
Modaline sulfate | 2856-75-9 | C10H17N3O4S | 275.32 | 2-methyl-3-piperidin-1-ylpyrazine;sulfuric acid MODALINE SULFATE Modaline (sulfate) 2-Methyl-3-piperidinopyrazine monosulfate 2856-75-9 UNII-NH3315AI6E NSC-89277 W3207B W 3207B W 3207 B Pyrazine, 2-methyl-3-piperidino-, sulfate Modaline sulfate |
ML 334 | 1432500-66-7 | C26H26N2O5 | 446.5 | (1S,2R)-2-[[(1S)-1-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-3,4-dihydro-2(1H)-isoquinolinyl]carbonyl]cyclohexanecarboxylic acid |
Modafinil-d5 Acid | 185142-72-6 | C15H9O3SD5 | 279.37 | Modafinil Carboxylate-d5; 2-[Di-(phenyl-d5)-methylsulfinyl]acetic Acid; Modafinil-d5 Acid; Modafinic Acid-d5; |
Modafinil Sulfone | 118779-53-6 | C15H15NO3S | 289.36 | Modafinil EP Impurity B;2-[(Diphenylmethyl)sulfonyl]acetamide; 2-(Benzhydrylsulfonyl)acetamide; |
Modafinil Impurity A | 1329496-95-8 | C15H15NO3S | 289.36 | 2-(benzhydrylsulfonyl)acetamide; Ethanimidic acid, 2-[(diphenylmethyl)sulfonyl]- |
Modafinil EP Impurity C | 63547-25-1 | C16H16O3S | 288.37 | Modafinil Carboxylate Methyl Ester; |
Modafinil Acid Sulfone | 101094-05-7 | C15H14O4S | 290.34 | Modafinil carboxylate sulfone; 2-(benzhydrylsulfinyl)acetic acid; [(Diphenylmethyl)sulfonyl]acetic acid |
Modafinil acid | 63547-24-0 | C15H14O3S | 274.34 | 2-[(Diphenylmethyl)sulfinyl]acetic Acid; Modafinil Acid; Modafinic Acid; USP Modafinil Related Compound A; Modafinil EP Impurity A; |
Moclobemide-N-Oxide | 64544-24-7 | C13H17ClN2O3 | 284.75 | 4-Chloro-N-[2-(4-morpholinyl)ethyl]benzamide N-Oxide; |
Moclobemide | 71320-77-9 | C13H17ClN2O2 | 268.74 | Ro11-1163; Ro 11-1163; Ro111163; Ro-111163; Ro 111163; Moclobemide; brand name: Amira; Aurorix; Clobemix; Depnil; Manerix; 4-chloro-N-(2-morpholin-4-ylethyl)benzamide |
Mocetinostat | 726169-73-9 | C23H20N6O | 396.454 | MGCD-0103; MGCD 0103 |
MNS | 1485-00-3 | C9H7NO4 | 193.16 | MDBN |
MNITMT | 177653-76-8 | C7H8N6O2S | 240.24 | 4-Methyl-3-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-4H-1,2,4-triazole |
MNI-caged-L-glutamate trifluoroacetate salt | 2226362-29-2 | C14H17N3O6·CF3COOH | 437.32 | |
MNI caged kainic acid | 1315378-75-6 | C19H23N3O6 | 389.4 | (2S,3S,4S)-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid 4-methoxy-7-nitro-1H-indolinyl amide |
MMK 1 | 271246-66-3 | C75H123N19O18S | 1610.97 | (4S)-4-[[(2S)-2-amino-4-methylpentanoyl]amino]-5-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxy-3-methylsulfanylpropyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxop |
MMP-2/MMP-9 Inhibitor II | 193807-60-2 | C21H20N2O4S | 396.46 | Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Inhibitor II; (2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide |
MMP-2/MMP-9 Inhibitor I | 193807-58-8 | C21H19NO4S | 381.4 | Matrix Metalloproteinase-2/Matrix Metalloproteinase-9 Inhibitor I; 3-phenyl-2-[(4-phenylphenyl)sulfonylamino]propanoic acid |
MMP-2 Inhibitor II | 869577-51-5 | C16H17NO6S2 | 383.4 | |
MMP-2 Inhibitor I | 10335-69-0 | C18H35NO2 | 297.5 | |
MMP-13 Inhibitor | 544678-85-5 | C22H20F2N4O2 | 410.4 | Collagenase-3 Inhibitor; Matrix Metalloproteinase-13 Inhibitor; 4,6-Pyrimidinedicarboxamide; N4,N6-Bis(4-fluoro-3-methylbenzyl)pyrimidine-4,6-dicarboxamide |
MMP Inhibitor II | 203915-59-7 | C21H27N3O8S2 | 513.6 | Matrix Metalloproteinase Inhibitor II; NHDDPC; PG 117025; PGE 4410186; N-hydroxy-1,3-bis[(4-methoxyphenyl)sulfonyl]-5,5-dimethyl-1,3-diazinane-2-carboxamide |
m-Methoxytopolin-9-glucoside | 1226978-21-7 | C19H23N5O6 | 417.42 | 6-(3-Methoxybenzylamino)-9-b-Dglucopyranosylpurine |
MM-22 | 956605-71-3 | C36H60N4O5S | 660.95 | (3aS,4S,6aR)-Hexahydro-2-oxo-N-[2-[2-[2-[[(5Z,8Z,11Z,14Z)-1-oxo-5,8,11,14-eicosatetraen-1-yl]amino]ethoxy]ethoxy]ethyl]-1H-thieno[3,4-d]imidazole-4-pentanamide |
MM-206 | 1809581-87-0 | C22H12F5NO3S2 | 497.5 | 2,3,4,5,6-Pentafluoro-N-(4-hydroxy-3-phenylsulfanylnaphthalen-1-yl)benzenesulfonamide |
MM-102 | 1417329-24-8 | C35H49F2N7O4 | 669.8 | HMTase Inhibitor IX |